<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Sample Articles</title>

  <!-- Bootstrap CSS -->
  <link
    href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.1/dist/css/bootstrap.min.css"
    rel="stylesheet"
  />

  <!-- FontAwesome Icons -->
  <link
    rel="stylesheet"
    href="https://pro.fontawesome.com/releases/v5.10.0/css/all.css"
  />

  <!-- Favicon (Optional) -->
  <link rel="icon" href="./assets/images/favicon.png" type="image/png" sizes="64x64" />
  <link rel="shortcut icon" href="./assets/images/favicon.png" type="image/png" sizes="64x64" />
  <link rel="apple-touch-icon" href="./assets/images/favicon.png" type="image/png" />

  <!-- Additional CSS (Optional) -->
  <link rel="stylesheet" href="./assets/css/style.css" />

  <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">

    <link rel="icon" href="./assets/images/favicon.png" type="image/gif" sizes="64x64">
    <link rel="shortcut icon" href="./assets/images/favicon.png" type="image/gif" sizes="64x64">
    <link rel="apple-touch-icon" href="./assets/images/favicon.png" type="image/gif">


    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700&display=swap" />
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.2/dist/css/bootstrap.min.css" rel="stylesheet"
        integrity="sha384-EVSTQN3/azprG1Anm3QDgpJLIm9Nao0Yz1ztcQTwFspd3yD65VohhpuuCOmLASjC" crossorigin="anonymous">
    <link rel="stylesheet" href="https://pro.fontawesome.com/releases/v5.10.0/css/all.css"
        integrity="sha384-AYmEC3Yw5cVb3ZcuHtOA93w35dYTsvhLPVnYs9eStHfGJvOvKxVfELGroGkvsg+p" crossorigin="anonymous" />

    <link href="https://unpkg.com/@yaireo/tagify/dist/tagify.css" rel="stylesheet" type="text/css" />

    

  <style>
    /* ========== Navbar Shadow ========== */
    .navbar-shadow {
      box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    }

    /* ========== Card Hover Effects ========== */
    .article-card {
      height: auto;
      display: flex;
      flex-direction: column;
      opacity: 0; /* Initial animation state */
      transform: translateX(-20px);
      animation: fadeInLeft 0.8s ease-out forwards;
    }


    .article-card .card {
      width: 100%;
      display: flex;
      flex-direction: column;
      height: auto;
      box-shadow: 0 4px 8px rgba(0, 0, 0, 0.1);
      transition: transform 0.3s ease;
    }

    .article-card .card:hover {
      transform: translateY(-5px) scale(1.02);
    }

    .article-card .card-img-top {
      height: 180px;
      object-fit: cover;
    }

    .article-card .card-body {
      flex-grow: 1;
      display: flex;
      flex-direction: column;
    }

    .article-card .card-text {
      flex-grow: 1;
    }

    .article-card .read-more-btn {
      margin-top: auto;
    }

    .col-md-4 {
  display: flex;
  flex-direction: column;
  margin-bottom: 20px;
}

    


.equal-height-row {
  display: flex;
  flex-wrap: wrap;
}

.equal-height-row > [class*='col-'] {
  display: flex;
  flex-direction: column;
}

/* Let the card size by its content (no flex:1) */
.equal-height-row .card {
  display: flex;
  flex-direction: column;
}

/* Force the button down inside the card, but do NOT force the entire card to match the tallest card */
.equal-height-row .card-body {
  display: flex;
  flex-direction: column;
  flex-grow: 1; /* This grows inside the card, but not the entire card itself */
}

.equal-height-row .read-more-btn {
  margin-top: auto; /* pushes the button to the bottom of the card body */
}

  </style>
</head>

<body>     <!-- Navbar Start -->
  <div class="navbar-shadow">
    <div class="container">
      <nav class="navbar navbar-expand-lg navbar-light">
          <div class="logo" style="
          font-family: Arial, sans-serif; 
          font-size: 24px; 
          font-weight: bold;
          background: linear-gradient(to right, #337EFF, #8E5CFF);
          -webkit-background-clip: text;
          -webkit-text-fill-color: transparent;
      ">
          MediMind AI
      </div>
      
      
          <!-- Toggler (for mobile view) -->
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse"
            data-bs-target="#navbarSupportedContent" aria-controls="navbarSupportedContent"
            aria-expanded="false" aria-label="Toggle navigation">
            <span class="navbar-toggler-icon"></span>
          </button>
  
          <!-- Navbar Items -->
          <div class="collapse navbar-collapse" id="navbarSupportedContent">
  
            <!-- Main Nav Links -->
            <ul class="navbar-nav me-auto mb-2 mb-lg-0 mx-auto">
              <li class="nav-item">
                <a class="nav-link" href="index.html">Home</a>
              </li>
              <li class="nav-item">
                <a class="nav-link" href="heart-checkup.html">Heart Checkup</a>
              </li>
              <li class="nav-item">
                <a class="nav-link text-danger" href="Covid.html">Covid-19</a>
              </li>
              <li class="nav-item">
                <a class="nav-link text-danger" href="about.html">About Us</a>
              </li>
            </ul>
  
            <!-- Search Bar -->
            <form class="d-flex me-3">
              <!-- Optionally limit the input width -->
              <input class="form-control me-2" type="search" placeholder="Search..." aria-label="Search"
                     style="max-width: 200px;">
              <button class="btn btn-outline-success" type="submit">
                <i class="fas fa-search"></i>
              </button>
            </form>
  
            <!-- Services Dropdown -->
            <div class="dropdown me-3">
              <button class="btn btn-danger dropdown-toggle" type="button" id="servicesDropdown"
                data-bs-toggle="dropdown" aria-expanded="false">
                Services
              </button>
              <ul class="dropdown-menu" aria-labelledby="servicesDropdown">
                <li><a class="dropdown-item" href="cancer.html">Cancer</a></li>
             
              </ul>
            </div>
  
            <!-- Dark Mode Toggle (Optional) -->
            <button class="btn btn-secondary me-3" onclick="toggleTheme()">
              <i class="fas fa-adjust"></i>
            </button>
  
          
  
          </div>
        </div>
      </nav>
    </div>
  </div>
  <!-- Navbar End -->
  

  <!-- Health Tips and Articles Section -->
  <section class="health-tips-section py-5">
    <div class="container">
        <h2 class="text-center mb-4">Cancer Treatments</h2>
        <div class="row mb-4">
            <div class="col-md-8 mx-auto">
                <input type="text" id="searchInput" class="form-control"
                    placeholder="Search for articles by keywords or categories...">
            </div>
        </div>



<!-- No Results Found (hidden by default) -->
<div id="noResults" class="mt-3 text-center" style="display: none;">
<div class="alert alert-warning" role="alert">
No results found
</div>
</div>

<script>
  function scrollToSearch() {
    if (document.getElementById("searchInput").value.length > 0) {
      window.scrollTo({
        top: 0, 
        behavior: "smooth"
      });
    }
  }
</script>


<div class="row equal-height-row" id="articlesContainer">
  <!-- 1) Acute Lymphoblastic Leukemia (ALL) Card -->
  <div class="col-md-4 mb-4 article-card" data-category="all">
    <div class="card">
      <img
        src="https://www.aptitudehealth.com/wp-content/uploads/2020/01/Aptitude-Health-acute-lymphoblastic-leukemia-Post-2020.jpg"
        class="card-img-top"
        alt="Acute Lymphoblastic Leukemia (ALL)"
      />
      <div class="card-body">
        <h5 class="card-title">Acute Lymphoblastic Leukemia (ALL)</h5>
        <!-- Short Text -->
        <p class="card-text short-text">
          A fast-growing blood cancer that affects immature white blood cells (lymphocytes), 
          often seen in children and young adults.
        </p>
        <!-- Full Text (hidden by default) -->
        <p class="card-text full-text" style="display: none;">
          <strong>Overview:</strong><br>
          Acute Lymphoblastic Leukemia (ALL) is a cancer of the bone marrow and blood, characterized by the overproduction of immature lymphocytes.
          
          <br><br><strong>Causes:</strong>
          <ul>
            <li>Genetic abnormalities (e.g., certain chromosomal changes)</li>
            <li>Exposure to high levels of radiation</li>
            <li>Family history of leukemia</li>
          </ul>

          <strong>Symptoms:</strong>
          <ul>
            <li>Fatigue and weakness</li>
            <li>Frequent infections or fever</li>
            <li>Easy bruising or bleeding (nosebleeds, gums)</li>
            <li>Pain in bones or joints</li>
          </ul>

          <strong>Diagnosis:</strong>
          <ul>
            <li>Complete blood count (CBC) and blood smear</li>
            <li>Bone marrow biopsy</li>
            <li>Genetic and molecular testing</li>
          </ul>

          <strong>Treatment:</strong>
          <ul>
            <li>Chemotherapy (mainstay of treatment)</li>
            <li>Targeted therapies (e.g., monoclonal antibodies)</li>
            <li>Radiation therapy (in some cases)</li>
            <li>Stem cell transplant (for high-risk cases)</li>
          </ul>

          <strong>Prevention:</strong>
          <ul>
            <li>Generally not preventable due to genetic factors</li>
            <li>Minimize unnecessary exposure to radiation/chemicals</li>
            <li>Maintain a healthy lifestyle for overall well-being</li>
          </ul>

          <strong>References:</strong>
          <ol>
            <li><a href="https://www.cancer.gov/types/leukemia/patient/adult-all-treatment-pdq">NCI: ALL Treatment</a></li>
            <li><a href="https://www.lls.org/leukemia/acute-lymphoblastic-leukemia">Leukemia & Lymphoma Society: ALL</a></li>
          </ol>
        </p>
        <button class="btn btn-primary read-more-btn">Read More</button>
      </div>
    </div>
  </div>

  <!-- 2) Acute Myeloid Leukemia (AML) Card -->
  <div class="col-md-4 mb-4 article-card" data-category="aml">
    <div class="card">
      <img
        src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSN-YfyTsrJIv_N7yb0MZ4BZ080JBADLhwrmg&s"
        class="card-img-top"
        alt="Acute Myeloid Leukemia (AML)"
      />
      <div class="card-body">
        <h5 class="card-title">Acute Myeloid Leukemia (AML)</h5>
        <!-- Short Text -->
        <p class="card-text short-text">
          A type of cancer that starts in the bone marrow’s myeloid cells, leading to rapid abnormal cell growth.
        </p>
        <!-- Full Text (hidden by default) -->
        <p class="card-text full-text" style="display: none;">
          <strong>Overview:</strong><br>
          Acute Myeloid Leukemia (AML) involves the overproduction of immature myeloid cells, 
          affecting red cells, white cells, and platelets.

          <br><br><strong>Causes:</strong>
          <ul>
            <li>Genetic mutations or chromosomal abnormalities</li>
            <li>Exposure to certain chemicals (e.g., benzene)</li>
            <li>Previous chemotherapy or radiation therapy</li>
          </ul>

          <strong>Symptoms:</strong>
          <ul>
            <li>Anemia (fatigue, paleness, shortness of breath)</li>
            <li>Recurrent infections or fevers</li>
            <li>Bleeding or bruising easily</li>
            <li>Bone or joint pain</li>
          </ul>

          <strong>Diagnosis:</strong>
          <ul>
            <li>Blood tests (CBC, peripheral smear)</li>
            <li>Bone marrow aspiration and biopsy</li>
            <li>Genetic and cytogenetic analysis</li>
          </ul>

          <strong>Treatment:</strong>
          <ul>
            <li>Intensive chemotherapy (induction therapy)</li>
            <li>Consolidation therapy with additional chemo or stem cell transplant</li>
            <li>Targeted therapies (FLT3 inhibitors, IDH inhibitors)</li>
          </ul>

          <strong>Prevention:</strong>
          <ul>
            <li>Limit exposure to known carcinogens (e.g., benzene)</li>
            <li>Regular check-ups if at higher risk</li>
            <li>Maintain overall healthy lifestyle</li>
          </ul>

          <strong>References:</strong>
          <ol>
            <li><a href="https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq">NCI: AML Treatment</a></li>
            <li><a href="https://www.lls.org/leukemia/acute-myeloid-leukemia">Leukemia & Lymphoma Society: AML</a></li>
          </ol>
        </p>
        <button class="btn btn-primary read-more-btn">Read More</button>
      </div>
    </div>
  </div>

  <!-- 3) Adolescents, Cancer in -->
  <div class="col-md-4 mb-4 article-card" data-category="adolescent-cancer">
    <div class="card">
      <img
        src="https://www.healthychildren.org/SiteCollectionImagesArticleImages/CANCER_TEEN_CHILD_ARTICLE.jpg?RenditionID=3"
        class="card-img-top"
        alt="Adolescents, Cancer in"
      />
      <div class="card-body">
        <h5 class="card-title">Adolescents, Cancer in</h5>
        <!-- Short Text -->
        <p class="card-text short-text">
          Teenagers and young adults face unique challenges when diagnosed with cancer, including social, emotional, and developmental factors.
        </p>
        <!-- Full Text (hidden by default) -->
        <p class="card-text full-text" style="display: none;">
          <strong>Overview:</strong><br>
          Cancer in adolescents often includes leukemias, lymphomas, and certain solid tumors. 
          Early detection and specialized care are crucial.

          <br><br><strong>Causes:</strong>
          <ul>
            <li>Genetic predispositions (e.g., familial syndromes)</li>
            <li>Viral infections (e.g., HPV) for some cancers</li>
            <li>Environmental exposures</li>
          </ul>

          <strong>Symptoms:</strong>
          <ul>
            <li>Unexplained weight loss or fatigue</li>
            <li>Persistent pain or lumps</li>
            <li>Frequent infections or fever</li>
            <li>Changes in moles or skin lesions</li>
          </ul>

          <strong>Diagnosis:</strong>
          <ul>
            <li>Physical exam and medical history</li>
            <li>Imaging (X-ray, MRI, CT) and lab tests</li>
            <li>Biopsy of suspicious areas</li>
          </ul>

          <strong>Treatment:</strong>
          <ul>
            <li>Depends on cancer type (chemotherapy, radiation, surgery)</li>
            <li>Targeted therapy or immunotherapy</li>
            <li>Psychosocial support and counseling</li>
          </ul>

          <strong>Prevention:</strong>
          <ul>
            <li>HPV vaccination to reduce cervical and other cancers</li>
            <li>Healthy lifestyle (diet, exercise, no tobacco)</li>
            <li>Awareness of family history and genetic counseling</li>
          </ul>

          <strong>References:</strong>
          <ol>
            <li><a href="https://www.cancer.gov/types/aya">NCI: Adolescents and Young Adults with Cancer</a></li>
            <li><a href="https://www.who.int/health-topics/cancer#tab=tab_1">WHO: Cancer Overview</a></li>
          </ol>
        </p>
        <button class="btn btn-primary read-more-btn">Read More</button>
      </div>
    </div>
  </div>
<!-- Adrenocortical Carcinoma Card -->
<div class="col-md-4 mb-4 article-card" data-category="cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSUraX3rOe94n8Ve8UQ3u8Vd8IKJ4NCKN1-hw&s"
      class="card-img-top"
      alt="Adrenocortical Carcinoma"
    />
    <div class="card-body">
      <h5 class="card-title">Adrenocortical Carcinoma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare and aggressive cancer that develops in the outer layer (cortex) of the adrenal gland.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Adrenocortical carcinoma (ACC) is an uncommon malignancy arising in the cortex of the adrenal gland. It can produce excess hormones (like cortisol or aldosterone) or be nonfunctional. Often diagnosed at advanced stages, it requires prompt evaluation and management.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic syndromes (e.g., Li-Fraumeni, Beckwith-Wiedemann)</li>
          <li>Inherited gene mutations (TP53, etc.)</li>
          <li>Hormonal imbalances and rare familial conditions</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Signs of excess cortisol (weight gain, high blood pressure, high blood sugar)</li>
          <li>Abdominal or flank pain</li>
          <li>Noticeable lump in the abdomen</li>
          <li>Hormone-related changes (e.g., virilization in women)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Hormonal tests (cortisol, aldosterone, etc.)</li>
          <li>Imaging (CT, MRI) to identify adrenal tumors</li>
          <li>Biopsy (in select cases)</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection (adrenalectomy) if operable</li>
          <li>Mitotane therapy to suppress adrenal function</li>
          <li>Chemotherapy or radiation for advanced disease</li>
        </ul>
        <strong>Prognosis & Follow-Up:</strong>
        <p>
          Prognosis depends on the stage at diagnosis. Early detection can improve outcomes. Lifelong follow-up is often required to manage recurrence or hormonal imbalances.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/adrenocortical" target="_blank">NCI: Adrenocortical Carcinoma</a></li>
          <li><a href="https://www.cancer.org/cancer/adrenal-cancer.html" target="_blank">American Cancer Society: Adrenal Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- AIDS-Related Cancers Card -->
<div class="col-md-4 mb-4 article-card" data-category="cancer">
  <div class="card">
    <img
      src="https://www.mdpi.com/cancers/cancers-16-00546/article_deploy/html/images/cancers-16-00546-g001.png"
      class="card-img-top"
      alt="AIDS-Related Cancers"
    />
    <div class="card-body">
      <h5 class="card-title">AIDS-Related Cancers</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Certain cancers, like Kaposi Sarcoma and lymphomas, are more prevalent in individuals with HIV/AIDS.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        AIDS-related cancers typically occur in people with compromised immune systems due to HIV infection. Common examples include Kaposi Sarcoma, non-Hodgkin lymphoma, and invasive cervical cancer. Early and effective antiretroviral therapy (ART) can lower the risk.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Severe immunosuppression from HIV/AIDS</li>
          <li>Coinfections with oncogenic viruses (e.g., HHV-8, EBV, HPV)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Skin lesions or nodules (Kaposi Sarcoma)</li>
          <li>Swollen lymph nodes, unexplained weight loss</li>
          <li>Fever and night sweats</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Biopsy of suspicious lesions</li>
          <li>HIV status and immune function tests (CD4 count)</li>
          <li>Imaging (CT, MRI) for lymphoma staging</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Antiretroviral therapy (ART) to improve immune function</li>
          <li>Chemotherapy, radiation therapy depending on cancer type</li>
          <li>Immunotherapy in certain cases</li>
        </ul>
        <strong>Prevention & Management:</strong>
        <ul>
          <li>Early HIV diagnosis and consistent ART adherence</li>
          <li>Regular screenings (e.g., cervical cancer screening)</li>
          <li>Lifestyle modifications to strengthen the immune system</li>
        </ul>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hiv-fact-sheet" target="_blank">NCI: HIV and Cancer</a></li>
          <li><a href="https://www.cdc.gov/hiv/clinicians/diagnosis/cancers.html" target="_blank">CDC: HIV-Related Cancers</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Kaposi Sarcoma (Soft Tissue Sarcoma) Card -->
<div class="col-md-4 mb-4 article-card" data-category="cancer">
  <div class="card">
    <img
      src="https://upload.wikimedia.org/wikipedia/commons/1/1c/Kaposis_sarcoma_01.jpg"
      class="card-img-top"
      alt="Kaposi Sarcoma (Soft Tissue Sarcoma)"
    />
    <div class="card-body">
      <h5 class="card-title">Kaposi Sarcoma (Soft Tissue Sarcoma)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare cancer that forms in the lining of blood and lymph vessels, often linked to HHV-8 infection.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Kaposi Sarcoma is a type of soft tissue sarcoma that typically appears as lesions on the skin, mouth, or internal organs. It is frequently associated with immunocompromised individuals (e.g., HIV/AIDS).
        <br /><br />
        <strong>Causes:</strong>
        <ul>
          <li>Human herpesvirus 8 (HHV-8) infection</li>
          <li>Immunosuppression (e.g., HIV/AIDS, organ transplant patients)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Red, purple, or brown skin lesions</li>
          <li>Swelling in the limbs</li>
          <li>Possible GI or respiratory symptoms if internal organs are involved</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Biopsy of skin or organ lesions</li>
          <li>Imaging (X-ray, CT scan) if internal involvement is suspected</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Antiretroviral therapy (ART) in HIV-positive patients</li>
          <li>Local therapies (cryotherapy, radiation) for skin lesions</li>
          <li>Systemic chemotherapy for advanced cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on immune status and extent of disease. Restoring immune function through ART can help control lesion progression in HIV-positive patients.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq" target="_blank">NCI: Kaposi Sarcoma</a></li>
          <li><a href="https://www.cancer.org/cancer/kaposi-sarcoma.html" target="_blank">American Cancer Society: Kaposi Sarcoma</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- AIDS-Related Lymphoma (Lymphoma) Card -->
<div class="col-md-4 mb-4 article-card" data-category="cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS-Y_GK0xHoxo3yOb-4Q8VJkKkWWemGiyQoNg&s"
      class="card-img-top"
      alt="AIDS-Related Lymphoma (Lymphoma)"
    />
    <div class="card-body">
      <h5 class="card-title">AIDS-Related Lymphoma (Lymphoma)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A group of non-Hodgkin lymphomas that occur in individuals with HIV/AIDS and compromised immune systems.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        AIDS-related lymphoma refers to several types of non-Hodgkin lymphoma that develop in people with HIV/AIDS. The weakened immune system allows abnormal lymphocytes to proliferate more easily.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Severe immunosuppression due to HIV infection</li>
          <li>Co-infection with certain viruses (e.g., EBV)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Swollen lymph nodes (neck, groin, armpit)</li>
          <li>Fever, night sweats, unexplained weight loss</li>
          <li>Fatigue and weakness</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Biopsy of lymph nodes or affected tissues</li>
          <li>Imaging (CT, PET scans) to stage lymphoma</li>
          <li>Blood tests including CD4 count and viral load</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Combination chemotherapy (CHOP, EPOCH, etc.)</li>
          <li>Antiretroviral therapy (ART) to improve immune status</li>
          <li>Radiation therapy in certain localized cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on the type of lymphoma, stage at diagnosis, and effectiveness of ART. Early detection and maintaining higher CD4 counts can significantly improve outcomes.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/lymphoma/hp/hiv-related-treatment-pdq" target="_blank">NCI: HIV-Related Lymphoma</a></li>
          <li><a href="https://www.cancer.org/cancer/non-hodgkin-lymphoma.html" target="_blank">American Cancer Society: Non-Hodgkin Lymphoma</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Primary CNS Lymphoma (Lymphoma) Card -->
<div class="col-md-4 mb-4 article-card" data-category="cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQZmqcBn1aUPWQa2byhxtmzHWFSoN5eVPl9bA&s"
      class="card-img-top"
      alt="Primary CNS Lymphoma (Lymphoma)"
    />
    <div class="card-body">
      <h5 class="card-title">Primary CNS Lymphoma (Lymphoma)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare non-Hodgkin lymphoma occurring in the brain, spinal cord, or eye, often linked to immunosuppression.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Primary CNS lymphoma is a non-Hodgkin lymphoma that arises within the central nervous system (CNS). It can affect the brain, spinal cord, or eyes (intraocular lymphoma). It's more common in immunocompromised individuals, such as those with HIV/AIDS.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>HIV/AIDS or other causes of immunodeficiency</li>
          <li>Epstein-Barr virus (EBV) association</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Neurological deficits (weakness, confusion, seizures)</li>
          <li>Vision changes or eye lesions if intraocular</li>
          <li>Headaches, nausea, or vomiting</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI or CT scans of the brain/spine</li>
          <li>Lumbar puncture to analyze cerebrospinal fluid</li>
          <li>Brain biopsy for definitive diagnosis</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>High-dose methotrexate-based chemotherapy</li>
          <li>Radiation therapy in certain cases</li>
          <li>Antiretroviral therapy (ART) if HIV-positive</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on the patient’s immune status and tumor response. Aggressive treatment can yield remission, but close follow-up is necessary due to potential relapse or neurological complications.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/lymphoma/hp/primary-cns-lymphoma-treatment-pdq" target="_blank">NCI: Primary CNS Lymphoma</a></li>
          <li><a href="https://www.cancer.org/cancer/lymphoma.html" target="_blank">American Cancer Society: Lymphoma</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Anal Cancer Card -->
<div class="col-md-4 mb-4 article-card" data-category="cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTsBPjIrTz5EKIAroC1mzmSNVy2UXYD2d7YRg&s"
      class="card-img-top"
      alt="Anal Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Anal Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A malignancy arising in the tissues of the anus, often linked to HPV infection.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Anal cancer forms in the anal canal or around the anal opening. Human papillomavirus (HPV) infection is a key risk factor. Early detection can significantly improve treatment outcomes.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Chronic HPV infection</li>
          <li>Smoking</li>
          <li>Immunosuppression (e.g., HIV)</li>
          <li>History of cervical, vaginal, or vulvar cancer</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Rectal bleeding or blood in stool</li>
          <li>A lump or mass near the anus</li>
          <li>Itching or discharge</li>
          <li>Changes in bowel habits</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Digital rectal exam (DRE)</li>
          <li>Anoscopy or proctoscopy</li>
          <li>Biopsy of suspicious lesions</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Combined chemotherapy and radiation (chemoradiation)</li>
          <li>Surgery for persistent or recurrent tumors</li>
          <li>HPV vaccination to reduce future risk</li>
        </ul>
        <strong>Prognosis & Prevention:</strong>
        <p>
          Prognosis depends on the stage at diagnosis. Early-stage anal cancer often responds well to chemoradiation. Preventive measures include safe sex practices, HPV vaccination, and regular screenings, especially in high-risk groups.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/anal" target="_blank">NCI: Anal Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/anal-cancer.html" target="_blank">American Cancer Society: Anal Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- 1) Appendix Cancer - see Gastrointestinal Neuroendocrine Tumors -->
<div class="col-md-4 mb-4 article-card" data-category="appendix-cancer">
  <div class="card">
    <img
      src="https://www.pathologyoutlines.com/imgau/appendixwdneuroendocrinegross1.jpg"
      class="card-img-top"
      alt="Appendix Cancer - Gastrointestinal Neuroendocrine Tumors"
    />
    <div class="card-body">
      <h5 class="card-title">Appendix Cancer (Gastrointestinal Neuroendocrine Tumors)</h5>
      
      <!-- Short Text -->
      <p class="card-text short-text">
        A rare type of gastrointestinal (GI) tumor often discovered incidentally during imaging or surgery. 
        Commonly known as GI neuroendocrine tumors when arising in the appendix.
      </p>
      
      <!-- Full Text (hidden by default) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br>
        Appendix cancers are uncommon malignancies that can be neuroendocrine in nature. They may not present 
        obvious symptoms until they grow large or spread. Often discovered accidentally during an appendectomy 
        or abdominal scan.
        
        <br><br><strong>Causes:</strong>
        <ul>
          <li>Genetic factors or familial syndromes (rare)</li>
          <li>Possible links to certain endocrine/hormonal imbalances</li>
          <li>Exact cause often unclear</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li>Abdominal pain or discomfort</li>
          <li>Bloating or changes in bowel habits</li>
          <li>In many cases, no symptoms at early stages</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li>Imaging studies (CT, MRI) and colonoscopy</li>
          <li>Biopsy and histopathological analysis</li>
          <li>Blood tests (tumor markers like chromogranin A)</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li>Surgical removal of the appendix or affected section of colon</li>
          <li>Possible chemotherapy or targeted therapy if metastatic</li>
          <li>Follow-up imaging and blood tests to monitor recurrence</li>
        </ul>

        <strong>Prevention:</strong>
        <ul>
          <li>No definitive prevention methods due to rarity</li>
          <li>Routine check-ups if you have a family history of GI tumors</li>
          <li>Healthy lifestyle (balanced diet, exercise) for overall well-being</li>
        </ul>

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/gi-net">NCI: Gastrointestinal Neuroendocrine Tumors</a></li>
          <li><a href="https://www.cancer.org/cancer/gastrointestinal-carcinoid-tumor.html">ACS: GI Carcinoid Tumors</a></li>
        </ol>
      </p>
      
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- 2) Astrocytomas, Childhood (Brain Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="astrocytoma-childhood">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTapaoCE2gCemMZwG3uAQEe3eGEaVxe5JfoRg&s"
      class="card-img-top"
      alt="Astrocytomas, Childhood (Brain Cancer)"
    />
    <div class="card-body">
      <h5 class="card-title">Astrocytomas, Childhood (Brain Cancer)</h5>
      
      <!-- Short Text -->
      <p class="card-text short-text">
        A group of brain tumors in children arising from astrocytes—star-shaped cells in the brain’s supportive tissue.
      </p>
      
      <!-- Full Text (hidden by default) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br>
        Childhood astrocytomas are primary brain tumors that originate from astrocytes. They range from low-grade 
        (slow-growing) to high-grade (fast-growing) and can affect various parts of the central nervous system.
        
        <br><br><strong>Causes:</strong>
        <ul>
          <li>Genetic conditions (e.g., Neurofibromatosis type 1)</li>
          <li>Previous radiation exposure to the head</li>
          <li>Most cases are sporadic with no clear risk factors</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li>Headaches and nausea (often worse in the morning)</li>
          <li>Vision, speech, or balance problems</li>
          <li>Seizures or changes in behavior</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI or CT scan of the brain</li>
          <li>Neurological exams and evaluation of symptoms</li>
          <li>Biopsy or surgical resection for definitive histology</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li>Surgical removal or debulking of the tumor</li>
          <li>Radiation therapy (depending on child’s age and tumor grade)</li>
          <li>Chemotherapy for high-grade or inoperable tumors</li>
          <li>Targeted therapies under clinical trials</li>
        </ul>

        <strong>Prevention:</strong>
        <ul>
          <li>Genetic counseling if there’s a family history of syndromes</li>
          <li>Limit unnecessary exposure to radiation</li>
          <li>Early medical attention if neurological symptoms arise</li>
        </ul>

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/brain/patient/child-astrocytoma-treatment-pdq">NCI: Childhood Astrocytomas</a></li>
          <li><a href="https://www.stjude.org/disease/childhood-astrocytoma.html">St. Jude: Childhood Astrocytoma</a></li>
        </ol>
      </p>
      
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- 3) Atypical Teratoid/Rhabdoid Tumor (AT/RT), Childhood, Central Nervous System (Brain Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="atypical-teratoid-rhabdoid">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTClAo3azYjwRhnuxL0rTAiq7GNkFrJa3ibAQ&s"
      class="card-img-top"
      alt="Atypical Teratoid/Rhabdoid Tumor (AT/RT), Childhood"
    />
    <div class="card-body">
      <h5 class="card-title">Atypical Teratoid/Rhabdoid Tumor (AT/RT), Childhood (CNS)</h5>
      
      <!-- Short Text -->
      <p class="card-text short-text">
        A rare, fast-growing brain tumor found mostly in children under age 3, affecting the central nervous system.
      </p>
      
      <!-- Full Text (hidden by default) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br>
        AT/RT is a highly aggressive tumor that typically originates in the cerebellum or brainstem. It can also 
        appear in the spinal cord. Due to its rapid growth, early detection and treatment are critical.
        
        <br><br><strong>Causes:</strong>
        <ul>
          <li>Often linked to genetic changes (INI1 gene mutations)</li>
          <li>Familial predisposition in very few cases</li>
          <li>Exact etiology is still under research</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li>Increased intracranial pressure (headache, vomiting)</li>
          <li>Difficulty with coordination or walking</li>
          <li>Irritability and changes in behavior in very young children</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI scan to locate tumor and assess extent</li>
          <li>Biopsy or surgical resection for pathology</li>
          <li>Genetic testing (INI1 deletion/mutation)</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li>Multimodal approach: surgery, chemotherapy, radiation (when age-appropriate)</li>
          <li>High-dose chemotherapy with stem cell support in some cases</li>
          <li>Clinical trials for novel targeted therapies</li>
        </ul>

        <strong>Prevention:</strong>
        <ul>
          <li>Currently no known prevention methods</li>
          <li>Genetic counseling if a family history of rhabdoid tumors</li>
          <li>Early medical evaluation for neurological symptoms</li>
        </ul>

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/rare-brain-spine-tumor/atrt">NCI: Atypical Teratoid/Rhabdoid Tumor</a></li>
          <li><a href="https://www.stjude.org/disease/atypical-teratoid-rhabdoid-tumor.html">St. Jude: AT/RT</a></li>
        </ol>
      </p>
      
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<div class="col-md-4 mb-4 article-card" data-category="basal-cell-carcinoma">
  <div class="card">
    <img src="https://upload.wikimedia.org/wikipedia/commons/thumb/1/1a/Superficial_basal_cell_carcinoma.jpg/800px-Superficial_basal_cell_carcinoma.jpg" class="card-img-top" alt="Basal Cell Carcinoma (Skin Cancer)">
    <div class="card-body">
      <h5 class="card-title">Basal Cell Carcinoma (Skin Cancer)</h5>
      <p class="card-text short-text">The most common skin cancer, usually caused by prolonged sun exposure.</p>
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br>
        Basal Cell Carcinoma (BCC) is a slow-growing skin cancer that originates in the basal cells of the epidermis. It rarely spreads but can cause serious local damage.
        
        <br><br><strong>Causes:</strong>
        <ul>
          <li>Prolonged UV radiation from the sun or tanning beds</li>
          <li>Fair skin, light-colored eyes, and a tendency to sunburn</li>
          <li>Genetic conditions like Gorlin syndrome</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li>Pearly or waxy bumps</li>
          <li>Open sores that don’t heal</li>
          <li>Red, scaly patches or shiny nodules</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li>Skin examination by a dermatologist</li>
          <li>Biopsy for histological confirmation</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li>Mohs micrographic surgery (precise tumor removal)</li>
          <li>Cryotherapy (freezing cancer cells)</li>
          <li>Topical chemotherapy or radiation in severe cases</li>
        </ul>

        <strong>Prevention:</strong>
        <ul>
          <li>Use broad-spectrum sunscreen daily</li>
          <li>Avoid prolonged sun exposure</li>
          <li>Regular skin checks for early detection</li>
        </ul>

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.org/cancer/basal-cell-carcinoma.html">American Cancer Society</a></li>
          <li><a href="https://www.skincancer.org/">Skin Cancer Foundation</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<div class="col-md-4 mb-4 article-card" data-category="bile-duct-cancer">
  <div class="card">
    <img src="https://missiongastrohospital.com/wp-content/uploads/2024/04/cholangiocarcinoma.jpg" class="card-img-top" alt="Bile Duct Cancer">
    <div class="card-body">
      <h5 class="card-title">Bile Duct Cancer (Cholangiocarcinoma)</h5>
      <p class="card-text short-text">A rare cancer affecting the bile ducts that transport bile from the liver to the small intestine.</p>
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br>
        Bile duct cancer, or cholangiocarcinoma, occurs in the tubes carrying bile from the liver to the intestine. It is often aggressive and diagnosed late. A rare cancer that starts in the bile ducts, the tubes that carry bile from the liver and gallbladder to the small intestine.
        
        <br><br><strong>Causes:</strong>
        <ul>
          <li>Chronic liver disease (cirrhosis, hepatitis)</li>
          <li>Biliary infections (e.g., liver flukes)</li>
          <li>Primary sclerosing cholangitis (PSC)</li>

        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li>Jaundice (yellowing of skin and eyes)</li>
          <li>Dark urine and pale stools</li>
          <li>Unexplained weight loss and fatigue</li>
         <li> Dark urine and pale stools </li>
<li>Unexplained weight loss and fatigue </li>
<li>Abdominal pain and bloating </li>
<li>Itching (pruritus) </li>
<li>Fever and night sweats </li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li>Blood tests (liver function tests, tumor markers)</li>
          <li>Imaging (MRI, CT scan, ERCP)</li>
          <li>Biopsy for histological analysis</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li>Surgery if detected early</li>
          <li>Radiation and chemotherapy for advanced cases</li>
        </ul>

        <strong>Prevention:</strong>
        <ul>
          <li>Maintain liver health</li>
          <li>Prevent liver infections and inflammation</li>
        </ul>

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/liver/patient/bile-duct-treatment-pdq">National Cancer Institute</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<div class="col-md-4 mb-4 article-card" data-category="bladder-cancer">
  <div class="card">
    <img 
      src="https://images.ctfassets.net/yixw23k2v6vo/7i0XI7TagEgBqSRFpwIhei/80409443925299a762fce7b43bce6751/1024px-Bladder_Cancer.jpg" 
      class="card-img-top" 
      alt="Bladder Cancer" 
    />
    <div class="card-body">
      <h5 class="card-title">Bladder Cancer</h5>
      
      <!-- Short Text (shown by default) -->
      <p class="card-text short-text">
        A malignancy in the lining of the bladder, often linked to smoking and chemical exposures.
      </p>
      
      <!-- Full Text (hidden by default) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br>
        Bladder cancer typically begins in the urothelium (the inner lining of the bladder) and can be **non-muscle invasive** (confined to the lining) or **muscle-invasive** (spread into deeper layers). Early detection often leads to better outcomes, but the disease can recur even after treatment.

        <br><br><strong>Causes:</strong>
        <ul>
     <li><strong>Chemical Exposure:</strong> Certain industrial dyes, paints, rubber, and arsenic in drinking water.</li>
          <li><strong>Chronic Bladder Irritation:</strong> Long-term catheter use or infections.</li>
        
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Hematuria:</strong> Blood in the urine (often painless).</li>
          <li>Frequent or painful urination.</li>
          <li>Pelvic or lower back pain in advanced stages.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Cystoscopy:</strong> A scope used to view the inside of the bladder and take biopsies.</li>
          <li><strong>Urine Cytology:</strong> Examining urine for abnormal cells.</li>
                </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Transurethral Resection (TURBT):</strong> First-line to remove superficial tumors.</li>
          <li><strong>Intravesical Therapy (BCG or chemotherapy):</strong> For non-muscle invasive cases to prevent recurrence.</li>
        
         
        </ul>

        <strong>Prevention:</strong>
        <ul>
           <li>Limit exposure to industrial chemicals (use protective measures).</li>
          <li>Stay hydrated to flush out toxins.</li>
          <li>Regular check-ups if high risk (e.g., history of bladder cancer).</li>
        </ul>

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/bladder">National Cancer Institute: Bladder Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/bladder-cancer.html">American Cancer Society: Bladder Cancer</a></li>
        </ol>
      </p>
      
      <!-- "Read More" Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>



<div class="col-md-4 mb-4 article-card" data-category="bone-cancer">
  <div class="card">
    <img src="https://www.researchgate.net/profile/Stephane-Teletchea/publication/51970235/figure/fig2/AS:305750900527110@1449908103670/Radiographies-of-osteosarcoma-A-and-Ewings-sarcoma-B-Ill-defined-osteolytic-lesion.png" class="card-img-top" alt="Bone Cancer">
    <div class="card-body">
      <h5 class="card-title">Bone Cancer (Includes Ewing Sarcoma & Osteosarcoma)</h5>
      <p class="card-text short-text">A rare but aggressive cancer that affects bone tissues, often in young adults and children.</p>
      <p class="card-text full-text" style="display: none;">
        
        <strong>Overview:</strong><br>
        Bone cancer is an uncommon type of cancer that originates in the bone tissue. The most common forms include **Osteosarcoma**, **Ewing Sarcoma**, and **Malignant Fibrous Histiocytoma (MFH)**. This cancer can be primary (starting in the bone) or secondary (spreading from another site).

        

       

        <br><strong>Symptoms:</strong>
        <ul>
          <li>Persistent bone pain (worse at night)</li>
          <li>Swelling or lumps near bones</li>
          <li>Fractures or bone weakness</li>
       
        </ul>

        <br><strong>Diagnosis:</strong>
        <ul>
          <li><strong>X-ray:</strong> Identifies abnormal bone growth.</li>
          <li><strong>MRI/CT Scan:</strong> Provides a detailed view of tumor size and spread.</li>
          <li><strong>Bone Biopsy:</strong> Confirms the presence of cancerous cells.</li>
          <li><strong>Blood Tests:</strong> Elevated levels of alkaline phosphatase may indicate bone cancer.</li>
        </ul>

        <br><strong>Treatment:</strong>
        <ul>
          <li><strong>Surgery:</strong> Removal of the tumor (sometimes limb-sparing surgery or amputation).</li>
          <li><strong>Chemotherapy:</strong> Used for aggressive cases like osteosarcoma and Ewing sarcoma.</li>
          <li><strong>Radiation Therapy:</strong> Common for Ewing sarcoma to shrink tumors before surgery.</li>
         
        </ul>

        <br><strong>Prevention:</strong>
        <ul>
          <li>Avoid exposure to ionizing radiation unless necessary.</li>
          <li>Regular health screenings if you have a family history of bone cancer.</li>
      
        </ul>

        <br><strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/bone">National Cancer Institute - Bone Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/bone-cancer.html">American Cancer Society</a></li>
        </ol>

      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


  <div class="col-md-4 mb-4 article-card" data-category="brain-tumors">
    <div class="card">
      <img 
        src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSVVDQkI7hpJnxYnpXkJBA9owmLo59GZxRpaA&s"
        class="card-img-top" 
        alt="Brain Tumors"
      />
      <div class="card-body">
        <h5 class="card-title">Brain Tumors</h5>
        <p class="card-text short-text">
          Abnormal growths in or around the brain, which can be benign or malignant, affecting vital functions.
        </p>
        <p class="card-text full-text" style="display: none;">
          <strong>Overview:</strong><br>
          Brain tumors can arise from different cell types in the brain (primary tumors) or spread from cancers elsewhere in the body (metastatic tumors). They vary widely in aggressiveness and prognosis.
          
          <br><br><strong>Causes:</strong>
          <ul>
            <li>Genetic factors (e.g., Neurofibromatosis, Li-Fraumeni syndrome)</li>
            <li>Previous radiation therapy to the head</li>
            <li>Mostly sporadic with no clear risk factors</li>

          </ul>

          <strong>Symptoms:</strong>
          <ul>
            <li>Headaches (often worse in the morning)</li>
            <li>Nausea and vomiting</li>
            <li>Seizures or changes in behavior</li>
            <li>Vision, speech, or balance difficulties</li>
            

          </ul>

          <strong>Diagnosis:</strong>
          <ul>
            <li>Neurological exam and imaging (MRI, CT scan)</li>
            <li>Biopsy or surgical resection for histopathology</li>
            <li>Genetic and molecular testing (e.g., MGMT, IDH1)</li>
          </ul>

          <strong>Treatment:</strong>
          <ul>
            <li><strong>Surgery:</strong> To remove or reduce tumor size</li>
            <li><strong>Radiation Therapy:</strong> External beam or stereotactic radiosurgery</li>
            <li><strong>Chemotherapy:</strong> Temozolomide and other agents</li>
            <li><strong>Targeted Therapy/Immunotherapy:</strong> Depends on tumor genetics</li>
            <li><strong>Supportive Care:</strong> Steroids to reduce swelling, anti-seizure meds</li>
          </ul>

          <strong>Prevention:</strong>
          <ul>
            <li>Limit unnecessary exposure to ionizing radiation</li>
            <li>Genetic counseling if strong family history</li>
            <li>Maintain a healthy lifestyle for overall well-being</li>
          </ul>

          <strong>References:</strong>
          <ol>
            <li><a href="https://www.cancer.gov/types/brain">NCI: Brain Cancer</a></li>
            <li><a href="https://www.who.int/health-topics/brain-tumour">WHO: Brain Tumors</a></li>
          </ol>
        </p>
        <button class="btn btn-primary read-more-btn">Read More</button>
      </div>
    </div>
  </div>

  <!-- 2) Breast Cancer -->
  <div class="col-md-4 mb-4 article-card" data-category="breast-cancer">
    <div class="card">
      <img 
        src="https://d35oenyzp35321.cloudfront.net/Breast_cancer_pink_ribbon_03881df229.jpg"
        class="card-img-top" 
        alt="Breast Cancer"
      />
      <div class="card-body">
        <h5 class="card-title">Breast Cancer</h5>
        <p class="card-text short-text">
          A common cancer originating in breast tissue, often affecting milk ducts or lobules.
        </p>
        <p class="card-text full-text" style="display: none;">
          <strong>Overview:</strong><br>
          Breast cancer is one of the most frequently diagnosed cancers in women, though men can develop it too. Early detection significantly improves outcomes.
          
          <br><br><strong>Causes:</strong>
          <ul>
            <li>Genetic mutations (e.g., BRCA1/BRCA2)</li>
            <li>Hormonal factors (estrogen exposure)</li>
            <li>Lifestyle factors (obesity, lack of exercise)</li>
            <li>Family history of breast cancer</li>
          </ul>

          <strong>Symptoms:</strong>
          <ul>
            <li>Lump or thickening in the breast</li>
            <li>Changes in breast shape or size</li>
            <li>Nipple discharge or inversion</li>
            <li>Redness or dimpling of skin</li>
          </ul>

          <strong>Diagnosis:</strong>
          <ul>
            <li>Mammography, ultrasound, or MRI</li>
            <li>Biopsy for histopathological analysis</li>
            <li>Hormone receptor (ER, PR) and HER2 status testing</li>
          </ul>

          <strong>Treatment:</strong>
          <ul>
            <li><strong>Surgery:</strong> Lumpectomy or mastectomy</li>
            <li><strong>Radiation Therapy:</strong> Often post-surgery</li>
            <li><strong>Chemotherapy:</strong> Before or after surgery depending on stage</li>
            <li><strong>Hormonal Therapy:</strong> Tamoxifen, aromatase inhibitors for ER+ tumors</li>
            <li><strong>Targeted Therapy:</strong> Trastuzumab for HER2+ tumors</li>
          </ul>

          <strong>Prevention:</strong>
          <ul>
            <li>Regular screening (mammograms)</li>
            <li>Healthy diet, maintaining healthy weight</li>
            <li>Physical activity and limited alcohol intake</li>
            <li>Genetic testing/counseling if high-risk</li>
          </ul>

          <strong>References:</strong>
          <ol>
            <li><a href="https://www.cancer.gov/types/breast">NCI: Breast Cancer</a></li>
            <li><a href="https://www.cancer.org/cancer/breast-cancer.html">American Cancer Society</a></li>
          </ol>
        </p>
        <button class="btn btn-primary read-more-btn">Read More</button>
      </div>
    </div>
  </div>

  <!-- 3) Bronchial Tumors (Lung Cancer) -->
  <div class="col-md-4 mb-4 article-card" data-category="bronchial-tumors">
    <div class="card">
      <img 
        src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTUTU-PEyqAOLfDL7LCSUA238G70KhHzEu9bg&s"
        class="card-img-top" 
        alt="Bronchial Tumors (Lung Cancer)"
      />
      <div class="card-body">
        <h5 class="card-title">Bronchial Tumors (Lung Cancer)</h5>
        <p class="card-text short-text">
          Malignant growths in the airways (bronchi), a leading cause of cancer-related deaths worldwide.
        </p>
        <p class="card-text full-text" style="display: none;">
          <strong>Overview:</strong><br>
          Lung cancer often originates in the bronchi or alveoli. There are two main types: **Non-Small Cell Lung Cancer (NSCLC)** and **Small Cell Lung Cancer (SCLC)**.
          
          <br><br><strong>Causes:</strong>
          <ul>
            <li>Smoking (primary risk factor)</li>
            <li>Secondhand smoke exposure</li>
            <li>Occupational hazards (asbestos, radon)</li>
            <li>Genetic predispositions</li>
          </ul>

          <strong>Symptoms:</strong>
          <ul>
            <li>Persistent cough or hoarseness</li>
            <li>Coughing up blood (hemoptysis)</li>
            <li>Shortness of breath or chest pain</li>
            <li>Unexplained weight loss</li>
          </ul>

          <strong>Diagnosis:</strong>
          <ul>
            <li>Chest X-ray and CT scan</li>
            <li>Sputum cytology or bronchoscopy</li>
            <li>Biopsy for histological subtype</li>
          </ul>

          <strong>Treatment:</strong>
          <ul>
            <li><strong>Surgery:</strong> Lobectomy or pneumonectomy for NSCLC</li>
            <li><strong>Radiation Therapy:</strong> For localized tumors or palliative care</li>
            <li><strong>Chemotherapy:</strong> Often first-line for SCLC</li>
            <li><strong>Targeted Therapy:</strong> EGFR, ALK inhibitors in NSCLC with specific mutations</li>
            <li><strong>Immunotherapy:</strong> PD-1/PD-L1 inhibitors (e.g., nivolumab)</li>
          </ul>

          <strong>Prevention:</strong>
          <ul>
            <li>Avoid or quit smoking</li>
            <li>Test homes for radon</li>
            <li>Use protective gear if exposed to industrial pollutants</li>
            <li>Regular check-ups for high-risk individuals</li>
          </ul>

          <strong>References:</strong>
          <ol>
            <li><a href="https://www.cancer.gov/types/lung">NCI: Lung Cancer</a></li>
            <li><a href="https://www.cancer.org/cancer/lung-cancer.html">American Cancer Society</a></li>
          </ol>
        </p>
        <button class="btn btn-primary read-more-btn">Read More</button>
      </div>
    </div>
  </div>

  <!-- 4) Burkitt Lymphoma - see Non-Hodgkin Lymphoma -->
  <div class="col-md-4 mb-4 article-card" data-category="burkitt-lymphoma">
    <div class="card">
      <img 
        src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcT3cdOBn9--412qaqJ_nifeNLpasx49PUERfg&s"
        class="card-img-top" 
        alt="Burkitt Lymphoma (Non-Hodgkin Lymphoma)"
      />
      <div class="card-body">
        <h5 class="card-title">Burkitt Lymphoma (Non-Hodgkin Lymphoma)</h5>
        <p class="card-text short-text">
          A fast-growing type of Non-Hodgkin Lymphoma, most common in children. Often linked to EBV infection.
        </p>
        <p class="card-text full-text" style="display: none;">
          <strong>Overview:</strong><br>
          Burkitt lymphoma is a highly aggressive B-cell Non-Hodgkin Lymphoma. It presents in three main forms: **endemic**, **sporadic**, and **immunodeficiency-related**. 
          
          <br><br><strong>Causes:</strong>
          <ul>
            <li>Epstein-Barr Virus (EBV) infection (particularly in endemic form)</li>
            <li>Immunodeficiency (e.g., HIV/AIDS)</li>
            <li>Genetic mutations involving MYC gene translocation</li>
          </ul>

          <strong>Symptoms:</strong>
          <ul>
            <li>Rapidly growing tumor in jaw/abdomen (endemic form)</li>
            <li>Abdominal swelling or pain (sporadic form)</li>
            <li>Night sweats, fever, weight loss (“B” symptoms)</li>
          </ul>

          <strong>Diagnosis:</strong>
          <ul>
            <li>Biopsy of affected lymph nodes or tumor mass</li>
            <li>Immunophenotyping (CD10, CD19, CD20 positivity)</li>
            <li>Genetic tests (MYC translocation)</li>
          </ul>

          <strong>Treatment:</strong>
          <ul>
            <li>Intensive chemotherapy (e.g., CODOX-M/IVAC regimen)</li>
            <li>Intrathecal chemo for CNS prophylaxis</li>
            <li>Supportive care (hydration, infection prevention)</li>
          </ul>

          <strong>Prevention:</strong>
          <ul>
            <li>Early detection and treatment of EBV or HIV</li>
            <li>Regular medical follow-up for immunocompromised patients</li>
          </ul>

          <strong>References:</strong>
          <ol>
            <li><a href="https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq">NCI: Non-Hodgkin Lymphoma</a></li>
            <li><a href="https://www.lls.org/lymphoma/non-hodgkin-lymphoma/burkitt-lymphoma">Leukemia & Lymphoma Society</a></li>
          </ol>
        </p>
        <button class="btn btn-primary read-more-btn">Read More</button>
      </div>
    </div>
  </div>



    <!-- 1) Carcinoma of Unknown Primary (CUP) -->
    <div class="col-md-4 mb-4 article-card" data-category="cup">
      <div class="card">
        <img 
          src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTyDnsfrr_VB19SakrFkvXYTV5DES0sxspDLQ&s" 
          class="card-img-top" 
          alt="Carcinoma of Unknown Primary"
        />
        <div class="card-body">
          <h5 class="card-title">Carcinoma of Unknown Primary (CUP)</h5>
          <p class="card-text short-text">
            A rare condition where cancer is found but its origin (primary site) remains undetermined.
          </p>
          <p class="card-text full-text" style="display: none;">
            <strong>Overview:</strong><br>
            Carcinoma of Unknown Primary (CUP) refers to metastatic cancer where the primary tumor site cannot be identified despite medical evaluations. CUPs are challenging due to the unknown origin, and treatment often targets likely primary sites based on the tumor’s cell type and location.
  
            <br><br><strong>Causes:</strong>
            <ul>
              <li>Exact cause is unknown because the primary site isn’t located.</li>
              <li>General risk factors mirror those of other cancers (e.g., smoking, genetics, certain occupational exposures).</li>
            </ul>
  
            <strong>Symptoms:</strong>
            <ul>
              <li>Vary depending on where the cancer has spread (e.g., lymph nodes, liver, lungs).</li>
              <li>Unexplained weight loss, fatigue.</li>
              <li>Pain or swelling in the affected area.</li>
            </ul>
  
            <strong>Diagnosis:</strong>
            <ul>
              <li>Imaging studies (CT, PET, MRI) to search for a primary site.</li>
              <li>Biopsy of the metastatic lesion for histopathology.</li>
              <li>Blood tests (tumor markers), endoscopy, or genetic profiling to find clues about the origin.</li>
            </ul>
  
            <strong>Treatment:</strong>
            <ul>
              <li>Empiric chemotherapy based on tumor type (e.g., adenocarcinoma, squamous cell).</li>
              <li>Targeted therapies or immunotherapies if genetic markers are identified.</li>
              <li>Radiation therapy for local control or symptom relief.</li>
              <li>Supportive care to manage pain and other symptoms.</li>
            </ul>
  
            <strong>Prevention:</strong>
            <ul>
              <li>There is no specific prevention for CUP.</li>
              <li>Follow general cancer prevention guidelines: avoid tobacco, limit alcohol, maintain healthy weight.</li>
              <li>Early medical attention if suspicious symptoms arise.</li>
            </ul>
  
            <strong>References:</strong>
            <ol>
              <li><a href="https://www.cancer.gov/types/unknown-primary">National Cancer Institute: CUP</a></li>
              <li><a href="https://www.cancer.org/cancer/cancer-unknown-primary.html">American Cancer Society: CUP</a></li>
            </ol>
          </p>
          <button class="btn btn-primary read-more-btn">Read More</button>
        </div>
      </div>
    </div>
  
    <!-- 2) Central Nervous System (CNS) -->
    <div class="col-md-4 mb-4 article-card" data-category="cns">
      <div class="card">
        <img 
          src="https://www.verywellmind.com/thmb/CoPq8udVEWA_4xEEqTv-dFBiksk=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/brain_spinal_cord-57fe96b15f9b5805c26d5072.jpg" 
          class="card-img-top" 
          alt="Central Nervous System"
        />
        <div class="card-body">
          <h5 class="card-title">Central Nervous System (CNS)</h5>
          <p class="card-text short-text">
            Comprising the brain and spinal cord, the CNS can develop various tumors, both benign and malignant.
          </p>
          <p class="card-text full-text" style="display: none;">
            <strong>Overview:</strong><br>
            The Central Nervous System (CNS) includes the brain and spinal cord. Tumors here can be **primary** (originating in CNS tissues) or **secondary** (metastatic). Common primary tumors include gliomas (astrocytomas, oligodendrogliomas), meningiomas, and ependymomas.
  
            <br><br><strong>Causes:</strong>
            <ul>
              <li>Genetic syndromes (e.g., Neurofibromatosis, Von Hippel-Lindau).</li>
              <li>Exposure to high-dose ionizing radiation.</li>
              <li>Mostly sporadic with no identifiable risk factor.</li>
            </ul>
  
            <strong>Symptoms:</strong>
            <ul>
              <li>Headaches, often worse in the morning.</li>
              <li>Nausea, vomiting, seizures.</li>
              <li>Neurological deficits (vision, speech, motor function) depending on tumor location.</li>
              <li>Back pain, numbness, or tingling if spinal cord is involved.</li>
            </ul>
  
            <strong>Diagnosis:</strong>
            <ul>
              <li>MRI with contrast (gold standard for brain/spinal imaging).</li>
              <li>CT scan for quick assessment or if MRI is not feasible.</li>
              <li>Biopsy or surgical resection for definitive pathology.</li>
            </ul>
  
            <strong>Treatment:</strong>
            <ul>
              <li><strong>Surgery:</strong> Debulking or complete removal if possible.</li>
              <li><strong>Radiation Therapy:</strong> External beam or stereotactic radiosurgery.</li>
              <li><strong>Chemotherapy:</strong> Depending on tumor type (e.g., temozolomide for glioblastoma).</li>
              <li><strong>Targeted Therapies:</strong> For tumors with specific mutations (e.g., BRAF, IDH).</li>
              <li><strong>Supportive Care:</strong> Steroids to reduce intracranial pressure, seizure medications.</li>
            </ul>
  
            <strong>Prevention:</strong>
            <ul>
              <li>Limit unnecessary radiation exposure.</li>
              <li>Genetic counseling if strong family history of CNS tumors.</li>
              <li>Prompt medical evaluation for persistent neurological symptoms.</li>
            </ul>
  
            <strong>References:</strong>
            <ol>
              <li><a href="https://www.cancer.gov/types/brain">NCI: Brain & CNS Tumors</a></li>
              <li><a href="https://www.cancer.org/cancer/brain-spinal-cord-tumors.html">American Cancer Society: Brain & Spinal Cord Tumors</a></li>
            </ol>
          </p>
          <button class="btn btn-primary read-more-btn">Read More</button>
        </div>
      </div>
    </div>
  
    <!-- 3) Atypical Teratoid/Rhabdoid Tumor (AT/RT), Childhood -->
    <div class="col-md-4 mb-4 article-card" data-category="atypical-teratoid-rhabdoid">
      <div class="card">
        <img 
          src="https://neurosurgery.weillcornell.org/sites/default/files/condition/child-at-rt-lg_1.jpg" 
          class="card-img-top" 
          alt="Atypical Teratoid/Rhabdoid Tumor, Childhood"
        />
        <div class="card-body">
          <h5 class="card-title">Atypical Teratoid/Rhabdoid Tumor (AT/RT), Childhood</h5>
          <p class="card-text short-text">
            A rare, fast-growing childhood brain tumor affecting the central nervous system, most common in children under 3.
          </p>
          <p class="card-text full-text" style="display: none;">
            <strong>Overview:</strong><br>
            Atypical Teratoid/Rhabdoid Tumor (AT/RT) is a highly aggressive CNS tumor often occurring in the cerebellum or brainstem, but it can also appear in the spinal cord. Due to its rapid growth, early detection and intensive treatment are crucial.
  
            <br><br><strong>Causes:</strong>
            <ul>
              <li>Genetic changes in the SMARCB1/INI1 gene on chromosome 22.</li>
              <li>Rarely familial; most cases are sporadic mutations.</li>
            </ul>
  
            <strong>Symptoms:</strong>
            <ul>
              <li>Increased intracranial pressure (headache, vomiting, irritability).</li>
              <li>Difficulty with coordination or walking.</li>
              <li>Rapid changes in head size in infants (bulging fontanelle).</li>
              <li>Lethargy or developmental delays.</li>
            </ul>
  
            <strong>Diagnosis:</strong>
            <ul>
              <li>MRI to locate the tumor and assess spread.</li>
              <li>Biopsy or surgical resection for definitive pathology.</li>
              <li>Genetic testing for SMARCB1/INI1 deletion or mutation.</li>
            </ul>
  
            <strong>Treatment:</strong>
            <ul>
              <li><strong>Surgery:</strong> Maximal safe resection to remove as much tumor as possible.</li>
              <li><strong>Chemotherapy:</strong> High-dose regimens, often with stem cell rescue in very young children.</li>
              <li><strong>Radiation Therapy:</strong> Used cautiously, especially in very young patients.</li>
              <li><strong>Clinical Trials:</strong> Investigating targeted therapies or immunotherapies.</li>
            </ul>
  
            <strong>Prevention:</strong>
            <ul>
              <li>Currently no known preventive measures due to genetic nature.</li>
              <li>Early medical attention for any neurological symptoms in infants.</li>
              <li>Genetic counseling if there is a family history of rhabdoid tumors.</li>
            </ul>
  
            <strong>References:</strong>
            <ol>
              <li><a href="https://www.cancer.gov/rare-brain-spine-tumor/atrt">NCI: Atypical Teratoid/Rhabdoid Tumor</a></li>
              <li><a href="https://www.stjude.org/disease/atypical-teratoid-rhabdoid-tumor.html">St. Jude: AT/RT</a></li>
            </ol>
          </p>
          <button class="btn btn-primary read-more-btn">Read More</button>
        </div>
      </div>
    </div>





    <!-- Medulloblastoma (Childhood Brain Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="brain-cancer">
  <div class="card">
    <img
      src="https://www.uofmhealthsparrow.org/sites/default/files/mayo-api/popup/o/Medulloblastoma-8col-3802786-003-0.jpg"
      class="card-img-top"
      alt="Medulloblastoma (Childhood Brain Cancer)"
    />
    <div class="card-body">
      <h5 class="card-title">Medulloblastoma (Childhood Brain Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A fast-growing, malignant brain tumor originating in the cerebellum, most common in children.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Medulloblastoma is a highly malignant primary brain tumor that arises in the cerebellum, the region responsible for balance and coordination. It is the most common malignant brain tumor in children, but it can also appear in adolescents and, rarely, adults. These tumors can spread through cerebrospinal fluid (CSF) to other parts of the brain or spine.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic alterations in pathways like SHH (Sonic Hedgehog) or WNT</li>
          <li>Inherited syndromes (e.g., Gorlin syndrome, Turcot syndrome)</li>
          <li>Prior exposure to cranial radiation</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Headaches, often worse in the morning</li>
          <li>Persistent vomiting due to increased intracranial pressure</li>
          <li>Difficulty with balance or walking (ataxia)</li>
          <li>Changes in personality or school performance</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI of the brain and spine to detect tumor and metastasis</li>
          <li>CSF analysis (lumbar puncture) for tumor cells</li>
          <li>Biopsy or surgical resection for definitive histopathology</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection to remove as much tumor as possible</li>
          <li>Radiation therapy (craniospinal irradiation) to kill residual cells</li>
          <li>Chemotherapy to reduce recurrence and manage metastatic disease</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on the tumor subtype, extent of resection, and metastasis at diagnosis. With modern therapies, 5-year survival can exceed 70% in average-risk patients. Long-term follow-up is crucial for detecting recurrence and managing late effects (e.g., neurocognitive or endocrine issues).
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/brain/patient/child-medulloblastoma-treatment-pdq" target="_blank">NCI: Childhood Medulloblastoma</a></li>
          <li><a href="https://www.cancer.org/cancer/brain-spinal-cord-tumors-children.html" target="_blank">ACS: Brain Tumors in Children</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Germ Cell Tumor (Childhood Brain Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="brain-cancer">
  <div class="card">
    <img
      src="https://neurosurgery.weillcornell.org/sites/default/files/condition/germ-cell-tumor-pineal-lg.jpg"
      class="card-img-top"
      alt="Germ Cell Tumor (Childhood Brain Cancer)"
    />
    <div class="card-body">
      <h5 class="card-title">Germ Cell Tumor (Childhood Brain Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Rare brain tumors originating from embryonic germ cells, often affecting endocrine function in children.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood germ cell tumors of the brain arise when germ cells, normally found in the reproductive system, migrate abnormally during fetal development. These tumors often appear in the pineal or suprasellar regions, influencing hormone regulation and growth.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic predisposition (rare)</li>
          <li>Abnormal embryonic cell migration</li>
          <li>Possible links to certain inherited conditions</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Endocrine disturbances (e.g., diabetes insipidus)</li>
          <li>Precocious or delayed puberty</li>
          <li>Vision problems if the tumor compresses the optic pathway</li>
          <li>Headaches, nausea, or vomiting due to increased intracranial pressure</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI/CT imaging of the brain for tumor location</li>
          <li>Blood and CSF tests for tumor markers (AFP, β-hCG)</li>
          <li>Biopsy in certain cases for histological confirmation</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Chemotherapy to shrink or control tumor growth</li>
          <li>Radiation therapy, particularly for localized disease</li>
          <li>Surgical intervention for biopsy or resection if accessible</li>
          <li>Hormone replacement therapy if pituitary or hypothalamic function is compromised</li>
        </ul>
        <strong>Prognosis & Prevention:</strong>
        <p>
          Germ cell tumors in the brain often respond well to combined chemo-radiation, with 5-year survival rates above 80% for localized disease. Regular follow-up is essential for managing endocrine issues and detecting potential recurrence.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/brain/patient/child-germ-cell-treatment-pdq" target="_blank">NCI: Childhood Brain Germ Cell Tumors</a></li>
          <li><a href="https://www.stjude.org/disease/germ-cell-tumor.html" target="_blank">St. Jude: Germ Cell Tumors</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Primary CNS Lymphoma -->
<div class="col-md-4 mb-4 article-card" data-category="brain-cancer">
  <div class="card">
    <img
      src="https://case.edu/med/neurology/NR/cnslym1na.jpg"
      class="card-img-top"
      alt="Primary CNS Lymphoma"
    />
    <div class="card-body">
      <h5 class="card-title">Primary CNS Lymphoma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare non-Hodgkin lymphoma confined to the brain, spinal cord, or eyes, often linked to immune suppression.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Primary CNS lymphoma (PCNSL) is a form of non-Hodgkin lymphoma that originates within the central nervous system, including the brain, spinal cord, and sometimes the eyes (primary intraocular lymphoma). It typically involves B-lymphocytes and is often associated with immunocompromised states, such as HIV/AIDS or post-transplant immunosuppression.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>HIV infection or AIDS (significantly higher risk)</li>
          <li>Use of immunosuppressive drugs (e.g., organ transplant patients)</li>
          <li>Association with Epstein-Barr virus (EBV) in immunocompromised individuals</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Neurological deficits (weakness, cognitive changes, speech difficulties)</li>
          <li>Seizures or cranial nerve deficits</li>
          <li>Vision changes if the lymphoma involves the eye</li>
          <li>Headaches, confusion, or personality changes</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI of the brain/spine showing single or multiple lesions</li>
          <li>Lumbar puncture to check CSF for malignant cells</li>
          <li>Brain biopsy for definitive histopathological diagnosis</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>High-dose methotrexate-based chemotherapy (primary modality)</li>
          <li>Radiation therapy in select or refractory cases</li>
          <li>Antiretroviral therapy (ART) if HIV-positive</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on immune status and tumor response. With aggressive chemotherapy, many patients achieve remission. Regular neurological assessments and imaging are critical to detect relapse or complications.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/lymphoma/hp/primary-cns-lymphoma-treatment-pdq" target="_blank">NCI: Primary CNS Lymphoma</a></li>
          <li><a href="https://www.cancer.org/cancer/lymphoma.html" target="_blank">ACS: Lymphoma Overview</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Cervical Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="cervical-cancer">
  <div class="card">
    <img
      src="https://regencyhealthcare.in/wp-content/uploads/2024/01/What-are-the-Early-Warning-Signs-of-Cervical-Cancer.jpg"
      class="card-img-top"
      alt="Cervical Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Cervical Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A common gynecologic cancer often caused by persistent HPV infection, affecting the cervix.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Cervical cancer arises from the cells lining the cervix, which is the lower part of the uterus connecting to the vagina. Most cases are directly linked to high-risk human papillomavirus (HPV) infections. Early detection through screening significantly improves survival rates.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Persistent infection with high-risk HPV strains (e.g., HPV 16 and 18)</li>
          <li>Smoking and immunosuppression</li>
          <li>Multiple sexual partners or early sexual activity</li>
          <li>Long-term use of oral contraceptives (slight increased risk)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Abnormal vaginal bleeding (after intercourse or between periods)</li>
          <li>Foul-smelling or unusual vaginal discharge</li>
          <li>Pelvic pain or pain during intercourse</li>
          <li>Advanced stages: Weight loss, fatigue, or leg swelling</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Pap smear and HPV co-testing for screening</li>
          <li>Colposcopy and biopsy for suspicious lesions</li>
          <li>Imaging (CT, MRI) to stage advanced disease</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Early-stage: Conization or radical hysterectomy</li>
          <li>Locally advanced: Concurrent chemoradiation</li>
          <li>Targeted therapies (e.g., bevacizumab) for metastatic cases</li>
        </ul>
        <strong>Prognosis & Prevention:</strong>
        <p>
          Early detection leads to high survival rates, often exceeding 90% at Stage I. Preventive measures include HPV vaccination, regular Pap tests, and safe sex practices to reduce HPV transmission.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/cervical" target="_blank">NCI: Cervical Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/cervical-cancer.html" target="_blank">ACS: Cervical Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>





<!-- Childhood Cancers -->
<div class="col-md-4 mb-4 article-card" data-category="childhood-cancers">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcREUjAGZjo34dp0kSaU_g0zRQb-jOp1n8oI-Q&s"
      class="card-img-top"
      alt="Childhood Cancers"
    />
    <div class="card-body">
      <h5 class="card-title">Childhood Cancers</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        An overview of common pediatric cancers like leukemia, brain tumors, and lymphomas, emphasizing early detection and specialized treatments.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood cancers are a group of malignancies occurring in patients typically under the age of 15. Common types include leukemia (blood cancer), brain and spinal cord tumors, lymphomas, and solid tumors like neuroblastoma or Wilms tumor. Despite being less frequent than adult cancers, pediatric cancers often require specialized, multidisciplinary care.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic predispositions (e.g., Down syndrome, Li-Fraumeni syndrome)</li>
          <li>Inherited gene mutations (e.g., RB1 for retinoblastoma)</li>
          <li>Exposure to high-dose radiation or certain chemicals (rare)</li>
          <li>Most childhood cancers occur without a clear cause</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Unexplained fever, persistent fatigue</li>
          <li>Pain or swelling in bones or joints</li>
          <li>Unusual lumps, persistent headaches, or vision changes</li>
          <li>Frequent infections, easy bruising, or bleeding</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Physical exam and medical history</li>
          <li>Imaging (MRI, CT, ultrasound) to locate tumors</li>
          <li>Blood tests (CBC, tumor markers)</li>
          <li>Biopsy or bone marrow aspiration for definitive diagnosis</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Chemotherapy tailored to pediatric protocols</li>
          <li>Surgery or radiation therapy, depending on tumor type and location</li>
          <li>Immunotherapy and targeted therapies in certain cases</li>
          <li>Supportive care (nutrition, psychosocial support)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Advances in treatment have significantly improved survival rates for many childhood cancers, often exceeding 80% overall. However, lifelong follow-up may be required to manage late effects of therapy (e.g., growth, fertility, and secondary cancers).
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/childhood-cancers" target="_blank">NCI: Childhood Cancers</a></li>
          <li><a href="https://www.cancer.org/cancer/cancer-in-children.html" target="_blank">American Cancer Society: Children and Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Childhood Cardiac Tumors Treatment -->
<div class="col-md-4 mb-4 article-card" data-category="childhood-cancers">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRMTha0YKMKpY6QyT8mRazpH8xtsk3RILtnrg&s"
      class="card-img-top"
      alt="Childhood Cardiac Tumors"
    />
    <div class="card-body">
      <h5 class="card-title">Childhood Cardiac Tumors Treatment</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Rare tumors affecting the heart in children, often requiring a specialized, multidisciplinary treatment approach.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood cardiac tumors are extremely rare and can be benign (e.g., rhabdomyomas, fibromas) or malignant (e.g., sarcomas). These tumors may appear in the myocardium, endocardium, or pericardium, potentially impacting heart function and overall health.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic syndromes (e.g., tuberous sclerosis for rhabdomyomas)</li>
          <li>Congenital anomalies</li>
          <li>Family history of cardiac or other tumors (rare)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Heart murmurs or arrhythmias</li>
          <li>Shortness of breath, especially during exertion</li>
          <li>Chest pain or palpitations</li>
          <li>Signs of heart failure (e.g., edema, fatigue)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Echocardiogram (ultrasound of the heart)</li>
          <li>MRI or CT scan for detailed cardiac imaging</li>
          <li>Biopsy or surgical exploration (in certain cases)</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection if the tumor is resectable and symptomatic</li>
          <li>Medical management for heart failure or arrhythmias</li>
          <li>Chemotherapy or radiation for malignant tumors</li>
          <li>Cardiac transplantation in extremely rare, severe cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Many pediatric cardiac tumors are benign and may regress over time, particularly rhabdomyomas. Regular follow-up with a pediatric cardiologist is essential to monitor cardiac function and detect any recurrence or complications.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/childhood-cancers" target="_blank">NCI: Childhood Cancers (Cardiac Tumors)</a></li>
          <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223898/" target="_blank">National Library of Medicine: Cardiac Tumors in Children</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Cancers of Childhood, Rare -->
<div class="col-md-4 mb-4 article-card" data-category="childhood-cancers">
  <div class="card">
    <img
      src="https://static.toiimg.com/thumb/msid-118265176,width-400,resizemode-4/118265176.jpg"
      class="card-img-top"
      alt="Rare Cancers of Childhood"
    />
    <div class="card-body">
      <h5 class="card-title">Cancers of Childhood, Rare</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A group of uncommon pediatric malignancies that demand specialized diagnostic and treatment approaches.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Rare childhood cancers include a broad range of malignancies affecting fewer than 15 cases per 1 million children annually. Examples include retinoblastoma, hepatoblastoma, pleuropulmonary blastoma, and certain soft tissue sarcomas. Due to their rarity, they often require specialized pediatric oncology centers for proper diagnosis and treatment.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic mutations or inherited conditions (e.g., RB1 gene in retinoblastoma)</li>
          <li>Family history of rare cancers</li>
          <li>Environmental exposures (though less common in children)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Specific to the tumor type (e.g., eye abnormalities in retinoblastoma)</li>
          <li>General cancer symptoms like fatigue, weight loss, or pain</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Imaging studies tailored to suspected cancer type</li>
          <li>Blood tests, genetic testing, or tumor marker analysis</li>
          <li>Biopsy for histopathological confirmation</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgery, chemotherapy, or radiation depending on tumor type</li>
          <li>Targeted therapies or immunotherapies for specific genetic alterations</li>
          <li>Supportive care (e.g., pain management, nutritional support)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis varies widely by tumor type and stage. Early detection and treatment in specialized centers can improve outcomes. Collaboration among pediatric oncologists, surgeons, and researchers is critical for developing new therapies.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/childhood-cancers/rare" target="_blank">NCI: Rare Cancers of Childhood</a></li>
          <li><a href="https://www.cancer.org/cancer/cancer-in-children/rare-childhood-cancers.html" target="_blank">ACS: Rare Childhood Cancers</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Cholangiocarcinoma (Bile Duct Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="bile-duct-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTSSPCtkvu__WlFiIT2jcCj6PyPa1rOtyCFCg&s"
      class="card-img-top"
      alt="Cholangiocarcinoma (Bile Duct Cancer)"
    />
    <div class="card-body">
      <h5 class="card-title">Cholangiocarcinoma (Bile Duct Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare cancer that develops in the bile ducts, also referred to as cholangiocarcinoma.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Cholangiocarcinoma is a malignancy arising from the epithelial cells lining the bile ducts. These ducts connect the liver and gallbladder to the small intestine. Tumors may form inside the liver (intrahepatic), just outside it (perihilar), or farther down the ducts (distal).
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Chronic biliary irritation (e.g., primary sclerosing cholangitis)</li>
          <li>Parasitic infections (liver flukes) in certain geographic regions</li>
          <li>Cirrhosis or chronic hepatitis</li>
          <li>Congenital abnormalities of the bile ducts</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Jaundice (yellowing of the skin and eyes)</li>
          <li>Dark urine, pale stools, and itching</li>
          <li>Abdominal pain and unexplained weight loss</li>
          <li>Loss of appetite or fatigue</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Blood tests (liver function, CA 19-9 tumor marker)</li>
          <li>Imaging (ultrasound, CT, MRI, MRCP)</li>
          <li>Endoscopic procedures (ERCP) for biopsy and stent placement</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection or liver transplantation if feasible</li>
          <li>Radiation therapy (external beam or brachytherapy)</li>
          <li>Chemotherapy regimens (e.g., gemcitabine-cisplatin)</li>
          <li>Targeted therapies (e.g., FGFR inhibitors for specific mutations)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on tumor location, stage, and resectability. Early detection offers the best chance for curative surgery. Palliative measures, including stenting, can relieve symptoms and improve quality of life in advanced cases.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/liver/cholangiocarcinoma" target="_blank">NCI: Cholangiocarcinoma</a></li>
          <li><a href="https://www.cancer.org/cancer/bile-duct-cancer.html" target="_blank">ACS: Bile Duct Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>








<!-- Chordoma, Childhood (Bone Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="bone-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQsqSOfAbloX-KruP_Vt8CtDDCrJRyLWKpcKw&s"
      class="card-img-top"
      alt="Chordoma, Childhood (Bone Cancer)"
    />
    <div class="card-body">
      <h5 class="card-title">Chordoma, Childhood (Bone Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare bone tumor typically occurring along the spine in children, requiring specialized treatment.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood chordoma is a rare, slow-growing bone cancer that arises from remnants of the notochord. It often appears at the base of the skull (clivus) or in the sacrum. Though slow to progress, chordomas can be locally aggressive and challenging to treat.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic mutations (e.g., T gene alterations in some familial cases)</li>
          <li>No well-defined environmental risk factors</li>
          <li>Most cases appear sporadically</li>

        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Persistent neck or back pain</li>
          <li>Numbness or weakness in limbs if spinal cord compression occurs</li>
          <li>Headaches or cranial nerve deficits (for skull-based tumors)</li>
          <li>Bowel or bladder dysfunction in advanced cases</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI/CT of the spine or skull to localize the tumor</li>
          <li>Biopsy for histopathological confirmation</li>
          <li>Genetic testing in selected familial cases</li>
          <li>Bowel or bladder dysfunction in advanced cases</li>
          

        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection (often challenging due to tumor location)</li>
          <li>High-dose radiation therapy (proton beam therapy may be used)</li>
          <li>Targeted therapies in clinical trials for advanced or recurrent cases</li>

        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis varies based on tumor location and resectability. Complete surgical removal offers the best chance for long-term control. Regular follow-up is crucial to detect recurrence or complications.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/pediatric-adult-rare-tumor/chordoma" target="_blank">NCI: Chordoma</a></li>
          <li><a href="https://www.chordomafoundation.org/" target="_blank">Chordoma Foundation</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Chronic Lymphocytic Leukemia (CLL) -->
<div class="col-md-4 mb-4 article-card" data-category="leukemia">
  <div class="card">
    <img
      src="https://cllsupport.calquence.com/hc/article_attachments/19370824696731"
      class="card-img-top"
      alt="Chronic Lymphocytic Leukemia (CLL)"
    />
    <div class="card-body">
      <h5 class="card-title">Chronic Lymphocytic Leukemia (CLL)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A slow-growing leukemia characterized by excess mature lymphocytes, often affecting older adults.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Chronic Lymphocytic Leukemia (CLL) is a type of blood cancer involving the overproduction of mature-looking but dysfunctional B lymphocytes. It typically progresses slowly and is often diagnosed incidentally through routine blood tests.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic predisposition and family history of CLL</li>
          <li>Exposure to certain chemicals (e.g., Agent Orange) may increase risk</li>
          <li>More common in older adults (median age at diagnosis is ~70)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Swollen lymph nodes, especially in the neck, armpits, or groin</li>
          <li>Fatigue, weakness, or shortness of breath</li>
          <li>Frequent infections due to compromised immunity</li>
          <li>Night sweats or unintended weight loss</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Complete blood count (CBC) showing elevated lymphocyte count</li>
          <li>Flow cytometry to confirm clonal B cells (CD5+, CD19+, CD23+)</li>
          <li>Imaging (CT scans) to assess lymphadenopathy or organ involvement</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Watchful waiting for asymptomatic, early-stage CLL</li>
          <li>Targeted therapies (e.g., BTK inhibitors like ibrutinib)</li>
          <li>Chemoimmunotherapy (FCR regimen: fludarabine, cyclophosphamide, rituximab)</li>
          <li>Stem cell transplant in refractory or aggressive cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Many patients remain stable for years without treatment. Novel targeted agents have improved outcomes for those requiring therapy. Prognosis depends on molecular markers (e.g., IGHV mutation status) and disease stage.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq" target="_blank">NCI: CLL Treatment</a></li>
          <li><a href="https://www.lls.org/leukemia/chronic-lymphocytic-leukemia" target="_blank">Leukemia & Lymphoma Society: CLL</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Chronic Myelogenous Leukemia (CML) -->
<div class="col-md-4 mb-4 article-card" data-category="leukemia">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTD4k7Woii-XE_gxsPuyDxt86AuqNBxckhGsQ&s"
      class="card-img-top"
      alt="Chronic Myelogenous Leukemia (CML)"
    />
    <div class="card-body">
      <h5 class="card-title">Chronic Myelogenous Leukemia (CML)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A slow-progressing leukemia involving the overproduction of myeloid cells, often linked to the Philadelphia chromosome.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Chronic Myelogenous Leukemia (CML) is a myeloproliferative disorder characterized by the presence of the Philadelphia chromosome (translocation between chromosomes 9 and 22), which produces the BCR-ABL fusion gene. This genetic abnormality leads to uncontrolled growth of myeloid cells in the bone marrow.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Philadelphia chromosome (BCR-ABL) found in ~95% of CML cases</li>
          <li>Exposure to high-dose ionizing radiation (rare)</li>
          <li>Most cases occur sporadically without clear risk factors</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Fatigue, weakness, or night sweats</li>
          <li>Splenomegaly causing fullness in the left abdomen</li>
          <li>Frequent infections or bleeding due to marrow dysfunction</li>
          <li>Elevated white blood cell counts on routine blood work</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Complete blood count (CBC) showing elevated WBC with left shift</li>
          <li>Cytogenetic or FISH testing to detect the Philadelphia chromosome</li>
          <li>Bone marrow aspiration for cellular morphology and BCR-ABL analysis</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Tyrosine kinase inhibitors (TKIs) like imatinib, dasatinib, nilotinib</li>
          <li>Monitoring BCR-ABL transcript levels (PCR) to assess response</li>
          <li>Stem cell transplant in cases resistant to TKIs</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          TKIs have transformed CML into a manageable chronic disease for most patients. Regular follow-up and molecular monitoring are essential to detect resistance or progression to accelerated/blast phase.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/leukemia/patient/cml-treatment-pdq" target="_blank">NCI: CML Treatment</a></li>
          <li><a href="https://www.lls.org/leukemia/chronic-myeloid-leukemia" target="_blank">Leukemia & Lymphoma Society: CML</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Colorectal Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="colorectal-cancer">
  <div class="card">
    <img
      src="https://static.bookinghealth.com/uploads/blog/1612437441_1518559099_otr_depositphotos_157632006_xl-2015-1.jpg"
      class="card-img-top"
      alt="Colorectal Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Colorectal Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A common cancer affecting the colon or rectum, often linked to lifestyle factors and genetic predispositions.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Colorectal cancer (CRC) originates in the lining of the colon or rectum. It usually begins as benign polyps that can become malignant over time. Early screening through colonoscopies significantly improves detection and survival.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Diet high in red/processed meats, low in fiber</li>
          <li>Obesity, sedentary lifestyle, smoking, heavy alcohol use</li>
          <li>Family history (e.g., hereditary syndromes like Lynch syndrome, FAP)</li>
          <li>Inflammatory bowel disease (Crohn’s, ulcerative colitis)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Changes in bowel habits (diarrhea, constipation)</li>
          <li>Rectal bleeding or blood in the stool</li>
          <li>Abdominal pain, bloating, or cramps</li>
          <li>Unintentional weight loss or fatigue</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Colonoscopy to visualize and biopsy polyps or tumors</li>
          <li>Fecal occult blood tests or stool DNA tests</li>
          <li>CT or MRI scans for staging</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection of the tumor and nearby lymph nodes</li>
          <li>Chemotherapy for advanced or high-risk stages</li>
          <li>Radiation therapy (especially for rectal cancer)</li>
          <li>Targeted therapies (e.g., EGFR inhibitors, VEGF inhibitors)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Early-stage colorectal cancer has a high cure rate with surgery alone. Later stages may require combined treatments. Regular screenings starting at age 45 (or earlier for high-risk individuals) can significantly reduce mortality.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/colorectal" target="_blank">NCI: Colorectal Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/colon-rectal-cancer.html" target="_blank">American Cancer Society: Colorectal Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Craniopharyngioma, Childhood (Brain Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="brain-cancer">
  <div class="card">
    <img
      src="https://i1.ytimg.com/vi/8sXDVFANtdE/maxresdefault.jpg"
      class="card-img-top"
      alt="Craniopharyngioma, Childhood (Brain Cancer)"
    />
    <div class="card-body">
      <h5 class="card-title">Craniopharyngioma, Childhood (Brain Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A benign yet locally invasive brain tumor near the pituitary gland, commonly diagnosed in children.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood craniopharyngioma is a slow-growing, benign tumor that typically develops near the pituitary gland and hypothalamus. Although benign, it can be locally aggressive, causing significant neurological and endocrine problems.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Originates from remnants of Rathke's pouch</li>
          <li>No well-established genetic or environmental causes</li>
          <li>Most cases occur sporadically without familial patterns</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Headaches and vision changes (due to pressure on optic nerves)</li>
          <li>Hormonal deficiencies (growth or thyroid issues)</li>
          <li>Increased intracranial pressure (nausea, vomiting)</li>
          <li>Behavioral or cognitive changes</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI or CT scan to locate tumor and assess calcifications</li>
          <li>Hormone tests (pituitary function evaluation)</li>
          <li>Neuro-ophthalmological exam for vision changes</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection or debulking</li>
          <li>Radiation therapy (especially for residual or recurrent tumors)</li>
          <li>Hormone replacement therapy if pituitary function is affected</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          While complete surgical removal can be curative, tumor location often complicates surgery. Long-term follow-up is vital to manage recurrence risk and address endocrine deficiencies.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/brain/patient/child-craniopharyngioma-treatment-pdq" target="_blank">NCI: Childhood Craniopharyngioma</a></li>
          <li><a href="https://www.cancer.org/cancer/brain-spinal-cord-tumors-children.html" target="_blank">ACS: Brain & Spinal Cord Tumors in Children</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Cutaneous T-Cell Lymphoma (Mycosis Fungoides & Sézary Syndrome) -->
<div class="col-md-4 mb-4 article-card" data-category="lymphoma">
  <div class="card">
    <img
      src="https://images.everydayhealth.com/images/cancer/mycosis-fungoides-sezary-syndrome-722x406.jpg"
      class="card-img-top"
      alt="Cutaneous T-Cell Lymphoma (Mycosis Fungoides & Sézary Syndrome)"
    />
    <div class="card-body">
      <h5 class="card-title">Cutaneous T-Cell Lymphoma (Mycosis Fungoides & Sézary Syndrome)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare subset of non-Hodgkin lymphoma affecting T-cells that primarily localize in the skin, presenting as patches, plaques, or tumors.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Cutaneous T-cell lymphoma (CTCL) is a group of non-Hodgkin lymphomas in which malignant T-lymphocytes localize in the skin. Mycosis Fungoides is the most common form, typically starting as patchy skin lesions. Sézary Syndrome is a leukemic variant characterized by malignant T-cells circulating in the blood.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Exact cause unknown; possible genetic and immunologic components</li>
          <li>Chronic antigenic stimulation or viral triggers (unproven)</li>
          <li>More common in older adults</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Red, scaly patches or plaques on the skin</li>
          <li>Itching (pruritus), which can be severe</li>
          <li>Thickened lesions or nodules in advanced stages</li>
          <li>Swollen lymph nodes or Sézary cells in the bloodstream (Sézary Syndrome)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Skin biopsy for histopathological examination</li>
          <li>Immunophenotyping (T-cell markers)</li>
          <li>Blood tests (Sézary cells) and imaging for staging</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Topical therapies (corticosteroids, retinoids, phototherapy)</li>
          <li>Systemic treatments (oral retinoids, interferon-alpha, chemotherapy)</li>
          <li>Extracorporeal photopheresis for Sézary Syndrome</li>
          <li>Biologic agents (e.g., mogamulizumab) for refractory disease</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis varies by stage. Early-stage disease often remains stable for years, managed with skin-directed therapies. Advanced or Sézary Syndrome requires more aggressive treatment and close monitoring.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/lymphoma/hp/adult-cutaneous-t-cell-treatment-pdq" target="_blank">NCI: Adult Cutaneous T-Cell Lymphoma Treatment</a></li>
          <li><a href="https://www.cancer.org/cancer/lymphoma.html" target="_blank">ACS: Lymphoma Overview</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>



<!-- Ductal Carcinoma In Situ (DCIS) - see Breast Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="breast-cancer">
  <div class="card">
    <img
      src="https://www.mayoclinic.org/-/media/kcms/gbs/patient-consumer/images/2013/11/15/17/39/ds00328_-ds00982_-ds000983_-ds01063_-ds01070_-hq00348_im01880_r7_breastthu_jpg.jpg"
      class="card-img-top"
      alt="Ductal Carcinoma In Situ (DCIS)"
    />
    <div class="card-body">
      <h5 class="card-title">Ductal Carcinoma In Situ (DCIS)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A noninvasive or pre-invasive breast cancer where abnormal cells are confined to the milk ducts.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Ductal Carcinoma In Situ (DCIS) is often referred to as Stage 0 breast cancer. It involves abnormal cancer-like cells that are confined within the ductal system of the breast and have not invaded surrounding tissues. While DCIS is not life-threatening by itself, it can progress to invasive breast cancer if left untreated.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic predisposition (e.g., BRCA1/BRCA2 mutations)</li>
          <li>Family history of breast cancer</li>
          <li>Hormone replacement therapy (HRT) use</li>
          <li>Early menarche or late menopause (longer estrogen exposure)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Often asymptomatic and detected by routine mammogram</li>
          <li>Possible breast lump or unusual discharge (rare)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Mammography (microcalcifications are a common finding)</li>
          <li>Breast MRI for further evaluation</li>
          <li>Core needle biopsy to confirm pathology</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Breast-conserving surgery (lumpectomy) plus radiation therapy</li>
          <li>Mastectomy for extensive or multifocal DCIS</li>
          <li>Hormone therapy (e.g., tamoxifen) if tumor is hormone receptor–positive</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          DCIS has an excellent prognosis when treated appropriately. The main goal is to prevent progression to invasive breast cancer. Regular follow-up mammograms are essential for early detection of any recurrence or new lesions.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/breast/dcis-fact-sheet" target="_blank">NCI: DCIS Fact Sheet</a></li>
          <li><a href="https://www.cancer.org/cancer/breast-cancer/about/what-is-breast-cancer.html" target="_blank">ACS: Breast Cancer Overview</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Diffuse Intrinsic Pontine Glioma (DIPG) (Brain Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="brain-cancer">
  <div class="card">
    <img
      src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41984-023-00242-9/MediaObjects/41984_2023_242_Fig1_HTML.png"
      class="card-img-top"
      alt="Diffuse Intrinsic Pontine Glioma (DIPG)"
    />
    <div class="card-body">
      <h5 class="card-title">Diffuse Intrinsic Pontine Glioma (DIPG)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare and aggressive pediatric brain tumor located in the pons, critical for vital functions like breathing and heart rate.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Diffuse Intrinsic Pontine Glioma (DIPG) is a high-grade glioma found in the pons region of the brainstem, which is vital for basic life functions. DIPG primarily affects children, typically between the ages of 5 and 10, and is known for its poor prognosis and limited treatment options due to its sensitive location.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Exact cause unknown; likely sporadic genetic mutations</li>
          <li>No well-established environmental risk factors</li>
          <li>Rare familial cases or syndromes (extremely uncommon)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Cranial nerve deficits (facial weakness, difficulty swallowing)</li>
          <li>Problems with balance and coordination (ataxia)</li>
          <li>Headaches, morning vomiting due to increased intracranial pressure</li>
          <li>Double vision or other visual disturbances</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI of the brainstem (gold standard imaging)</li>
          <li>Biopsy is rarely performed due to high risk</li>
          <li>Neurological exams and symptom assessment</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Radiation therapy to temporarily shrink the tumor</li>
          <li>Experimental therapies and clinical trials (e.g., targeted agents)</li>
          <li>Supportive care (steroids, physical therapy, palliative measures)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          DIPG has a poor prognosis, with median survival under a year. Ongoing research focuses on molecular targets and novel drug delivery methods (convection-enhanced delivery). Supportive care is crucial to maintain quality of life.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/brain/patient/child-brain-stem-treatment-pdq" target="_blank">NCI: Brain Stem Glioma (Childhood)</a></li>
          <li><a href="https://www.stjude.org/disease/diffuse-intrinsic-pontine-glioma-dipg.html" target="_blank">St. Jude: DIPG</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Embryonal Tumors, Medulloblastoma and Other CNS, Childhood (Brain Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="brain-cancer">
  <div class="card">
    <img
      src="https://www.researchgate.net/profile/John-Johnsen-3/publication/24175946/figure/fig1/AS:601657196953607@1520457662115/Medulloblastoma-and-neuroblastoma-localisation-a-Medulloblastoma-primary-tumours-arise.png"
      class="card-img-top"
      alt="Embryonal Tumors (Medulloblastoma & Other CNS)"
    />
    <div class="card-body">
      <h5 class="card-title">Embryonal Tumors (Medulloblastoma & Other CNS)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A group of aggressive brain tumors occurring in children, including medulloblastoma and other embryonal subtypes, often arising in the cerebellum.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood embryonal tumors of the central nervous system include medulloblastoma (the most common malignant pediatric brain tumor) and other rarer entities such as embryonal tumor with multilayered rosettes (ETMR). These tumors typically arise in the cerebellum or other parts of the brain and can spread via cerebrospinal fluid (CSF).
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic predispositions (e.g., Gorlin syndrome, Turcot syndrome for medulloblastoma)</li>
          <li>Possible environmental factors (though not well-established)</li>
          <li>Most cases occur sporadically without a clear cause</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Increased intracranial pressure (headaches, vomiting)</li>
          <li>Balance or coordination issues (ataxia), especially if cerebellum is involved</li>
          <li>Behavioral or cognitive changes</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI of the brain/spine to identify tumor location and possible spread</li>
          <li>Lumbar puncture to check for tumor cells in CSF</li>
          <li>Biopsy or surgical resection for definitive histopathological diagnosis</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection to remove or debulk the tumor</li>
          <li>Radiation therapy (craniospinal irradiation) to target residual cells</li>
          <li>Chemotherapy to treat metastatic disease or reduce recurrence</li>
          <li>Emerging targeted therapies for specific genetic mutations</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis varies by tumor subtype, molecular features, and extent of spread. Advances in multimodal therapy have improved survival rates, but long-term monitoring is critical for recurrence and treatment-related side effects.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/brain/patient/child-medulloblastoma-treatment-pdq" target="_blank">NCI: Childhood Medulloblastoma</a></li>
          <li><a href="https://www.stjude.org/disease/medulloblastoma.html" target="_blank">St. Jude: Medulloblastoma</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Endometrial Cancer (Uterine Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="uterine-cancer">
  <div class="card">
    <img
      src="https://www.moffitt.org/contentassets/0e1fb8613b27423f8c14f92a707faead/endometrial-cancer-florida.jpg"
      class="card-img-top"
      alt="Endometrial Cancer (Uterine Cancer)"
    />
    <div class="card-body">
      <h5 class="card-title">Endometrial Cancer (Uterine Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A common gynecologic cancer that arises from the lining of the uterus, often linked to prolonged estrogen exposure.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Endometrial cancer is the most common cancer of the female reproductive organs in developed countries. It originates in the endometrium, the lining of the uterus. Early detection through abnormal uterine bleeding is common, leading to relatively favorable outcomes if diagnosed early.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Excess estrogen (obesity, PCOS, hormone replacement therapy without progesterone)</li>
          <li>Lynch syndrome (hereditary nonpolyposis colorectal cancer, HNPCC)</li>
          <li>Increasing age, nulliparity (never having given birth)</li>
          <li>Diabetes and hypertension often co-exist</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Abnormal uterine bleeding or spotting (especially postmenopausal bleeding)</li>
          <li>Pelvic pain or pressure</li>
          <li>Unusual vaginal discharge</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Endometrial biopsy or dilation and curettage (D&C)</li>
          <li>Transvaginal ultrasound to measure endometrial thickness</li>
          <li>Pelvic MRI or CT scan for staging</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical hysterectomy with bilateral salpingo-oophorectomy</li>
          <li>Radiation therapy for higher-stage or high-risk disease</li>
          <li>Hormonal therapy (e.g., progestins) for fertility-sparing or metastatic disease</li>
          <li>Chemotherapy in advanced or recurrent cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Early-stage endometrial cancer has a high cure rate. Regular follow-up is essential for detecting recurrence. Lifestyle modifications (weight management, exercise) can help reduce risk.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/uterine" target="_blank">NCI: Endometrial (Uterine) Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/endometrial-cancer.html" target="_blank">ACS: Endometrial Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Ependymoma, Childhood (Brain Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="brain-cancer">
  <div class="card">
    <img
      src="https://rallyfoundation.org/wp-content/uploads/2021/01/ependymoma-blog-featured.jpg"
      class="card-img-top"
      alt="Ependymoma, Childhood (Brain Cancer)"
    />
    <div class="card-body">
      <h5 class="card-title">Ependymoma, Childhood (Brain Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A tumor arising from ependymal cells in the brain or spinal cord, commonly found in children.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood ependymoma is a primary central nervous system tumor that originates from ependymal cells lining the ventricles or the central canal of the spinal cord. These tumors can block cerebrospinal fluid flow, increasing intracranial pressure and causing various neurological symptoms.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Mostly sporadic; few identified genetic syndromes</li>
          <li>Possible association with neurofibromatosis type 2 (rare)</li>
          <li>Exposure to ionizing radiation in childhood (rare risk factor)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Headaches, nausea, or vomiting due to hydrocephalus</li>
          <li>Balance and coordination difficulties</li>
          <li>Spinal cord tumors may cause back pain or motor deficits</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI of the brain and/or spinal cord to localize the tumor</li>
          <li>Biopsy or surgical resection for histological confirmation</li>
          <li>CSF analysis if spread is suspected</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection to remove as much tumor as possible</li>
          <li>Radiation therapy, especially for residual disease</li>
          <li>Chemotherapy in certain high-risk or recurrent cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on tumor grade, location, and extent of resection. Gross total resection generally improves outcomes. Long-term follow-up is required to monitor for recurrence and manage neurologic or endocrine complications.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/brain/patient/child-ependymoma-treatment-pdq" target="_blank">NCI: Childhood Ependymoma</a></li>
          <li><a href="https://www.stjude.org/disease/ependymoma.html" target="_blank">St. Jude: Ependymoma</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Esophageal Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="esophageal-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRRVhh5bP83ndj3ArDf-8LZqTMC0ZsRqEDKzw&s"
      class="card-img-top"
      alt="Esophageal Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Esophageal Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A malignancy of the esophagus, often linked to chronic irritation, acid reflux, or tobacco/alcohol use.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Esophageal cancer forms in the lining of the esophagus and is primarily of two types: squamous cell carcinoma (linked to smoking and alcohol) and adenocarcinoma (linked to Barrett’s esophagus and chronic acid reflux). Early detection is often challenging, as symptoms may not appear until the disease is advanced.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Smoking and heavy alcohol use (squamous cell carcinoma)</li>
          <li>Chronic gastroesophageal reflux disease (GERD) leading to Barrett’s esophagus (adenocarcinoma)</li>
          <li>Obesity, low intake of fruits/vegetables</li>
          <li>Male gender and older age</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Difficulty swallowing (dysphagia) progressing from solids to liquids</li>
          <li>Unintended weight loss</li>
          <li>Chest pain or discomfort</li>
          <li>Hoarseness or persistent cough</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Endoscopy with biopsy of suspicious areas</li>
          <li>Barium swallow X-ray for structural assessment</li>
          <li>CT/PET scans to evaluate spread or staging</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection (esophagectomy) for resectable disease</li>
          <li>Chemoradiation before or after surgery (neoadjuvant/adjuvant)</li>
          <li>Endoscopic treatments for very early lesions</li>
          <li>Targeted therapies (e.g., HER2 inhibitors) or immunotherapy in advanced cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on the stage at diagnosis. Early detection can significantly improve outcomes. Lifestyle changes, such as quitting smoking and managing acid reflux, can reduce risk.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/esophageal" target="_blank">NCI: Esophageal Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/esophagus-cancer.html" target="_blank">ACS: Esophageal Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Esthesioneuroblastoma (Head and Neck Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="head-neck-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTa-HiHdfaVAZS1EHSCTp80w3WGivQ4V1ORZQ&s"
      class="card-img-top"
      alt="Esthesioneuroblastoma"
    />
    <div class="card-body">
      <h5 class="card-title">Esthesioneuroblastoma (Head and Neck Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare malignant tumor originating from the olfactory epithelium in the nasal cavity, often called olfactory neuroblastoma.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Esthesioneuroblastoma (olfactory neuroblastoma) is a rare head and neck cancer arising from specialized nerve cells in the olfactory epithelium of the upper nasal cavity. It can be locally invasive, affecting sinuses and potentially extending into the cranial cavity.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Exact cause unknown; likely sporadic genetic mutations</li>
          <li>No well-defined environmental or occupational exposures</li>
          <li>May present in both younger and older adults</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Persistent nasal congestion or blockage</li>
          <li>Nosebleeds (epistaxis) or a runny nose</li>
          <li>Loss of smell (anosmia) in some cases</li>
          <li>Facial pain or pressure around the sinuses</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Nasal endoscopy and imaging (CT/MRI) to evaluate tumor extent</li>
          <li>Biopsy for histopathological confirmation</li>
          <li>Staging via PET/CT for possible metastasis</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection with negative margins (often endoscopic approaches)</li>
          <li>Radiation therapy post-surgery to control residual disease</li>
          <li>Chemotherapy in advanced or metastatic cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis varies with tumor stage and location. Early detection and complete surgical removal significantly improve outcomes. Regular follow-up is crucial to detect recurrence or metastasis.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/pediatric-adult-rare-tumor/head-neck/esthesioneuroblastoma" target="_blank">NCI: Olfactory Neuroblastoma</a></li>
          <li><a href="https://www.cancer.org/cancer/nasal-cavity-and-paranasal-sinus-cancer.html" target="_blank">ACS: Nasal Cavity & Paranasal Sinus Cancers</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Ewing Sarcoma (Bone Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="bone-cancer">
  <div class="card">
    <img
      src="https://i0.wp.com/post.healthline.com/wp-content/uploads/2021/09/X-ray-of-the-left-knee-joint.-Ewing-sarcoma-lymphoma-myeloma-thigh-bone-1296x728-body-1.jpg?w=1155&h=1528"
      class="card-img-top"
      alt="Ewing Sarcoma"
    />
    <div class="card-body">
      <h5 class="card-title">Ewing Sarcoma (Bone Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A highly malignant bone or soft tissue tumor often affecting children and adolescents, characterized by a translocation in the EWSR1 gene.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Ewing Sarcoma is part of the Ewing Family of Tumors (EFT), typically arising in the long bones (femur, tibia) or pelvis. It’s driven by a characteristic chromosomal translocation (commonly t(11;22)), leading to the EWS-FLI1 fusion gene.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic translocation (EWS-FLI1) in most cases</li>
          <li>Occurs more often in children and adolescents</li>
          <li>No strong environmental risk factors identified</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Localized pain and swelling in the affected area</li>
          <li>Fever or fatigue mimicking infection</li>
          <li>Fractures with minimal trauma if bone weakened</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>X-ray and MRI of the affected bone</li>
          <li>Biopsy for histology and molecular testing (EWSR1 rearrangement)</li>
          <li>PET/CT scan to assess metastatic spread</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Neoadjuvant chemotherapy to shrink tumor</li>
          <li>Surgical resection or limb-salvage procedures</li>
          <li>Radiation therapy if surgery not fully feasible or margins are positive</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Multi-modal therapy has significantly improved survival, particularly in localized disease. Long-term follow-up is essential to monitor for recurrence, metastasis, and late treatment effects.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/bone/patient/ewing-treatment-pdq" target="_blank">NCI: Ewing Sarcoma Treatment</a></li>
          <li><a href="https://www.stjude.org/disease/ewing-sarcoma.html" target="_blank">St. Jude: Ewing Sarcoma</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Extracranial Germ Cell Tumor, Childhood -->
<div class="col-md-4 mb-4 article-card" data-category="childhood-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR3Oj_yYgPWWwMp3BQiAvT4egbXk3TPs6-DoESR_FCKwm203V07mlZHmgmV4Exdo1EddXc&usqp=CAU"
      class="card-img-top"
      alt="Extracranial Germ Cell Tumor, Childhood"
    />
    <div class="card-body">
      <h5 class="card-title">Extracranial Germ Cell Tumor, Childhood</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Rare pediatric tumors arising from germ cells outside the brain, often located in the gonads or other sites like the sacrococcygeal area.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood extracranial germ cell tumors develop from primordial germ cells in locations other than the central nervous system, such as the ovaries, testes, or sacrococcygeal region in infants. These tumors can be benign (mature teratomas) or malignant (yolk sac tumor, embryonal carcinoma).
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic conditions (e.g., Klinefelter syndrome, Swyer syndrome) may predispose</li>
          <li>Family history of germ cell tumors (rare)</li>
          <li>In most cases, no identifiable cause</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Palpable mass in the gonads or sacrococcygeal area</li>
          <li>Abdominal distension or pain</li>
          <li>Hormonal symptoms (e.g., precocious puberty if tumor secretes hormones)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Imaging (ultrasound, MRI) to locate and characterize the tumor</li>
          <li>Serum tumor markers (AFP, β-hCG)</li>
          <li>Biopsy or surgical resection for histological confirmation</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgery to remove the tumor (often curative for localized disease)</li>
          <li>Chemotherapy for malignant or advanced tumors</li>
          <li>Radiation therapy in certain metastatic cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on tumor type, location, and stage. Most children respond well to surgery and chemotherapy, with high survival rates for localized disease. Long-term follow-up is important for detecting recurrence and monitoring development.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/germ-cell/patient/child-germ-cell-treatment-pdq" target="_blank">NCI: Childhood Extracranial Germ Cell Tumors</a></li>
          <li><a href="https://www.stjude.org/disease/germ-cell-tumor.html" target="_blank">St. Jude: Germ Cell Tumors</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Extragonadal Germ Cell Tumor -->
<div class="col-md-4 mb-4 article-card" data-category="germ-cell-tumor">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSp6qJC8GgtZmCp5kk8pPaYIm0rHNoh_AVgng&s"
      class="card-img-top"
      alt="Extragonadal Germ Cell Tumor"
    />
    <div class="card-body">
      <h5 class="card-title">Extragonadal Germ Cell Tumor</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A germ cell tumor arising outside the gonads, often found in midline locations such as the mediastinum or retroperitoneum.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Extragonadal germ cell tumors develop from misplaced germ cells that settle in areas other than the ovaries or testes. Common sites include the anterior mediastinum, retroperitoneum, or pineal gland in the brain (though the latter is typically considered intracranial).
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Aberrant migration of germ cells during embryonic development</li>
          <li>Possible genetic factors in rare cases</li>
          <li>More common in young adults</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Chest pain or shortness of breath if in the mediastinum</li>
          <li>Abdominal pain or swelling in retroperitoneal tumors</li>
          <li>Compression of nearby structures (e.g., blood vessels, nerves)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Imaging (CT, MRI) of the suspected region</li>
          <li>Serum tumor markers (AFP, β-hCG) depending on tumor subtype</li>
          <li>Biopsy or surgical exploration for definitive histology</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Combination chemotherapy (e.g., BEP regimen) for malignant tumors</li>
          <li>Surgical resection of residual masses</li>
          <li>Radiation therapy in certain refractory or specific subtypes</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on histology (seminoma vs. non-seminoma), tumor markers, and stage at diagnosis. Many extragonadal germ cell tumors respond well to chemotherapy, but follow-up is essential to detect recurrence or late effects.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/testicular/patient/testicular-treatment-pdq#_284" target="_blank">NCI: Extragonadal Germ Cell Tumors</a></li>
          <li><a href="https://www.cancer.org/cancer/testicular-cancer.html" target="_blank">ACS: Testicular & Germ Cell Tumors (Related Info)</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Eye Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="eye-cancer">
  <div class="card">
    <img
      src="https://mmchokshieyehospital.com/wp-content/uploads/2023/11/20220216_010847_352849_ung-thu-mat.max-1800x1800-1.jpg"
      class="card-img-top"
      alt="Eye Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Eye Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A group of malignancies that can occur in or around the eye, affecting vision and potentially spreading if untreated.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Eye cancer encompasses several types of malignancies in the eye or surrounding structures, including the eyelid, orbit, or conjunctiva. Primary intraocular cancers, such as melanoma or lymphoma, arise within the eyeball itself, while others can metastasize to the eye from elsewhere.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic predisposition (e.g., retinoblastoma in children)</li>
          <li>Excessive UV exposure (linked to ocular melanoma)</li>
          <li>Weakened immune system (e.g., HIV, immunosuppression)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Blurry vision or partial loss of vision</li>
          <li>Seeing flashes of light, floaters, or shadows</li>
          <li>Bulging of the eye or a noticeable mass</li>
          <li>Changes in the appearance of the pupil or iris</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Ophthalmic exam and fundoscopy</li>
          <li>Ultrasound, CT, or MRI to assess tumor size and location</li>
          <li>Biopsy in select cases for histopathological confirmation</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Laser therapy or radiation (plaque brachytherapy) for small tumors</li>
          <li>Surgical resection (enucleation in advanced cases)</li>
          <li>Immunotherapy or chemotherapy for metastatic or aggressive types</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on the tumor type and stage. Early detection can preserve vision and reduce the risk of spread. Regular eye exams are critical for high-risk individuals.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/eye" target="_blank">NCI: Eye Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/eye-cancer.html" target="_blank">ACS: Eye Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Intraocular Melanoma -->
<div class="col-md-4 mb-4 article-card" data-category="eye-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSgp5CUQxINnVxV2xxVZk0V7oBorBh5s1jOzg&s"
      class="card-img-top"
      alt="Intraocular Melanoma"
    />
    <div class="card-body">
      <h5 class="card-title">Intraocular Melanoma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A primary melanoma that forms inside the eye, commonly in the uveal tract (iris, ciliary body, or choroid).
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Intraocular (uveal) melanoma is the most common primary eye cancer in adults. It develops from melanocytes in the uveal tract, which includes the iris, ciliary body, and choroid. Though rare, it can spread to other organs, particularly the liver.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Light eye color (blue or green eyes)</li>
          <li>Excessive ultraviolet (UV) exposure</li>
          <li>Certain genetic mutations (e.g., BAP1, GNAQ, GNA11)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Blurred vision or visual field loss</li>
          <li>Seeing flashes or floating spots</li>
          <li>Changes in the shape of the pupil</li>
          <li>Dark spots on the iris or white area of the eye</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Ophthalmic examination with slit-lamp and indirect ophthalmoscopy</li>
          <li>Ultrasound of the eye to measure tumor size</li>
          <li>Fluorescein angiography or MRI for detailed imaging</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Radiation therapy (brachytherapy) for small to medium tumors</li>
          <li>Enucleation (surgical removal of the eye) for large or advanced tumors</li>
          <li>Proton beam therapy for precise targeting</li>
          <li>Immunotherapy in metastatic cases (e.g., checkpoint inhibitors)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Early detection can preserve vision and reduce metastasis risk. Advanced intraocular melanoma can spread to the liver, making regular systemic follow-up crucial.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/eye/patient/ocular-melanoma-treatment-pdq" target="_blank">NCI: Intraocular (Uveal) Melanoma</a></li>
          <li><a href="https://www.cancer.org/cancer/eye-cancer/about/what-is-eye-cancer.html" target="_blank">ACS: Eye Cancer Overview</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Retinoblastoma -->
<div class="col-md-4 mb-4 article-card" data-category="eye-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQX1g0dKpDGMtnoZwra9LDkuuV2DVq-v0hPjg&s"
      class="card-img-top"
      alt="Retinoblastoma"
    />
    <div class="card-body">
      <h5 class="card-title">Retinoblastoma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare childhood eye cancer that develops in the retina, often detectable through a “white pupillary reflex” in photos.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Retinoblastoma is a pediatric eye cancer originating in the retinal cells. It can be hereditary (involving mutations in the RB1 gene) or sporadic. Early detection is critical for preserving vision and preventing spread.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Germline mutations in the RB1 gene for hereditary cases</li>
          <li>Sporadic mutations in one eye (non-hereditary)</li>
          <li>Family history of retinoblastoma increases risk</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Leukocoria (white pupillary reflex) often noticed in flash photography</li>
          <li>Strabismus (crossed eyes) or poor vision</li>
          <li>Redness or swelling of the eye</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Fundoscopic exam by a pediatric ophthalmologist</li>
          <li>Ultrasound or MRI of the eye to confirm tumor presence</li>
          <li>Genetic testing for RB1 mutations in hereditary cases</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Focal therapies (laser photocoagulation, cryotherapy) for small tumors</li>
          <li>Chemotherapy (systemic or intra-arterial) to shrink larger tumors</li>
          <li>Enucleation for advanced cases threatening vision or life</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          With early detection, cure rates are high. Children with hereditary retinoblastoma require lifelong monitoring for second malignancies. Vision preservation depends on tumor location and size at diagnosis.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/eye/patient/retinoblastoma-treatment-pdq" target="_blank">NCI: Retinoblastoma</a></li>
          <li><a href="https://www.stjude.org/disease/retinoblastoma.html" target="_blank">St. Jude: Retinoblastoma</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Gastric (Stomach) Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="gastrointestinal-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTGJEI2kFbX9z0W6aKfeH25sXYOhHtGWnfv5Q&s"
      class="card-img-top"
      alt="Gastric (Stomach) Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Gastric (Stomach) Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A malignancy that originates in the stomach lining, often linked to Helicobacter pylori infection and dietary factors.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Gastric cancer arises from the mucosal lining of the stomach, typically presenting as adenocarcinoma. It is more common in East Asia and is often associated with chronic inflammation or infection (e.g., H. pylori).
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Helicobacter pylori infection (chronic gastritis)</li>
          <li>Diet high in smoked, salted, or pickled foods</li>
          <li>Smoking and excessive alcohol use</li>
          <li>Genetic predispositions (e.g., hereditary diffuse gastric cancer with CDH1 mutations)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Indigestion, heartburn, or stomach discomfort</li>
          <li>Unintended weight loss or persistent nausea</li>
          <li>Loss of appetite and feeling full early (early satiety)</li>
          <li>Bloody or black stools (melena)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Upper endoscopy (EGD) with biopsy</li>
          <li>CT scan for staging and extent of disease</li>
          <li>Endoscopic ultrasound to assess tumor depth</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection (subtotal or total gastrectomy)</li>
          <li>Chemotherapy and/or radiation (neoadjuvant or adjuvant)</li>
          <li>Targeted therapy (e.g., HER2 inhibitors for HER2-positive tumors)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on the stage at diagnosis. Early-stage detection improves outcomes significantly. Lifestyle modifications (e.g., reducing salt intake, treating H. pylori) can help lower risk.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/stomach" target="_blank">NCI: Stomach (Gastric) Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/stomach-cancer.html" target="_blank">ACS: Stomach Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Gastrointestinal Neuroendocrine Tumors -->
<div class="col-md-4 mb-4 article-card" data-category="gastrointestinal-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTmQNspxyDiSSPrM2blKxCbEkvm9E5__VWINg&s"
      class="card-img-top"
      alt="Gastrointestinal Neuroendocrine Tumors"
    />
    <div class="card-body">
      <h5 class="card-title">Gastrointestinal Neuroendocrine Tumors</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A group of rare tumors arising from hormone-producing cells in the GI tract, often called carcinoid tumors.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Gastrointestinal neuroendocrine tumors (NETs), sometimes referred to as carcinoid tumors, originate from neuroendocrine cells in the GI tract. Common sites include the small intestine, appendix, and rectum. They may secrete hormones leading to distinct clinical syndromes (e.g., carcinoid syndrome).
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic syndromes (e.g., Multiple Endocrine Neoplasia type 1)</li>
          <li>Chronic atrophic gastritis (for gastric NETs)</li>
          <li>Smoking and certain lifestyle factors (minor contributors)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Abdominal pain, bloating, or changes in bowel habits</li>
          <li>Carcinoid syndrome: flushing, diarrhea, wheezing (if tumor secretes serotonin and metastasizes to liver)</li>
          <li>Occult bleeding or anemia</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Endoscopy or colonoscopy for direct visualization</li>
          <li>Imaging (CT, MRI) to locate primary tumor and metastases</li>
          <li>Blood/urine tests (chromogranin A, 5-HIAA)</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection for localized disease</li>
          <li>Somatostatin analogs (octreotide) to control hormone-related symptoms</li>
          <li>Targeted therapies (e.g., everolimus, sunitinib) for advanced NETs</li>
          <li>Peptide receptor radionuclide therapy (PRRT) in certain cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on tumor grade, size, and spread. Many NETs grow slowly, allowing for extended survival. Lifelong follow-up is essential due to the potential for late recurrence or progression.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/gi-net" target="_blank">NCI: Gastrointestinal Neuroendocrine Tumors</a></li>
          <li><a href="https://www.cancer.org/cancer/gastrointestinal-carcinoid-tumor.html" target="_blank">ACS: GI Carcinoid Tumors</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Gastrointestinal Stromal Tumors (GIST) (Soft Tissue Sarcoma) -->
<div class="col-md-4 mb-4 article-card" data-category="sarcoma">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSR_P9Xk0MyDYrbLORSK6TeThq2m0bfNfSQuA&s"
      class="card-img-top"
      alt="Gastrointestinal Stromal Tumors (GIST)"
    />
    <div class="card-body">
      <h5 class="card-title">Gastrointestinal Stromal Tumors (GIST)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A type of soft tissue sarcoma found in the GI tract, often driven by mutations in the KIT or PDGFRA genes.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors arising from the interstitial cells of Cajal or related stem cells in the GI tract. Most occur in the stomach or small intestine and may present with bleeding or obstruction.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Mutations in KIT (CD117) or PDGFRA genes in ~85-90% of cases</li>
          <li>Familial GIST syndromes (rare)</li>
          <li>Neurofibromatosis type 1 (NF1) may predispose</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>GI bleeding (melena or hematemesis)</li>
          <li>Abdominal pain or fullness</li>
          <li>Fatigue, anemia if chronic blood loss</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Endoscopic ultrasound or CT scan for tumor detection</li>
          <li>Biopsy for histopathology and immunohistochemistry (CD117 staining)</li>
          <li>Molecular testing for KIT/PDGFRA mutations</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection for localized GIST</li>
          <li>Tyrosine kinase inhibitors (e.g., imatinib) for advanced or unresectable GIST</li>
          <li>Adjuvant therapy with imatinib to reduce recurrence risk post-surgery</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on tumor size, location, mitotic rate, and mutational status. Targeted therapies have dramatically improved outcomes for advanced GIST. Long-term follow-up is essential to monitor for recurrence.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/soft-tissue-sarcoma/patient/gist-treatment-pdq" target="_blank">NCI: GIST Treatment</a></li>
          <li><a href="https://www.cancer.org/cancer/gastrointestinal-stromal-tumor.html" target="_blank">ACS: Gastrointestinal Stromal Tumors</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>



<!-- Fallopian Tube Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="gynecologic-cancer">
  <div class="card">
    <img
      src="https://www.artfertilityclinics.com/in/wp-content/uploads/sites/4/2024/03/Fallopian-Tube-Cancer-_-Causes-Symptoms-and-Treatment.jpg"
      class="card-img-top"
      alt="Fallopian Tube Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Fallopian Tube Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare gynecologic malignancy arising in the fallopian tubes, often resembling ovarian cancer in presentation.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Fallopian tube cancer originates in the tubes that connect the ovaries to the uterus. It is considered uncommon and shares many similarities with ovarian cancer in terms of symptoms, spread patterns, and treatment approaches.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>BRCA1/BRCA2 gene mutations (associated with hereditary breast and ovarian cancer)</li>
          <li>Family history of ovarian or breast cancer</li>
          <li>Increasing age, especially postmenopausal</li>
          <li>Possible association with prolonged hormone replacement therapy</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Pelvic pain or pressure</li>
          <li>Abdominal bloating or swelling</li>
          <li>Unusual vaginal bleeding or discharge</li>
          <li>Fatigue, weight loss</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Pelvic exam and transvaginal ultrasound</li>
          <li>CT scan or MRI for tumor extent</li>
          <li>CA-125 blood test (tumor marker)</li>
          <li>Definitive diagnosis often made during surgery</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection (total hysterectomy with bilateral salpingo-oophorectomy)</li>
          <li>Chemotherapy (often platinum-based, similar to ovarian cancer)</li>
          <li>Targeted therapies (e.g., PARP inhibitors for BRCA-mutated cases)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Early detection can improve outcomes, but fallopian tube cancer is often diagnosed at advanced stages. Long-term follow-up is essential for monitoring recurrence and managing side effects.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/ovarian/patient/fallopian-treatment-pdq" target="_blank">NCI: Fallopian Tube Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/ovarian-cancer.html" target="_blank">ACS: Ovarian & Related Cancers</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Gallbladder Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="gastrointestinal-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS5rJ2mA_NAXDGm5uHDHQAp_YtV3IUEr92L0g&s"
      class="card-img-top"
      alt="Gallbladder Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Gallbladder Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare gastrointestinal malignancy originating in the gallbladder, often diagnosed incidentally after surgery for gallstones.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Gallbladder cancer arises from the inner lining (mucosa) of the gallbladder. It is more common in older adults and women, and is often discovered at an advanced stage due to nonspecific symptoms.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Chronic gallbladder inflammation (cholelithiasis, gallstones)</li>
          <li>Gallbladder polyps larger than 1 cm</li>
          <li>Female gender, older age</li>
          <li>Geographic prevalence (e.g., high rates in South America, Japan)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Abdominal pain (particularly in the upper right quadrant)</li>
          <li>Jaundice (yellowing of the skin/eyes), dark urine</li>
          <li>Nausea, vomiting, and loss of appetite</li>
          <li>Unintended weight loss</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Imaging (ultrasound, CT, MRI) to identify masses</li>
          <li>Blood tests (liver function, tumor markers like CA 19-9)</li>
          <li>Definitive diagnosis often after surgical removal</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection (cholecystectomy) with partial liver resection and lymph node dissection</li>
          <li>Chemotherapy and/or radiation for advanced stages</li>
          <li>Palliative stenting for biliary obstruction</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Early-stage gallbladder cancer may be curable by surgery, but advanced disease carries a poor prognosis. Regular follow-up is vital to detect recurrence or manage complications.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/liver/patient/gallbladder-treatment-pdq" target="_blank">NCI: Gallbladder Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/gallbladder-cancer.html" target="_blank">ACS: Gallbladder Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Germ Cell Tumors -->
<div class="col-md-4 mb-4 article-card" data-category="germ-cell-tumor">
  <div class="card">
    <img
      src="https://www.webpathology.com/_next/image?url=https%3A%2F%2Fd3cyex60hhnlth.cloudfront.net%2Ffit-in%2F650x650%2Ffilters%3Aformat(webp)%2Fcase%2Fdetail_images%2Fc3681_detail.jpg&w=1920&q=75"
      class="card-img-top"
      alt="Germ Cell Tumors"
    />
    <div class="card-body">
      <h5 class="card-title">Germ Cell Tumors</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A diverse group of tumors arising from germ cells, often occurring in the ovaries or testes but also in extragonadal sites.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Germ cell tumors develop from germ cells that form eggs (in females) or sperm (in males). They most commonly appear in the ovaries or testes but can also occur extragonadally (e.g., mediastinum, retroperitoneum). Subtypes include seminomas, non-seminomatous tumors, and teratomas.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic predispositions (e.g., Klinefelter syndrome in males)</li>
          <li>Undescended testicle (cryptorchidism) for testicular germ cell tumors</li>
          <li>Family history of germ cell tumors</li>
          <li>Abnormal embryonic cell migration (extragonadal tumors)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Testicular mass or swelling, abdominal mass</li>
          <li>Pain or discomfort in the affected area</li>
          <li>Hormonal changes (e.g., precocious puberty if hormone-producing)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Imaging (ultrasound, CT, MRI) of the affected region</li>
          <li>Serum tumor markers (AFP, β-hCG, LDH)</li>
          <li>Biopsy or surgical resection for histological confirmation</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgery (e.g., orchiectomy for testicular tumors)</li>
          <li>Chemotherapy (e.g., BEP regimen: bleomycin, etoposide, cisplatin)</li>
          <li>Radiation therapy for seminomas in certain stages</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Most germ cell tumors have a high cure rate when detected early. Long-term follow-up is essential to monitor for recurrence and manage late effects of treatment.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/testicular/patient/testicular-treatment-pdq" target="_blank">NCI: Germ Cell Tumors (Testicular)</a></li>
          <li><a href="https://www.cancer.org/cancer/ovarian-cancer.html" target="_blank">ACS: Ovarian Germ Cell Tumors</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Childhood Central Nervous System Germ Cell Tumors (Brain Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="brain-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTyGuiWLRKOWfB68q9zHiaHNgQA-0euFzTOdDCqgnqLzIB7DvAa_iNZPhoEbCiAkuf2J18&usqp=CAU"
      class="card-img-top"
      alt="Childhood CNS Germ Cell Tumors (Brain Cancer)"
    />
    <div class="card-body">
      <h5 class="card-title">Childhood CNS Germ Cell Tumors (Brain Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Germ cell tumors that develop within the brain or spinal cord in children, often located in the pineal or suprasellar regions.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood CNS germ cell tumors occur when germ cells migrate abnormally to the central nervous system (CNS). Common sites include the pineal gland and the area above the pituitary gland (suprasellar region). They can be either benign (e.g., mature teratomas) or malignant (e.g., germinomas, nongerminomatous germ cell tumors).
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Abnormal embryonic migration of germ cells</li>
          <li>Rare genetic syndromes in some cases</li>
          <li>Mostly sporadic with no identifiable risk factors</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Increased intracranial pressure (headaches, vomiting)</li>
          <li>Hormonal imbalances (diabetes insipidus, growth issues)</li>
          <li>Visual disturbances if the optic pathway is compressed</li>
          <li>Early or delayed puberty</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>MRI of the brain/spine to identify tumor location</li>
          <li>Serum/CSF tumor markers (AFP, β-hCG)</li>
          <li>Biopsy or surgical resection for histological confirmation</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Chemotherapy and radiation therapy for malignant germ cell tumors</li>
          <li>Surgical resection if accessible and safe to remove</li>
          <li>Hormone replacement therapy if pituitary/hypothalamic function is affected</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis varies by tumor type and stage. Germinomas generally respond well to treatment, with high cure rates. Lifelong follow-up is essential to address endocrine issues and monitor for recurrence.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/brain/patient/child-germ-cell-treatment-pdq" target="_blank">NCI: Childhood CNS Germ Cell Tumors</a></li>
          <li><a href="https://www.stjude.org/disease/germ-cell-tumor.html" target="_blank">St. Jude: CNS Germ Cell Tumors</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Childhood Extracranial Germ Cell Tumors -->
<div class="col-md-4 mb-4 article-card" data-category="childhood-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSIWVZIC9bR2TcasrG-LJXLURA-Vev2BX4Ieg&s"
      class="card-img-top"
      alt="Childhood Extracranial Germ Cell Tumors"
    />
    <div class="card-body">
      <h5 class="card-title">Childhood Extracranial Germ Cell Tumors</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Rare pediatric germ cell tumors occurring outside the brain, often in the gonads or sacrococcygeal region.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood extracranial germ cell tumors appear in locations other than the central nervous system, such as the ovaries, testes, or sacrococcygeal area. These tumors can be benign (mature teratoma) or malignant (yolk sac tumor, embryonal carcinoma).
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic conditions (e.g., Klinefelter syndrome, Swyer syndrome)</li>
          <li>Family history of germ cell tumors (rare)</li>
          <li>Abnormal embryonic cell migration in the sacrococcygeal region</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Palpable mass in the gonads or sacrococcygeal area</li>
          <li>Abdominal swelling or pain</li>
          <li>Hormonal imbalances if tumor secretes hormones</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Imaging (ultrasound, MRI) to characterize the mass</li>
          <li>Serum tumor markers (AFP, β-hCG)</li>
          <li>Biopsy or surgical resection for definitive pathology</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical removal (often curative if localized)</li>
          <li>Chemotherapy for malignant or advanced tumors</li>
          <li>Radiation therapy in selected metastatic cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Most children respond well to surgery and chemotherapy, with favorable survival rates for localized disease. Long-term follow-up is important to detect recurrence and manage potential late effects of treatment.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/germ-cell/patient/child-germ-cell-treatment-pdq" target="_blank">NCI: Childhood Extracranial Germ Cell Tumors</a></li>
          <li><a href="https://www.stjude.org/disease/germ-cell-tumor.html" target="_blank">St. Jude: Germ Cell Tumors</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Extragonadal Germ Cell Tumors -->
<div class="col-md-4 mb-4 article-card" data-category="germ-cell-tumor">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTTkwxQ821rdB9YDqu7Rzq9HiwRcFXIcaS-pMcpHFbglid_22kL7Bf1_CvTM6F_qFzzN2w&usqp=CAU"
      class="card-img-top"
      alt="Extragonadal Germ Cell Tumors"
    />
    <div class="card-body">
      <h5 class="card-title">Extragonadal Germ Cell Tumors</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A group of germ cell tumors that develop outside the gonads, often found in midline locations such as the mediastinum or retroperitoneum.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Extragonadal germ cell tumors arise from germ cells that migrate incorrectly during embryonic development, settling in areas other than the ovaries or testes. Common sites include the anterior mediastinum, retroperitoneum, or pineal gland in the brain. These tumors can be seminomatous or non-seminomatous, each with distinct treatment approaches.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Embryonic misplacement of germ cells</li>
          <li>Possible genetic predispositions (rare)</li>
          <li>More frequent in adolescents and young adults</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Chest pain or shortness of breath (mediastinal tumors)</li>
          <li>Abdominal pain or fullness (retroperitoneal tumors)</li>
          <li>Compression of nearby structures (blood vessels, nerves)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Imaging (CT, MRI) of the suspected region</li>
          <li>Serum tumor markers (AFP, β-hCG)</li>
          <li>Biopsy or surgical exploration for histological confirmation</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Combination chemotherapy (e.g., BEP regimen) for malignant tumors</li>
          <li>Surgical resection of residual masses</li>
          <li>Radiation therapy in select refractory or specific subtypes</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on tumor type, stage, and marker levels. Many extragonadal germ cell tumors respond well to chemotherapy, but long-term follow-up is necessary to detect recurrence and manage late effects.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/testicular/patient/testicular-treatment-pdq#_284" target="_blank">NCI: Extragonadal Germ Cell Tumors</a></li>
          <li><a href="https://www.cancer.org/cancer/testicular-cancer.html" target="_blank">ACS: Germ Cell Tumors (Related Info)</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Ovarian Germ Cell Tumors -->
<div class="col-md-4 mb-4 article-card" data-category="ovarian-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR9NPwm19fJdpOD_M7ubk4xZnu8FTKUPHmwWA&s"
      class="card-img-top"
      alt="Ovarian Germ Cell Tumors"
    />
    <div class="card-body">
      <h5 class="card-title">Ovarian Germ Cell Tumors</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A subset of ovarian cancers arising from germ cells in the ovary, often affecting adolescents and young women.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Ovarian germ cell tumors originate from the reproductive (germ) cells within the ovary. They can range from benign teratomas (dermoid cysts) to malignant subtypes like dysgerminoma, yolk sac tumor, and embryonal carcinoma. While less common than epithelial ovarian cancers, they tend to occur in younger women.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic predispositions (e.g., dysgerminoma in gonadal dysgenesis)</li>
          <li>Family history of germ cell tumors (rare)</li>
          <li>Most cases are sporadic with no clear risk factors</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Abdominal or pelvic pain</li>
          <li>Swelling or a palpable mass</li>
          <li>Irregular menstrual cycles</li>
          <li>Possible hormonal effects (e.g., precocious puberty)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Pelvic ultrasound, CT, or MRI to visualize ovarian masses</li>
          <li>Serum tumor markers (AFP, β-hCG, LDH)</li>
          <li>Surgical evaluation (exploratory laparotomy or laparoscopy)</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection (oophorectomy) for localized disease</li>
          <li>Combination chemotherapy (e.g., BEP regimen) for malignant subtypes</li>
          <li>Fertility-sparing surgery in early-stage disease if possible</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Many ovarian germ cell tumors have excellent cure rates, especially when detected early. Long-term follow-up is vital to detect recurrence and preserve fertility.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/ovarian/patient/ovarian-germ-cell-treatment-pdq" target="_blank">NCI: Ovarian Germ Cell Tumors</a></li>
          <li><a href="https://www.cancer.org/cancer/ovarian-cancer.html" target="_blank">ACS: Ovarian Cancer</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Testicular Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="testicular-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRc4tNmQy00Y3NOfZ0Ln8ZNgc0sbRTBaTdd-Q&s"
      class="card-img-top"
      alt="Testicular Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Testicular Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A common cancer in young men, arising from germ cells in the testes and often highly treatable.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Testicular cancer typically originates in the germ cells of the testicles and is broadly classified into seminomas and non-seminomas. It is the most common solid tumor in young adult males and has one of the highest cure rates among cancers.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Undescended testicle (cryptorchidism)</li>
          <li>Family history of testicular cancer</li>
          <li>HIV infection or prior testicular cancer</li>
          <li>Certain genetic syndromes (e.g., Klinefelter syndrome)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Painless lump or swelling in one testicle</li>
          <li>Heaviness or ache in the lower abdomen or scrotum</li>
          <li>Breast growth or tenderness (rare)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Scrotal ultrasound to identify testicular masses</li>
          <li>Serum tumor markers (AFP, β-hCG, LDH)</li>
          <li>CT scan for staging and metastasis detection</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Radical inguinal orchiectomy (surgical removal of the affected testicle)</li>
          <li>Chemotherapy (e.g., BEP regimen) for advanced or non-seminomatous types</li>
          <li>Radiation therapy for seminomas in certain stages</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          With modern therapies, testicular cancer has an excellent prognosis, even in metastatic cases. Regular follow-up is crucial to detect recurrence. Fertility preservation should be discussed before treatment.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/testicular" target="_blank">NCI: Testicular Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/testicular-cancer.html" target="_blank">ACS: Testicular Cancer</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Gestational Trophoblastic Disease -->
<div class="col-md-4 mb-4 article-card" data-category="gynecologic-cancer">
  <div class="card">
    <img
      src="https://www.hcgmanavatacancer.org/wp-content/uploads/2022/08/Gestational-Trophoblastic-Diseasedesktopnew-banner.jpeg"
      class="card-img-top"
      alt="Gestational Trophoblastic Disease"
    />
    <div class="card-body">
      <h5 class="card-title">Gestational Trophoblastic Disease</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A group of pregnancy-related tumors arising from trophoblastic tissue, including hydatidiform moles and choriocarcinoma.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Gestational trophoblastic disease (GTD) encompasses several conditions, including complete and partial hydatidiform moles, invasive moles, choriocarcinoma, and placental-site trophoblastic tumors. These arise from the trophoblast, the tissue that normally develops into the placenta.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Abnormal fertilization events (e.g., empty ovum + single sperm duplication for complete mole)</li>
          <li>Previous molar pregnancy</li>
          <li>Extremes of maternal age (teenagers, women over 40)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Vaginal bleeding during or after pregnancy</li>
          <li>Excessively high hCG levels</li>
          <li>Uterus size larger or smaller than expected for gestational age</li>
          <li>Hyperemesis gravidarum (severe nausea and vomiting)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Ultrasound showing a “snowstorm” pattern (for molar pregnancies)</li>
          <li>Quantitative hCG blood tests</li>
          <li>Histopathological examination of evacuated tissue</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Suction curettage to remove molar tissue</li>
          <li>Chemotherapy (e.g., methotrexate) for persistent trophoblastic disease or choriocarcinoma</li>
          <li>Hysterectomy in select cases (patient’s choice, persistent disease)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Most molar pregnancies are benign and cured with evacuation, though follow-up hCG monitoring is critical to detect persistent disease. Choriocarcinoma responds well to chemotherapy, yielding high cure rates if diagnosed early.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/gestational-trophoblastic" target="_blank">NCI: Gestational Trophoblastic Disease</a></li>
          <li><a href="https://www.cancer.org/cancer/gestational-trophoblastic-disease.html" target="_blank">ACS: Gestational Trophoblastic Disease</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>



<!-- Hairy Cell Leukemia -->
<div class="col-md-4 mb-4 article-card" data-category="leukemia">
  <div class="card">
    <img
      src="https://images.squarespace-cdn.com/content/v1/5bb50ceeb10f2511ae4cfb96/1564940198863-6ZSO5X5VVL4D2VENBSWF/image-asset.jpeg?format=2500w"
      class="card-img-top"
      alt="Hairy Cell Leukemia"
    />
    <div class="card-body">
      <h5 class="card-title">Hairy Cell Leukemia</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare, slow-growing blood cancer characterized by abnormal B lymphocytes that appear “hairy” under the microscope.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Hairy cell leukemia (HCL) is a chronic B-cell lymphoproliferative disorder. It typically progresses slowly and is often discovered incidentally through routine blood work. The malignant cells have fine, hair-like projections on their surface when viewed under a microscope.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Exact cause unknown; likely genetic and environmental factors</li>
          <li>Male gender and middle age or older</li>
          <li>Exposure to certain chemicals (e.g., pesticides) suggested but not conclusive</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Fatigue and weakness due to anemia</li>
          <li>Frequent infections from low white blood cell counts</li>
          <li>Enlarged spleen (splenomegaly), abdominal fullness</li>
          <li>Easy bruising or bleeding (thrombocytopenia)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Complete blood count (CBC) showing pancytopenia</li>
          <li>Peripheral blood smear with characteristic “hairy” cells</li>
          <li>Bone marrow biopsy and flow cytometry (CD19+, CD20+, CD103+, CD25+)</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Watchful waiting for asymptomatic patients</li>
          <li>Purine analogs (e.g., cladribine, pentostatin) are first-line therapies</li>
          <li>Rituximab (monoclonal antibody) for refractory or relapsed disease</li>
          <li>Splenectomy in select cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Hairy cell leukemia often responds well to treatment, with long-lasting remissions. Regular follow-up is important to monitor for relapse or secondary malignancies.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/leukemia/patient/hairy-cell-leukemia-treatment-pdq" target="_blank">NCI: Hairy Cell Leukemia</a></li>
          <li><a href="https://www.cancer.org/cancer/hairy-cell-leukemia.html" target="_blank">ACS: Hairy Cell Leukemia</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Head and Neck Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="head-neck-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSDgZNiTZaPtkTMHeRD6W9v-f7MajgYXZvV2g&s"
      class="card-img-top"
      alt="Head and Neck Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Head and Neck Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A broad category of cancers affecting the oral cavity, pharynx, larynx, sinuses, or salivary glands, often linked to tobacco and alcohol use.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Head and neck cancers encompass a variety of malignancies arising in the squamous cells lining the mouth, throat, and voice box, as well as in glands like the salivary glands. Human papillomavirus (HPV) is also a significant risk factor for oropharyngeal cancers.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Smoking and heavy alcohol consumption</li>
          <li>HPV infection (especially for oropharyngeal cancers)</li>
          <li>Prolonged sun exposure (lip and skin cancers)</li>
          <li>Poor oral hygiene and certain occupational exposures</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>A persistent sore or lump in the mouth or throat</li>
          <li>Difficulty swallowing or persistent hoarseness</li>
          <li>Non-healing ulcer or red/white patch in the mouth</li>
          <li>Unexplained weight loss, ear pain, or swollen lymph nodes</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Physical examination (oral exam, nasopharyngoscopy)</li>
          <li>Imaging (CT, MRI, or PET scans) to assess tumor extent</li>
          <li>Biopsy for histopathological confirmation</li>
          <li>HPV testing for oropharyngeal cancers</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgery (tumor resection, neck dissection for lymph nodes)</li>
          <li>Radiation therapy alone or in combination with chemotherapy</li>
          <li>Targeted therapy (e.g., cetuximab) in certain cases</li>
          <li>Reconstructive surgery and rehabilitation (speech, swallowing) as needed</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on the tumor’s location, stage, and HPV status. Early detection significantly improves outcomes. Smoking cessation and moderation of alcohol intake are critical for prevention and improved survival.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/head-and-neck" target="_blank">NCI: Head and Neck Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/head-neck-cancer.html" target="_blank">ACS: Head and Neck Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Heart Tumors, Childhood -->
<div class="col-md-4 mb-4 article-card" data-category="childhood-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQNhRKhxG6Hsr0ccLqnPRS05Rl_te7yCPAVT38V-3ZqK5utlJZsb186MKYpvoTE8k070ok&usqp=CAU"
      class="card-img-top"
      alt="Heart Tumors, Childhood"
    />
    <div class="card-body">
      <h5 class="card-title">Heart Tumors, Childhood</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Rare pediatric tumors affecting the heart muscle or surrounding tissues, potentially impacting cardiac function.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Childhood heart tumors are exceptionally rare and can be benign (e.g., rhabdomyomas, fibromas) or malignant (e.g., sarcomas). These tumors may arise in the myocardium (heart muscle), endocardium, or pericardium, potentially affecting normal cardiac function and overall health.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic syndromes (e.g., tuberous sclerosis for rhabdomyomas)</li>
          <li>Congenital anomalies</li>
          <li>Family history of cardiac tumors (rare)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Arrhythmias (irregular heartbeats)</li>
          <li>Shortness of breath or difficulty feeding in infants</li>
          <li>Chest pain or palpitations</li>
          <li>Signs of heart failure (edema, fatigue)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Echocardiogram (ultrasound of the heart)</li>
          <li>MRI or CT scan for detailed cardiac imaging</li>
          <li>Biopsy or surgical exploration in select cases</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection if the tumor is symptomatic and resectable</li>
          <li>Medical management for arrhythmias or heart failure</li>
          <li>Chemotherapy or radiation for malignant tumors</li>
          <li>Heart transplantation in extremely rare, severe cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Most pediatric cardiac tumors (e.g., rhabdomyomas) are benign and may regress spontaneously. Long-term follow-up with a pediatric cardiologist is essential to monitor cardiac function and detect any recurrence.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/childhood-cancers" target="_blank">NCI: Childhood Cancers (Heart Tumors)</a></li>
          <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223898/" target="_blank">National Library of Medicine: Cardiac Tumors in Children</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Hepatocellular (Liver) Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="liver-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSyuvNnKM56T5EdyUMJ_urdxJuFfTxPz59MGg&s"
      class="card-img-top"
      alt="Hepatocellular (Liver) Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Hepatocellular (Liver) Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        The most common primary liver cancer, often arising in the setting of chronic liver disease or cirrhosis.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Hepatocellular carcinoma (HCC) is a primary malignant tumor of the liver, frequently associated with cirrhosis due to chronic hepatitis B or C infection, alcoholic liver disease, or nonalcoholic fatty liver disease (NAFLD). Early detection is crucial for potential curative treatment.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Chronic hepatitis B or C infection</li>
          <li>Alcohol-induced cirrhosis</li>
          <li>Obesity, diabetes, and NAFLD</li>
          <li>Aflatoxin exposure (common in some developing regions)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Abdominal pain, especially in the upper right quadrant</li>
          <li>Jaundice (yellowing of skin/eyes)</li>
          <li>Unexplained weight loss, fatigue</li>
          <li>Enlarged liver or palpable mass</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Imaging (ultrasound, CT, or MRI) with liver protocol</li>
          <li>Alpha-fetoprotein (AFP) blood test</li>
          <li>Liver biopsy in uncertain cases</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgical resection or liver transplantation for early-stage disease</li>
          <li>Ablation therapies (radiofrequency, microwave) for small tumors</li>
          <li>Transarterial chemoembolization (TACE) for intermediate disease</li>
          <li>Targeted therapies (e.g., sorafenib) or immunotherapy in advanced disease</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on tumor stage and underlying liver function. Screening programs for high-risk individuals (e.g., cirrhosis patients) can improve early detection and outcomes. Lifestyle modifications (limiting alcohol, managing weight) and treating viral hepatitis are key preventive measures.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/liver/patient/adult-liver-treatment-pdq" target="_blank">NCI: Adult Primary Liver Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/liver-cancer.html" target="_blank">ACS: Liver Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Histiocytosis, Langerhans Cell -->
<div class="col-md-4 mb-4 article-card" data-category="histiocytosis">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRIbXGiyi0kIzvISsLtV0ocFrPoN4rb32ah1A&s"
      class="card-img-top"
      alt="Langerhans Cell Histiocytosis"
    />
    <div class="card-body">
      <h5 class="card-title">Langerhans Cell Histiocytosis</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare disorder involving clonal proliferation of Langerhans-type cells, affecting both children and adults.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Langerhans Cell Histiocytosis (LCH) is characterized by an overproduction of Langerhans-type cells, which can infiltrate various tissues and organs. Although historically classified as a malignancy-like disease, LCH exhibits both inflammatory and neoplastic features.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Possible mutations in the BRAF or MAP2K1 genes</li>
          <li>Most cases are sporadic without a strong hereditary component</li>
          <li>Can occur at any age, but more common in children</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Bone lesions (skull, spine, ribs) causing pain or fractures</li>
          <li>Skin rashes resembling eczema or seborrheic dermatitis</li>
          <li>Swollen lymph nodes</li>
          <li>Organ dysfunction (liver, lungs) in multisystem disease</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Biopsy of affected tissue (immunohistochemical staining for CD1a, CD207)</li>
          <li>Imaging (X-ray, CT, MRI) to locate lesions</li>
          <li>Blood tests for organ function, hormone levels (if pituitary involvement)</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Observation for solitary lesions that may regress spontaneously</li>
          <li>Local therapies (surgical curettage, radiation) for isolated bone lesions</li>
          <li>Systemic chemotherapy or targeted therapy (e.g., BRAF inhibitors) in multisystem disease</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis varies based on the extent of organ involvement. Early detection and appropriate therapy can lead to good outcomes, especially in single-system disease. Lifelong follow-up may be needed to manage late effects or relapses.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/langerhans-cell-histiocytosis" target="_blank">NCI: Langerhans Cell Histiocytosis</a></li>
          <li><a href="https://www.histiocytesociety.org/" target="_blank">Histiocyte Society</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Hodgkin Lymphoma -->
<div class="col-md-4 mb-4 article-card" data-category="lymphoma">
  <div class="card">
    <img
      src="https://www.lymphoma.org.au/wp-content/uploads/2022/03/HodgkinLymphoma.png"
      class="card-img-top"
      alt="Hodgkin Lymphoma"
    />
    <div class="card-body">
      <h5 class="card-title">Hodgkin Lymphoma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A type of lymphoma distinguished by the presence of Reed-Sternberg cells, often affecting lymph nodes in the neck, chest, or underarms.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Hodgkin Lymphoma (HL) is a cancer of the lymphatic system characterized by large, abnormal lymphocytes called Reed-Sternberg cells. It commonly affects young adults and older adults, with a high treatment success rate.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Epstein-Barr virus (EBV) infection may increase risk</li>
          <li>Family history of lymphoma</li>
          <li>Immunosuppression (e.g., HIV/AIDS)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Painless swelling of lymph nodes (neck, armpit, groin)</li>
          <li>Fever, night sweats, unexplained weight loss (“B symptoms”)</li>
          <li>Fatigue and itching</li>
          <li>Cough or chest discomfort if mediastinal nodes are enlarged</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Lymph node biopsy to detect Reed-Sternberg cells</li>
          <li>Imaging (CT, PET scans) for staging</li>
          <li>Blood tests (CBC, ESR) and bone marrow biopsy if needed</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Combination chemotherapy (ABVD, BEACOPP) as first-line therapy</li>
          <li>Radiation therapy for localized disease</li>
          <li>Targeted therapies or immunotherapies (e.g., brentuximab vedotin, checkpoint inhibitors) for relapsed/refractory disease</li>
          <li>Stem cell transplant in certain advanced or recurrent cases</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Hodgkin Lymphoma is highly curable, with overall survival rates exceeding 80%. Early diagnosis and appropriate combination therapy yield the best outcomes. Regular follow-up is critical to monitor late effects and potential recurrence.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq" target="_blank">NCI: Adult Hodgkin Lymphoma</a></li>
          <li><a href="https://www.cancer.org/cancer/hodgkin-lymphoma.html" target="_blank">ACS: Hodgkin Lymphoma</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Hypopharyngeal Cancer (Head and Neck Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="head-neck-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQO2CgRXj5PWnNzNksenMyRWb9vOzhyBTrWtA&s"
      class="card-img-top"
      alt="Hypopharyngeal Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Hypopharyngeal Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A malignancy located in the hypopharynx, the lower part of the throat, often associated with tobacco and alcohol use.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Hypopharyngeal cancer arises in the hypopharynx, the region connecting the oropharynx to the esophagus. It is a subset of head and neck cancers, typically of squamous cell origin, and often diagnosed at advanced stages due to its subtle early symptoms.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Long-term tobacco use (smoking, chewing)</li>
          <li>Excessive alcohol consumption</li>
          <li>Nutritional deficiencies (e.g., low intake of fruits/vegetables)</li>
          <li>HPV infection may play a role in some cases</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Persistent sore throat or ear pain</li>
          <li>Difficulty swallowing (dysphagia) or a sensation of a lump in the throat</li>
          <li>Hoarseness or voice changes</li>
          <li>Unexplained weight loss</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Endoscopic examination (laryngoscopy) to visualize the hypopharynx</li>
          <li>Imaging (CT, MRI, PET) to assess tumor extent and lymph node involvement</li>
          <li>Biopsy for histopathological confirmation</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgery (partial or total pharyngectomy) for resectable tumors</li>
          <li>Chemoradiation therapy for advanced or unresectable disease</li>
          <li>Targeted therapies (e.g., cetuximab) in combination with radiation</li>
          <li>Speech and swallowing rehabilitation post-treatment</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on the tumor stage and patient’s overall health. Early detection is challenging, and advanced-stage disease may require aggressive combined therapies. Lifestyle modifications, such as quitting tobacco and alcohol, are essential for prevention and improved outcomes.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/head-and-neck/patient/hypopharyngeal-treatment-pdq" target="_blank">NCI: Hypopharyngeal Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/hypopharyngeal-cancer.html" target="_blank">ACS: Hypopharyngeal Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Intraocular Melanoma -->
<div class="col-md-4 mb-4 article-card" data-category="eye-cancer">
  <div class="card">
    <img
      src="https://treatcancer.com/wp-content/uploads/2015/10/bigoleye-1.jpg"
      class="card-img-top"
      alt="Intraocular Melanoma"
    />
    <div class="card-body">
      <h5 class="card-title">Intraocular Melanoma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare type of melanoma that develops in the eye, usually in the uveal tract (iris, ciliary body, or choroid).
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Intraocular melanoma is the most common primary eye cancer in adults, arising from melanocytes in the uveal tract. It is more frequently found in individuals with light-colored eyes.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic mutations (e.g., GNAQ, GNA11 genes)</li>
          <li>Prolonged UV exposure</li>
          <li>Light eye color (blue, green)</li>
          <li>Atypical mole syndrome or ocular melanocytosis</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Blurred or distorted vision</li>
          <li>Dark spots on the iris</li>
          <li>Flashes or floaters in vision</li>
          <li>Loss of peripheral vision</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Ophthalmologic examination (dilated eye exam, fundoscopy)</li>
          <li>Ultrasound of the eye</li>
          <li>Fluorescein angiography</li>
          <li>Biopsy (rarely needed if imaging confirms diagnosis)</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Radiation therapy (plaque brachytherapy, proton beam therapy)</li>
          <li>Laser therapy (if the tumor is small)</li>
          <li>Enucleation (eye removal) in advanced cases</li>
          <li>Targeted therapy for metastatic disease</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Early detection improves outcomes, but the risk of metastasis (especially to the liver) remains high. Regular follow-ups with an ophthalmologist and oncologist are critical.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/eye/patient/intraocular-melanoma-treatment-pdq" target="_blank">NCI: Intraocular Melanoma</a></li>
          <li><a href="https://www.cancer.org/cancer/eye-cancer.html" target="_blank">ACS: Eye Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Islet Cell Tumors (Pancreatic Neuroendocrine Tumors) -->
<div class="col-md-4 mb-4 article-card" data-category="pancreatic-tumors">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTSFbVmnW-NRVuaIYMt682oxt1cQHt1_DyvHQ&s"
      class="card-img-top"
      alt="Islet Cell Tumors"
    />
    <div class="card-body">
      <h5 class="card-title">Islet Cell Tumors (Pancreatic Neuroendocrine Tumors)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare form of pancreatic cancer arising from islet cells, which produce hormones such as insulin and glucagon.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Pancreatic neuroendocrine tumors (PNETs), also known as islet cell tumors, arise from hormone-producing cells in the pancreas. They are much rarer than pancreatic adenocarcinomas and may be either functional (hormone-secreting) or nonfunctional.
        <br /><br />
        <strong>Types of Islet Cell Tumors:</strong>
        <ul>
          <li><strong>Insulinomas:</strong> Secrete insulin, causing low blood sugar.</li>
          <li><strong>Gastrinomas:</strong> Produce excess gastrin, leading to Zollinger-Ellison syndrome.</li>
       
          <li><strong>VIPomas:</strong> Cause chronic diarrhea and electrolyte imbalances.</li>
        </ul>
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Genetic syndromes (e.g., MEN1, von Hippel-Lindau disease)</li>
          <li>Family history of endocrine tumors</li>
          <li>Most cases occur sporadically without a clear cause</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Weight loss, abdominal pain</li>
          <li>Jaundice (in larger tumors)</li>
          <li>Symptoms depend on hormone secretion (e.g., hypoglycemia for insulinomas)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Blood tests (hormone levels, chromogranin A)</li>
          <li>CT scan, MRI, or PET scan for tumor localization</li>
          <li>Endoscopic ultrasound-guided biopsy</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgery (curative for localized tumors)</li>
          <li>Targeted therapy (e.g., everolimus, sunitinib for advanced disease)</li>
        
          <li>Radiation therapy (Peptide Receptor Radionuclide Therapy, PRRT)</li>
        </ul>
      
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/pancreatic/patient/pnet-treatment-pdq" target="_blank">NCI: Pancreatic NETs</a></li>
          <li><a href="https://www.cancer.org/cancer/pancreatic-neuroendocrine-tumor.html" target="_blank">ACS: Pancreatic Neuroendocrine Tumors</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Kaposi Sarcoma -->
<div class="col-md-4 mb-4 article-card" data-category="soft-tissue-sarcoma">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQoSRfUF49Z714zBhiFKxqNTfe4OyzGqa8zEw&s"
      class="card-img-top"
      alt="Kaposi Sarcoma"
    />
    <div class="card-body">
      <h5 class="card-title">Kaposi Sarcoma (Soft Tissue Sarcoma)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare cancer that causes lesions on the skin, mouth, and internal organs, linked to human herpesvirus 8 (HHV-8).
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Kaposi Sarcoma (KS) is a rare type of soft tissue cancer caused by human herpesvirus 8 (HHV-8). It primarily affects individuals with weakened immune systems, such as those with HIV/AIDS.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Infection with HHV-8 (Kaposi Sarcoma-associated herpesvirus)</li>
          <li>Weakened immune system (HIV/AIDS, organ transplant recipients)</li>
          <li>Being of Mediterranean, African, or Eastern European descent</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Purple, red, or brown skin lesions</li>
          <li>Swelling in the limbs (lymphedema)</li>
          <li>Gastrointestinal bleeding (if internal lesions are present)</li>
          <li>Difficulty breathing (if lung involvement occurs)</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>Skin biopsy</li>
          <li>Endoscopy or bronchoscopy (if internal involvement is suspected)</li>
          <li>CD4 count and HIV testing for immunocompromised patients</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Antiretroviral therapy (for HIV-positive patients)</li>
          <li>Chemotherapy (liposomal doxorubicin)</li>
          <li>Radiation therapy for localized lesions</li>
          <li>Immunotherapy (pembrolizumab in certain cases)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Prognosis depends on the patient’s immune status. HIV-positive individuals often see significant improvement with antiretroviral therapy.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/kaposi" target="_blank">NCI: Kaposi Sarcoma</a></li>
          <li><a href="https://www.cancer.org/cancer/kaposi-sarcoma.html" target="_blank">ACS: Kaposi Sarcoma</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Kidney (Renal Cell) Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="kidney-cancer">
  <div class="card">
    <img
      src="https://media.post.rvohealth.io/wp-content/uploads/2020/09/642x361_RCC.jpg"
      class="card-img-top"
      alt="Kidney Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Kidney (Renal Cell) Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        The most common type of kidney cancer in adults, usually originating in the lining of the renal tubules.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Kidney cancer, also known as renal cell carcinoma (RCC), accounts for about 90% of kidney cancer cases. It originates in the renal tubules and is more common in men over 50.
        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li>Smoking</li>
          <li>Obesity</li>
          <li>High blood pressure</li>
          <li>Chronic kidney disease</li>
          <li>Genetic disorders (e.g., von Hippel-Lindau syndrome)</li>
        </ul>
        <strong>Symptoms:</strong>
        <ul>
          <li>Blood in urine (hematuria)</li>
          <li>Persistent lower back pain</li>
          <li>Unexplained weight loss</li>
          <li>Fatigue</li>
        </ul>
        <strong>Diagnosis:</strong>
        <ul>
          <li>CT scan or MRI</li>
          <li>Ultrasound</li>
          <li>Biopsy (if imaging is inconclusive)</li>
        </ul>
        <strong>Treatment:</strong>
        <ul>
          <li>Surgery (partial or total nephrectomy)</li>
          <li>Targeted therapy (e.g., sunitinib, pazopanib)</li>
          <li>Immunotherapy (e.g., nivolumab, pembrolizumab)</li>
          <li>Radiation therapy (for palliative care in advanced cases)</li>
        </ul>
        <strong>Prognosis & Management:</strong>
        <p>
          Early-stage kidney cancer has a high survival rate. Advanced cases may require combination therapy.
        </p>
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/kidney" target="_blank">NCI: Kidney Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/kidney-cancer.html" target="_blank">ACS: Kidney Cancer</a></li>
        </ol>
      </p>
      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Liver Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="liver-cancer">
  <div class="card">
    <img
      src="https://max-website20-images.s3.ap-south-1.amazonaws.com/liver_cancer_a221cfc41d.jpg"
      class="card-img-top"
      alt="Liver Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Liver Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Cancer that originates in the liver, most commonly as hepatocellular carcinoma, often linked to chronic liver disease.
      </p>

      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Liver cancer usually refers to **hepatocellular carcinoma (HCC)**, which develops from hepatocytes. Other less common types include **intrahepatic cholangiocarcinoma** and **angiosarcoma**. HCC often arises in a background of cirrhosis or chronic inflammation, making early detection crucial for successful treatment.

        <br /><br />
        <strong>Causes & Risk Factors:</strong>
        <ul>
          <li><strong>Hepatitis B &amp; C:</strong> Chronic viral infections are major contributors.</li>
          <li><strong>Alcohol-related cirrhosis:</strong> Long-term heavy drinking leads to liver scarring.</li>
          <li><strong>Nonalcoholic fatty liver disease (NAFLD):</strong> Obesity, diabetes, and metabolic syndrome can progress to cirrhosis.</li>

        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li>Unexplained weight loss and persistent fatigue</li>
          <li>Abdominal pain, especially in the upper right quadrant</li>
          <li>Jaundice (yellowing of skin and eyes), dark urine, pale stools</li>
          
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Imaging:</strong> Ultrasound, CT, or MRI scans to detect tumors.</li>
          <li><strong>Blood tests:</strong> Alpha-fetoprotein (AFP) often elevated in HCC.</li>
          <li><strong>Biopsy:</strong> In ambiguous cases to confirm malignancy.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgical resection:</strong> For early-stage tumors with good liver function.</li>
          <li><strong>Liver transplantation:</strong> Potentially curative if strict criteria are met.</li>
          <li><strong>Locoregional therapies:</strong> Radiofrequency ablation, TACE (chemoembolization), or Y-90 radioembolization.</li>
          
        </ul>

    
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/liver" target="_blank">NCI: Liver Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/liver-cancer.html" target="_blank">ACS: Liver Cancer</a></li>
        </ol>
      </p>

      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Lung Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="lung-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcShDsxSE5PsmYEzP9G4II5a0Hy7MSc_hKkMDA&s"
      class="card-img-top"
      alt="Lung Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Lung Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A diverse group of malignancies in the lungs, including Non-Small Cell, Small Cell, and rare pediatric or inflammatory tumors.
      </p>

      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Lung cancer generally falls into two broad categories: **Non-Small Cell Lung Cancer (NSCLC)** and **Small Cell Lung Cancer (SCLC)**. In addition, there are rarer entities such as **Pleuropulmonary Blastoma** (primarily in children), **Pulmonary Inflammatory Myofibroblastic Tumor** (often benign but locally aggressive), and **Tracheobronchial Tumors** affecting the airways.

        <br /><br />
        <strong>Types:</strong>
        <ul>
          <li><strong>Non-Small Cell Lung Cancer (NSCLC):</strong> Includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.</li>
          <li><strong>Small Cell Lung Cancer (SCLC):</strong> Highly aggressive with rapid growth, often metastasizes early.</li>
          <li><strong>Pleuropulmonary Blastoma:</strong> A rare pediatric tumor originating in lung or pleural tissue.</li>
         
          <li><strong>Tracheobronchial Tumor:</strong> Arises in the trachea or main bronchi (can be benign or malignant).</li>
        </ul>

        <strong>Risk Factors (primarily for adult lung cancers):</strong>
        <ul>
          <li>Smoking (cigarettes, pipes, cigars) – leading cause</li>
          <li>Secondhand smoke exposure</li>

        
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li>Persistent cough or changes in chronic cough</li>
    
          <li>Shortness of breath, wheezing</li>
          <li>Chest pain, hoarseness</li>
          
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Imaging:</strong> Chest X-ray, CT scan, or MRI to identify nodules or masses.</li>
       
          <li><strong>Molecular testing:</strong> EGFR, ALK, ROS1, and other mutations in NSCLC for targeted therapies.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgery:</strong> For early-stage NSCLC (lobectomy, segmentectomy).</li>
          <li><strong>Chemotherapy &amp; Radiation:</strong> Standard for advanced or unresectable cases, or for SCLC.</li>
          <li><strong>Targeted therapy:</strong> EGFR inhibitors, ALK inhibitors, etc., for mutation-driven cancers.</li>
        </ul>

       
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/lung" target="_blank">NCI: Lung Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/lung-cancer.html" target="_blank">ACS: Lung Cancer</a></li>
        </ol>
      </p>

      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Lymphoma -->
<div class="col-md-4 mb-4 article-card" data-category="lymphoma">
  <div class="card">
    <img
      src="https://media.post.rvohealth.io/wp-content/uploads/2020/09/lymphoma-symptoms_thumb-1-732x549.jpg"
      class="card-img-top"
      alt="Lymphoma"
    />
    <div class="card-body">
      <h5 class="card-title">Lymphoma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A group of blood cancers arising in the lymphatic system, broadly categorized as Hodgkin or Non-Hodgkin Lymphoma.
      </p>

      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Lymphoma is a malignancy of the lymphatic system, which includes lymph nodes, the spleen, thymus, bone marrow, and other organs. **Hodgkin Lymphoma (HL)** is marked by Reed-Sternberg cells, whereas **Non-Hodgkin Lymphoma (NHL)** encompasses diverse subtypes with varying behaviors and outcomes.

        <br /><br />
        <strong>Causes &amp; Risk Factors:</strong>
        <ul>
          <li>Immunodeficiency (HIV/AIDS, immunosuppressive drugs)</li>
          <li>Infections (Epstein-Barr virus, HTLV-1, Helicobacter pylori for certain MALT lymphomas)</li>
          <li>Genetic predisposition (family history, certain inherited syndromes)</li>
          <li>Exposure to chemicals (pesticides) or prior radiation therapy</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li>Painless swelling of lymph nodes (neck, armpits, groin)</li>
          
          <li>Unintended weight loss and fatigue</li>
          <li>Persistent cough or chest discomfort if mediastinal nodes enlarge</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
         
          <li><strong>Imaging:</strong> CT/PET scans for staging and to check spread.</li>
          <li><strong>Blood tests:</strong> CBC, LDH levels, and immunophenotyping.</li>
          <li><strong>Bone marrow biopsy:</strong> In many cases to determine extent of disease.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Chemotherapy:</strong> CHOP, ABVD, or other regimens depending on subtype.</li>
          <li><strong>Radiation therapy:</strong> Often used in early-stage HL or localized NHL.</li>
          <li><strong>Immunotherapy/Targeted therapy:</strong> Rituximab (anti-CD20), checkpoint inhibitors, CAR T-cell therapy in refractory cases.</li>
          
        </ul>

    es:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/lymphoma" target="_blank">NCI: Lymphoma</a></li>
          <li><a href="https://www.cancer.org/cancer/lymphoma.html" target="_blank">ACS: Lymphoma</a></li>
        </ol>
      </p>

      <!-- Read More Button -->
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Langerhans Cell Histiocytosis (LCH) -->
<div class="col-md-4 mb-4 article-card" data-category="histiocytosis">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS-WSVpeT7tRbVKlzwRz1qzQiK1LDgZVmeNwA&s"
      class="card-img-top"
      alt="Langerhans Cell Histiocytosis"
    />
    <div class="card-body">
      <h5 class="card-title">Langerhans Cell Histiocytosis (LCH)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare disorder in which excess immune system cells build up in organs, affecting bones, lungs, and skin.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Langerhans Cell Histiocytosis (LCH) is a rare disorder where clonal proliferation of Langerhans-type cells (a type of dendritic cell) leads to lesions in various tissues. Although previously referred to as a “histiocytic” disorder, modern research shows it shares neoplastic (cancer-like) and inflammatory features.

        <br /><br /><strong>Causes &amp; Risk Factors:</strong>
        <ul>
          <li><strong>Genetic Mutations:</strong> Many cases have mutations in the BRAF gene (e.g., BRAF V600E) or MAP2K1.</li>
          <li><strong>Immune Dysregulation:</strong> An abnormal immune response may contribute to proliferation of LCH cells.</li>
          <li><strong>Age Group:</strong> Most common in children under 10, but can occur at any age.</li>
          <li><strong>Smoking:</strong> Adult-onset pulmonary LCH is strongly linked to smoking.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Bone Pain:</strong> Especially in the skull, spine, or ribs due to lytic lesions.</li>
          <li><strong>Skin Rash:</strong> May resemble eczema or seborrheic dermatitis.</li>
          <li><strong>Organ Enlargement:</strong> Enlarged liver or spleen in multisystem disease.</li>
        
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Biopsy:</strong> Histopathological confirmation with CD1a and/or CD207 (langerin) staining.</li>
          <li><strong>Imaging:</strong> X-rays, CT, or MRI to identify lytic bone lesions or organ involvement.</li>
          <li><strong>Blood Tests:</strong> Evaluate organ function, pituitary hormones if diabetes insipidus is suspected.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Chemotherapy:</strong> Vinblastine, prednisone are common first-line for multisystem disease.</li>
          <li><strong>Steroids:</strong> Reduce inflammation, often used with chemotherapy.</li>
          <li><strong>Surgical Removal:</strong> For isolated bone lesions or diagnostic biopsy.</li>
          
          <li><strong>Radiation Therapy:</strong> Used sparingly, typically for localized lesions not responding to other treatments.</li>
        </ul>

      
        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/histiocytosis" target="_blank">NCI: LCH</a></li>
          <li><a href="https://rarediseases.org/rare-diseases/langerhans-cell-histiocytosis/" target="_blank">NORD: LCH Overview</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Laryngeal Cancer (Head & Neck Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="head-neck-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRiEA3Ct6cm1xSfdBwuaTHWgi6NwoEuH64vzw&s"
      class="card-img-top"
      alt="Laryngeal Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Laryngeal Cancer (Head &amp; Neck Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Cancer that forms in the tissues of the larynx, often linked to smoking and alcohol use.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Laryngeal cancer arises in the larynx (voice box), which includes the supraglottis, glottis, and subglottis. Most cases are squamous cell carcinomas. Early detection is key to preserving voice and swallowing function.

        <br /><br /><strong>Causes &amp; Risk Factors:</strong>
        <ul>
          <li><strong>Smoking &amp; Alcohol:</strong> Major risk factors, often acting synergistically.</li>
          <li><strong>HPV Infection:</strong> Can increase risk, especially for oropharyngeal regions, though less common in the larynx.</li>
          <li><strong>Occupational Exposures:</strong> Asbestos, wood dust, and certain chemicals.</li>
          <li><strong>Chronic Laryngitis/Reflux:</strong> Ongoing irritation may predispose to cancer.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Hoarseness/Voice Changes:</strong> Early sign if the tumor is on the vocal cords.</li>
          <li><strong>Persistent Sore Throat:</strong> Pain or irritation not resolving with usual treatments.</li>
          <li><strong>Difficulty Swallowing (Dysphagia):</strong> Tumor may obstruct the passage.</li>
          <li><strong>Neck Mass:</strong> Enlarged lymph nodes.</li>
          <li><strong>Ear Pain:</strong> Referred pain via cranial nerves.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Laryngoscopy:</strong> Direct or indirect visualization of the larynx.</li>
          <li><strong>Biopsy:</strong> Histopathological confirmation.</li>
          <li><strong>Imaging:</strong> CT, MRI, or PET scans to determine tumor extent.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Radiation Therapy:</strong> Often first-line for early-stage, especially glottic cancers.</li>
          <li><strong>Surgery:</strong> Partial or total laryngectomy in advanced cases, possibly with neck dissection.</li>
          <li><strong>Chemotherapy/Targeted Therapy:</strong> Used in combination with radiation for advanced disease (e.g., cisplatin, cetuximab).</li>
          <li><strong>Rehabilitation:</strong> Speech and swallowing therapy post-treatment.</li>
        </ul>

        <ol>
          <li><a href="https://www.cancer.org/cancer/laryngeal-and-hypopharyngeal-cancer.html" target="_blank">ACS: Laryngeal &amp; Hypopharyngeal Cancer</a></li>
          <li><a href="https://www.cancer.gov/types/head-and-neck/patient/adult/laryngeal-treatment-pdq" target="_blank">NCI: Laryngeal Cancer Treatment</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Leukemia -->
<div class="col-md-4 mb-4 article-card" data-category="blood-cancer">
  <div class="card">
    <img
      src="https://www.moffitt.org/globalassets/images/content-images/cancers/leukemia/petechiae-890.jpg"
      class="card-img-top"
      alt="Leukemia"
    />
    <div class="card-body">
      <h5 class="card-title">Leukemia</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A cancer of blood-forming tissues, affecting white blood cell production.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Leukemia is a broad category of cancers that originate in the bone marrow or blood, characterized by the uncontrolled production of abnormal white blood cells. It can be acute or chronic, and lymphoid or myeloid in origin.

        <br /><br /><strong>Types of Leukemia:</strong>
        <ul>
          <li><strong>Acute Lymphocytic Leukemia (ALL):</strong> Most common childhood leukemia.</li>
          <li><strong>Acute Myeloid Leukemia (AML):</strong> Common in adults; requires aggressive treatment.</li>
          <li><strong>Chronic Lymphocytic Leukemia (CLL):</strong> Slow-growing, often in older adults.</li>
          <li><strong>Chronic Myeloid Leukemia (CML):</strong> Linked to the Philadelphia chromosome (BCR-ABL fusion).</li>
        </ul>

        <strong>Risk Factors:</strong>
        <ul>
          <li>Exposure to high levels of radiation</li>
          <li>Previous chemotherapy</li>
          <li>Genetic syndromes (Down syndrome, Fanconi anemia)</li>
          <li>Smoking (mildly increases risk)</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Fatigue &amp; Weakness:</strong> Due to anemia.</li>
          <li><strong>Frequent Infections:</strong> Abnormal WBCs disrupt normal immunity.</li>
          <li><strong>Bruising &amp; Bleeding:</strong> Platelet counts can be low.</li>
          <li><strong>Bone or Joint Pain:</strong> Overcrowded bone marrow.</li>
          <li><strong>Swollen Lymph Nodes:</strong> Particularly in CLL.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Blood Tests:</strong> CBC with differential, peripheral smear.</li>
          <li><strong>Bone Marrow Aspiration/Biopsy:</strong> Definitive diagnosis.</li>
          <li><strong>Cytogenetic &amp; Molecular Testing:</strong> Identifies mutations (e.g., Philadelphia chromosome).</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Chemotherapy:</strong> Mainstay for most leukemias.</li>
          <li><strong>Bone Marrow Transplant (Hematopoietic Stem Cell Transplant):</strong> For high-risk or relapsed cases.</li>
          <li><strong>Targeted Therapy:</strong> (e.g., imatinib for CML, rituximab for certain ALL/CLL).</li>
          <li><strong>Immunotherapy:</strong> CAR T-cell therapy in refractory ALL.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Prognosis depends on leukemia subtype, genetic factors, and patient age. Many leukemias, especially in children, have high cure rates with modern therapy. Long-term monitoring is essential to detect relapse or late effects.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/leukemia" target="_blank">NCI: Leukemia</a></li>
          <li><a href="https://www.lls.org/" target="_blank">Leukemia &amp; Lymphoma Society</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Lip and Oral Cavity Cancer (Head & Neck Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="head-neck-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQDvWQJqQnJNt8SgttDA0laymJOV-G8cRWfzw&s"
      class="card-img-top"
      alt="Lip and Oral Cavity Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Lip and Oral Cavity Cancer (Head &amp; Neck Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A type of cancer affecting the lips, tongue, gums, and inner cheeks.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Lip and oral cavity cancers encompass malignancies of the lips, tongue, floor of the mouth, gums, and buccal mucosa. Most are squamous cell carcinomas, often associated with tobacco and alcohol use.

        <br /><br /><strong>Risk Factors:</strong>
        <ul>
          <li><strong>Tobacco Use:</strong> Smoking cigarettes, cigars, pipes, or using smokeless tobacco.</li>
          <li><strong>Heavy Alcohol Consumption:</strong> Synergistic effect with tobacco, greatly increasing risk.</li>
          <li><strong>HPV Infection:</strong> Certain oral cancers, especially of the oropharynx, linked to HPV (e.g., HPV-16).</li>
          <li><strong>Sun Exposure:</strong> Specifically for lip cancers.</li>
          <li><strong>Poor Oral Hygiene:</strong> Chronic irritation may predispose to malignancy.</li>
          <li><strong>Numbness:</strong> In the tongue or other areas of the mouth.</li>
          <li><strong>Difficulty Chewing/Swallowing:</strong> Dysphagia or odynophagia.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Non-healing Sores:</strong> Ulcers or lesions in the mouth lasting more than two weeks.</li>
          <li><strong>Pain or Bleeding:</strong> Persistent mouth pain, bleeding gums.</li>
          <li><strong>Difficulty Chewing/Swallowing:</strong> Dysphagia or odynophagia.</li>
          <li><strong>Lump or Thickening:</strong> In the cheek or lip.</li>
          <li><strong>Numbness:</strong> In the tongue or other areas of the mouth.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Sun Exposure:</strong> Specifically for lip cancers.</li>
          <li><strong>Oral Examination:</strong> Dentist or ENT specialist checks for lesions.</li>
          <li><strong>Biopsy:</strong> Excisional or incisional biopsy for histopathology.</li>
          <li><strong>Imaging:</strong> CT, MRI, or PET scans to stage the tumor.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgery:</strong> Wide local excision or partial mandibulectomy/maxillectomy depending on location.</li>
          <li><strong>Radiation Therapy:</strong> Often combined with chemotherapy for advanced disease.</li>
          <li><strong>Targeted Therapy:</strong> Cetuximab for certain squamous cell carcinomas.</li>
          <li><strong>Reconstruction &amp; Rehabilitation:</strong> Speech and swallowing therapy if large areas are removed.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Prognosis depends on stage and exact site. Early detection improves survival and functional outcomes. Regular dental check-ups and avoiding tobacco/alcohol are key preventive measures.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/head-and-neck/patient/oral-cavity-treatment-pdq" target="_blank">NCI: Oral Cavity Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/oral-cavity-and-oropharyngeal-cancer.html" target="_blank">ACS: Oral Cavity &amp; Oropharyngeal Cancer</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>


<!-- Liver Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="liver-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSB9bg9cQMmEMOGKMw46LMvTCwWU2pEfximsw&s"
      class="card-img-top"
      alt="Liver Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Liver Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A malignancy originating in the liver, often associated with chronic liver disease and cirrhosis.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Liver cancer typically refers to **hepatocellular carcinoma (HCC)**, which arises from liver cells (hepatocytes). Less common primary liver cancers include **intrahepatic cholangiocarcinoma** (bile duct cancer within the liver). Chronic liver inflammation or damage is the main driver behind most liver cancers.

        <br /><br /><strong>Risk Factors &amp; Causes:</strong>
        <ul>
          <li><strong>Chronic Hepatitis B or C:</strong> Long-standing viral infections lead to cirrhosis and DNA damage.</li>
          <li><strong>Cirrhosis:</strong> From alcohol abuse, nonalcoholic fatty liver disease (NAFLD), or autoimmune hepatitis.</li>
          <li><strong>Aflatoxin Exposure:</strong> Toxins produced by certain molds on improperly stored grains/nuts.</li>
          <li><strong>Metabolic Disorders:</strong> Hemochromatosis, alpha-1 antitrypsin deficiency.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Abdominal Pain &amp; Swelling:</strong> Particularly in the upper right quadrant.</li>
          <li><strong>Jaundice:</strong> Yellowing of the skin and eyes due to bilirubin buildup.</li>
          <li><strong>Unintended Weight Loss &amp; Fatigue:</strong> General signs of advanced disease.</li>
          <li><strong>Appetite Loss &amp; Nausea:</strong> Common in cirrhosis progression.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Imaging:</strong> Ultrasound, CT, or MRI with liver protocol to detect lesions.</li>
          <li><strong>Blood Tests:</strong> Alpha-fetoprotein (AFP) can be elevated in HCC.</li>
          <li><strong>Liver Biopsy:</strong> Confirms malignancy if imaging is inconclusive.</li>
          <li><strong>Staging Workup:</strong> Assesses tumor size, vascular invasion, and extrahepatic spread.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgical Resection:</strong> Removing part of the liver if the tumor is localized and function is adequate.</li>
          <li><strong>Liver Transplantation:</strong> An option for early-stage HCC in cirrhotic patients.</li>
          <li><strong>Locoregional Therapies:</strong> Ablation (RFA), chemoembolization (TACE), or radioembolization (TARE).</li>
          <li><strong>Targeted Therapies:</strong> Sorafenib, lenvatinib, and others for advanced disease.</li>
          <li><strong>Immunotherapy:</strong> Checkpoint inhibitors (e.g., nivolumab, pembrolizumab) in advanced settings.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Prognosis depends on tumor stage, liver function, and overall health. Early detection in cirrhotic patients via surveillance ultrasound can significantly improve outcomes. Ongoing follow-up is crucial to detect recurrence or manage complications of underlying liver disease.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/liver" target="_blank">NCI: Liver Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/liver-cancer.html" target="_blank">ACS: Liver Cancer</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Lung Cancer (Non-Small Cell, Small Cell, etc.) -->
<div class="col-md-4 mb-4 article-card" data-category="lung-cancer">
  <div class="card">
    <img
      src="https://www.parkwaycancercentre.com/images/default-source/cancer-type/screenshot-2024-01-29-at-10-15-12-am.webp?sfvrsn=ae80a749_1"
      class="card-img-top"
      alt="Lung Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Lung Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A group of malignancies in the lungs, including Non-Small Cell, Small Cell, and rarer pediatric or inflammatory tumors.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Lung cancer is broadly categorized into **Non-Small Cell Lung Cancer (NSCLC)** and **Small Cell Lung Cancer (SCLC)**. Rare forms include **Pleuropulmonary Blastoma** (in children), **Pulmonary Inflammatory Myofibroblastic Tumor**, and **Tracheobronchial Tumors** (benign or malignant growths in the airways).

        <br /><br /><strong>Types &amp; Subtypes:</strong>
        <ul>
          <li><strong>Non-Small Cell Lung Cancer (NSCLC):</strong> Includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Accounts for ~85% of lung cancers.</li>
          <li><strong>Small Cell Lung Cancer (SCLC):</strong> Aggressive, often metastatic at diagnosis, strongly linked to smoking.</li>
          <li><strong>Pleuropulmonary Blastoma:</strong> A rare pediatric tumor, arising in lung parenchyma or pleural surfaces.</li>
         </ul>

        <strong>Risk Factors:</strong>
        <ul>
          <li><strong>Smoking:</strong> The primary cause of both NSCLC and SCLC.</li>
          <li><strong>Secondhand Smoke:</strong> Also raises risk.</li>
          <li><strong>Occupational Exposures:</strong> Asbestos, radon, silica, or other carcinogens.</li>
          <li><strong>Genetic Predisposition:</strong> Family history and certain gene mutations (EGFR, ALK, ROS1, etc.).</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Persistent Cough:</strong> May produce blood-tinged sputum.</li>
          <li><strong>Shortness of Breath &amp; Wheezing:</strong> Especially if airways are obstructed.</li>
          <li><strong>Chest Pain:</strong> Worsens with deep breathing or coughing.</li>
          <li><strong>Fatigue &amp; Weight Loss:</strong> General cancer symptoms.</li>
          <li><strong>Recurrent Pneumonia or Bronchitis:</strong> Due to airway obstruction.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Imaging:</strong> Chest X-ray, CT scan, or MRI to identify lesions.</li>
          <li><strong>Biopsy:</strong> Bronchoscopy, CT-guided needle biopsy, or surgical resection for tissue diagnosis.</li>
          <li><strong>Molecular Testing:</strong> EGFR, ALK, KRAS, ROS1, etc. to guide targeted therapies.</li>
          <li><strong>Staging:</strong> PET scan, bone scan, or mediastinoscopy for nodal involvement.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgery:</strong> Lobectomy, pneumonectomy, or segmentectomy in early-stage NSCLC.</li>
          <li><strong>Radiation Therapy:</strong> Definitive or palliative, often combined with chemotherapy.</li>
          <li><strong>Chemotherapy:</strong> Platinum-based regimens for SCLC or advanced NSCLC.</li>
          <li><strong>Targeted Therapy:</strong> EGFR inhibitors (erlotinib), ALK inhibitors (crizotinib), etc. for specific mutations.</li>
          <li><strong>Immunotherapy:</strong> PD-1/PD-L1 inhibitors (nivolumab, pembrolizumab) for advanced disease.</li>
          </ul>


        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/lung" target="_blank">NCI: Lung Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/lung-cancer.html" target="_blank">ACS: Lung Cancer</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Lymphoma -->
<div class="col-md-4 mb-4 article-card" data-category="lymphoma">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQTMOV9NlvCdcig6oqYjvd-8iJWRR2vyyCEOw&s"
      class="card-img-top"
      alt="Lymphoma"
    />
    <div class="card-body">
      <h5 class="card-title">Lymphoma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A cancer of the lymphatic system, categorized broadly into Hodgkin and Non-Hodgkin Lymphoma.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Lymphoma originates in lymphocytes (a type of white blood cell) within the lymphatic system. It can spread to lymph nodes, spleen, bone marrow, and other organs. Two main categories exist: **Hodgkin Lymphoma (HL)** and **Non-Hodgkin Lymphoma (NHL)**.

        <br /><br /><strong>Types:</strong>
        <ul>
          <li><strong>Hodgkin Lymphoma (HL):</strong> Characterized by Reed-Sternberg cells. Often affects younger adults, with high cure rates.</li>
          <li><strong>Non-Hodgkin Lymphoma (NHL):</strong> More common, diverse subtypes (e.g., diffuse large B-cell, follicular, T-cell lymphomas).</li>
        </ul>

        <strong>Risk Factors:</strong>
        <ul>
          <li><strong>Immunodeficiency:</strong> HIV/AIDS, immunosuppressive therapy.</li>
          <li><strong>Autoimmune Disorders:</strong> Rheumatoid arthritis, Sjögren’s syndrome.</li>
          <li><strong>Viral Infections:</strong> EBV (Hodgkin, Burkitt lymphoma), HTLV-1, Hepatitis C.</li>
          <li><strong>Age &amp; Gender:</strong> NHL more common in older adults; HL often in young adults.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Lymph Node Swelling:</strong> Neck, armpit, or groin lumps, often painless.</li>
          <li><strong>B Symptoms:</strong> Fever, night sweats, weight loss.</li>
          <li><strong>Fatigue &amp; Weakness:</strong> From anemia or immune dysfunction.</li>
          <li><strong>Abdominal Pain or Fullness:</strong> If abdominal lymph nodes are enlarged.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Physical Exam:</strong> Check for lymphadenopathy or organomegaly.</li>
          <li><strong>Biopsy:</strong> Excisional lymph node biopsy to confirm subtype (HL vs. NHL).</li>
          <li><strong>Imaging:</strong> CT, PET scans for staging and extent of disease.</li>
          <li><strong>Blood Tests:</strong> LDH, CBC, flow cytometry to assess cell markers.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Chemotherapy:</strong> CHOP, ABVD, or other regimens depending on subtype.</li>
          <li><strong>Radiation Therapy:</strong> Often combined with chemo for HL or localized NHL.</li>
          <li><strong>Targeted Therapy:</strong> Rituximab for B-cell lymphomas, Brentuximab for HL.</li>
          <li><strong>Stem Cell Transplant:</strong> For relapsed or refractory disease.</li>
          <li><strong>Immunotherapy:</strong> CAR T-cell therapy in certain aggressive or refractory lymphomas.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Many lymphomas, especially Hodgkin and certain NHL subtypes, have high cure rates with modern treatments. Prognosis varies by subtype, stage, and patient factors. Long-term monitoring is vital to detect relapse and manage late effects.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/lymphoma" target="_blank">NCI: Lymphoma</a></li>
          <li><a href="https://www.cancer.org/cancer/lymphoma.html" target="_blank">ACS: Lymphoma</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>
<!-- Male Breast Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="male-breast-cancer">
  <div class="card">
    <img
      src="https://max-website20-images.s3.ap-south-1.amazonaws.com/male_breast_cancer_23_2149055244_b9813da9b8.jpg"
      class="card-img-top"
      alt="Male Breast Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Male Breast Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare form of breast cancer that occurs in men, often diagnosed at later stages due to lack of awareness.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Male breast cancer develops in the small amount of breast tissue found in men. Though less common than female breast cancer, it can be equally serious. Men typically present at a later stage, partly because they may not suspect breast-related issues.

        <br /><br /><strong>Risk Factors:</strong>
        <ul>
          <li><strong>Genetic Mutations:</strong> BRCA1/BRCA2 greatly increase risk.</li>
          <li><strong>Family History:</strong> Breast cancer in male or female relatives.</li>
          <li><strong>Hormonal Imbalances:</strong> Elevated estrogen, Klinefelter syndrome (XXY).</li>
          <li><strong>Liver Disease:</strong> Can affect hormone metabolism.</li>
          <li><strong>Age &amp; Radiation Exposure:</strong> Older men or those with prior chest radiation.</li>
          <li><strong>Swollen Lymph Nodes:</strong> In the armpit or around the collarbone.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Lump in the Breast:</strong> Usually under the nipple/areola.</li>
          <li><strong>Nipple Changes:</strong> Retraction, discharge (often bloody), or redness.</li>
          <li><strong>Skin Changes:</strong> Dimpling, scaling, or ulceration.</li>
          <li><strong>Swollen Lymph Nodes:</strong> In the armpit or around the collarbone.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Clinical Breast Exam &amp; Imaging:</strong> Mammography, ultrasound.</li>
          <li><strong>Biopsy:</strong> Core needle biopsy to confirm malignancy and subtype.</li>
          <li><strong>Hormone Receptor &amp; HER2 Testing:</strong> Determines treatment approach.</li>
          <li><strong>Genetic Testing:</strong> If strong family history or suspicion of BRCA mutation.</li>
          <li><strong>Radiation:</strong> Post-surgery to lower recurrence risk.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgery:</strong> Mastectomy is common; lumpectomy is less frequent.</li>
          <li><strong>Hormone Therapy:</strong> Tamoxifen or aromatase inhibitors if ER/PR positive.</li>
          <li><strong>Chemotherapy:</strong> For advanced or aggressive tumors.</li>
          <li><strong>Genetic Testing:</strong> If strong family history or suspicion of BRCA mutation.</li>
          <li><strong>Targeted Therapy:</strong> HER2-targeted drugs (e.g., trastuzumab) if HER2 positive.</li>
          <li><strong>Radiation:</strong> Post-surgery to lower recurrence risk.</li>

        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Prognosis depends on the stage and tumor biology. Early detection is crucial but often delayed due to lack of awareness. Regular follow-up includes imaging and physical exams to detect recurrence.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/breast/male-breast-cancer" target="_blank">NCI: Male Breast Cancer</a></li>
          <li><a href="https://www.cancer.org/cancer/breast-cancer-in-men.html" target="_blank">ACS: Breast Cancer in Men</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Melanoma -->
<div class="col-md-4 mb-4 article-card" data-category="skin-cancer">
  <div class="card">
    <img
      src="https://b693896.smushcdn.com/693896/wp-content/uploads/2020/07/waiting-even-month-remove-melanoma-deadly-mooresville-dermatology-center-300x166.jpg?lossy=1&strip=1&webp=1"
      class="card-img-top"
      alt="Melanoma"
    />
    <div class="card-body">
      <h5 class="card-title">Melanoma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        An aggressive skin cancer originating in melanocytes, the pigment-producing cells of the skin.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Melanoma is less common than other skin cancers (basal or squamous cell) but more likely to spread if not caught early. It arises from melanocytes, which produce the pigment melanin that gives skin its color.

        <br /><br /><strong>Risk Factors:</strong>
        <ul>
          <li><strong>UV Exposure:</strong> Excessive sunlight or tanning beds.</li>
          <li><strong>Fair Skin &amp; Light Eyes:</strong> Less natural protection against UV rays.</li>
          <li><strong>Family History:</strong> Inherited mutations (e.g., CDKN2A).</li>
          <li><strong>Numerous or Dysplastic Moles:</strong> Higher risk if you have many atypical moles.</li>
          <li><strong>Immunosuppression:</strong> Organ transplant recipients, HIV-positive individuals.</li>
        </ul>

        <strong>Symptoms &amp; Detection:</strong>
        <ul>
          <li><strong>A-B-C-D-E Rule:</strong> Asymmetry, Border irregularity, Color variation, Diameter &gt;6mm, Evolving moles.</li>
          <li><strong>Itching or Bleeding Moles:</strong> Can signal malignant change.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Skin Exam:</strong> By dermatologist using dermoscopy.</li>
          <li><strong>Excisional Biopsy:</strong> Entire mole removed for pathological analysis.</li>
          <li><strong>Breslow Thickness &amp; Staging:</strong> Depth of melanoma is crucial for prognosis.</li>
          <li><strong>Imaging (CT/PET):</strong> If suspicion of spread.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgical Excision:</strong> Wide local excision with margins.</li>
          <li><strong>Sentinel Lymph Node Biopsy:</strong> Checks for regional spread.</li>
          <li><strong>Immunotherapy:</strong> PD-1/CTLA-4 inhibitors (e.g., nivolumab, ipilimumab).</li>
          <li><strong>Targeted Therapy:</strong> BRAF/MEK inhibitors if tumor has BRAF mutation.</li>
          <li><strong>Radiation Therapy:</strong> For unresectable or metastatic lesions, sometimes palliative.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Early-stage melanoma is highly curable with surgery. Advanced cases may respond to immunotherapy or targeted treatments. Lifelong skin checks are recommended to catch new or recurrent lesions early.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/skin/melanoma" target="_blank">NCI: Melanoma</a></li>
          <li><a href="https://www.cancer.org/cancer/melanoma-skin-cancer.html" target="_blank">ACS: Melanoma Skin Cancer</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Melanoma, Intraocular (Eye) -->
<div class="col-md-4 mb-4 article-card" data-category="eye-cancer">
  <div class="card">
    <img
      src="https://treatcancer.com/wp-content/uploads/2015/10/bigoleye-1.jpg"
      class="card-img-top"
      alt="Melanoma, Intraocular (Eye)"
    />
    <div class="card-body">
      <h5 class="card-title">Melanoma, Intraocular (Eye)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare melanoma arising in the uveal tract of the eye (iris, ciliary body, or choroid), potentially affecting vision.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Intraocular (uveal) melanoma is the most common primary eye cancer in adults, though still relatively rare compared to cutaneous melanoma. It arises from melanocytes in the iris, ciliary body, or choroid.

        <br /><br /><strong>Risk Factors:</strong>
        <ul>
          <li><strong>Light Eye Color:</strong> Blue or green eyes have a slightly higher risk.</li>
          <li><strong>Genetic Alterations:</strong> Mutations in GNAQ, GNA11, or BAP1 genes.</li>
          <li><strong>Ocular Melanocytosis:</strong> Preexisting pigmented lesions in the eye.</li>
          <li><strong>UV Exposure:</strong> Possible contributing factor, though less established than for skin melanoma.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Visual Changes:</strong> Blurred vision, floaters, or flashes of light.</li>
          <li><strong>Dark Spots on the Iris:</strong> Possibly visible externally.</li>
          <li><strong>Peripheral Vision Loss:</strong> If the tumor grows large or affects the retina.</li>
          <li><strong>Asymptomatic:</strong> Many are found incidentally during routine eye exams.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Dilated Eye Exam:</strong> Ophthalmoscopy to visualize choroidal lesions.</li>
          <li><strong>Ultrasound of the Eye:</strong> Measures tumor size and location.</li>
          <li><strong>Fluorescein Angiography:</strong> Examines the blood supply to the lesion.</li>
          <li><strong>Biopsy (Rare):</strong> Only done if diagnosis is uncertain.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Radiation Therapy:</strong> Plaque brachytherapy or proton beam therapy.</li>
          <li><strong>Enucleation:</strong> Surgical removal of the eye for large or advanced tumors.</li>
          <li><strong>Laser Therapy:</strong> Transpupillary thermotherapy for small lesions.</li>
          <li><strong>Systemic Therapy:</strong> Immunotherapy or targeted drugs if metastatic.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Smaller tumors treated early often preserve vision. However, metastasis (especially to the liver) can occur, so ongoing monitoring is vital. Regular eye exams and imaging help detect progression or recurrence.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/eye/patient/intraocular-melanoma-treatment-pdq" target="_blank">NCI: Intraocular (Uveal) Melanoma</a></li>
          <li><a href="https://www.cancer.org/cancer/eye-cancer/about/what-is-eye-cancer.html" target="_blank">ACS: Eye Cancer Overview</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Merkel Cell Carcinoma (Skin Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="skin-cancer">
  <div class="card">
    <img
      src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQdPAAiKrDvufEW3WGBIgi_YcdGwyCDaMjuBw&s"
      class="card-img-top"
      alt="Merkel Cell Carcinoma"
    />
    <div class="card-body">
      <h5 class="card-title">Merkel Cell Carcinoma (Skin Cancer)</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare, aggressive skin cancer originating in Merkel cells, often associated with Merkel cell polyomavirus.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Merkel Cell Carcinoma (MCC) is a neuroendocrine skin cancer that grows quickly and can spread to lymph nodes or distant sites. Most cases are linked to the Merkel cell polyomavirus, and it commonly affects older or immunocompromised patients.

        <br /><br /><strong>Risk Factors:</strong>
        <ul>
          <li><strong>Merkel Cell Polyomavirus:</strong> Detected in the majority of MCC tumors.</li>
          <li><strong>UV Exposure:</strong> Chronic sun exposure significantly increases risk.</li>
          <li><strong>Immunosuppression:</strong> Organ transplant recipients, HIV-positive patients.</li>
          <li><strong>Age &amp; Fair Skin:</strong> Primarily occurs in older adults with lighter skin tones.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Firm, Painless Lesion:</strong> Red or purple nodule, often on sun-exposed areas (head, neck, arms).</li>
          <li><strong>Rapid Growth:</strong> Lesion can enlarge over weeks to months.</li>
          <li><strong>Ulceration or Bleeding:</strong> Advanced lesions may break down.</li>
          <li><strong>Lymph Node Involvement:</strong> Swollen nodes in the draining region.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Skin Biopsy:</strong> Histopathology shows neuroendocrine features (CK20+, etc.).</li>
          <li><strong>Imaging:</strong> CT or PET scans to check for spread.</li>
          <li><strong>Viral Testing:</strong> Can confirm Merkel cell polyomavirus association.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgical Excision:</strong> Wide local excision with clear margins.</li>
          <li><strong>Radiation Therapy:</strong> Often recommended post-surgery to reduce recurrence.</li>
          <li><strong>Immunotherapy:</strong> PD-1/PD-L1 inhibitors (e.g., avelumab, pembrolizumab) show success.</li>
          <li><strong>Chemotherapy:</strong> Sometimes used for advanced disease, though immunotherapy is preferred.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        MCC is aggressive, but early detection and combined modality treatment can improve outcomes. Frequent follow-up is essential due to the high risk of local recurrence and distant metastases.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/skin/merkel-cell" target="_blank">NCI: Merkel Cell Carcinoma</a></li>
          <li><a href="https://www.cancer.org/cancer/merkel-cell-skin-cancer.html" target="_blank">ACS: Merkel Cell Carcinoma</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Malignant Mesothelioma -->
<div class="col-md-4 mb-4 article-card" data-category="mesothelioma">
  <div class="card">
    <img
      src="https://my.clevelandclinic.org/-/scassets/images/org/health/articles/22432-mesothelioma-157430514"
      class="card-img-top"
      alt="Malignant Mesothelioma"
    />
    <div class="card-body">
      <h5 class="card-title">Malignant Mesothelioma</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare, aggressive cancer that develops in the mesothelial lining of the lungs, abdomen, or heart.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Malignant mesothelioma most commonly arises in the pleura (lining of the lungs) but can also affect the peritoneum, pericardium, or tunica vaginalis. It is strongly associated with asbestos exposure and can have a long latency period (20–50 years).

        <br /><br /><strong>Risk Factors &amp; Causes:</strong>
        <ul>
          <li><strong>Asbestos Exposure:</strong> The primary risk factor; occupational or environmental.</li>
          <li><strong>Long Latency:</strong> Decades can pass between exposure and disease onset.</li>
          <li><strong>Genetic Predisposition:</strong> Rare familial cases linked to BAP1 mutations.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Shortness of Breath &amp; Chest Pain:</strong> Due to pleural thickening or effusion.</li>
          <li><strong>Chronic Cough:</strong> May mimic other respiratory conditions.</li>
          <li><strong>Abdominal Pain &amp; Swelling:</strong> In peritoneal mesothelioma.</li>
          <li><strong>Fatigue &amp; Weight Loss:</strong> General signs of advanced disease.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Imaging:</strong> Chest X-ray, CT scan, or PET scan to identify lesions.</li>
          <li><strong>Biopsy:</strong> Thoracoscopic or laparoscopic biopsy for histopathological confirmation.</li>
          <li><strong>Biomarkers:</strong> Mesothelin-related peptides (e.g., SMRP) can support diagnosis.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgery:</strong> Extrapleural pneumonectomy or pleurectomy/decortication in selected cases.</li>
          <li><strong>Chemotherapy:</strong> Often pemetrexed plus cisplatin or carboplatin.</li>
          <li><strong>Radiation Therapy:</strong> May be used post-surgery or for palliation.</li>
          <li><strong>Immunotherapy:</strong> Checkpoint inhibitors (nivolumab, pembrolizumab) in advanced or refractory disease.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Prognosis is often poor, but early detection and aggressive multimodal therapy can improve outcomes. Ongoing surveillance is crucial to manage recurrences or complications.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/mesothelioma" target="_blank">NCI: Malignant Mesothelioma</a></li>
          <li><a href="https://www.cancer.org/cancer/malignant-mesothelioma.html" target="_blank">ACS: Mesothelioma</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Metastatic Cancer -->
<div class="col-md-4 mb-4 article-card" data-category="metastatic-cancer">
  <div class="card">
    <img
      src="https://via.placeholder.com/350x200?text=Metastatic+Cancer"
      class="card-img-top"
      alt="Metastatic Cancer"
    />
    <div class="card-body">
      <h5 class="card-title">Metastatic Cancer</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        Cancer that has spread from the primary site to distant organs or tissues, also known as Stage IV cancer.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Metastatic cancer refers to malignancies that have spread beyond their original (primary) site to other parts of the body (secondary sites). This spread occurs via the bloodstream or lymphatic system. Common metastatic sites include bones, liver, lungs, and brain.

        <br /><br /><strong>Mechanisms of Spread:</strong>
        <ul>
          <li><strong>Lymphatic Spread:</strong> Cancer cells enter lymphatic vessels and travel to lymph nodes or beyond.</li>
          <li><strong>Hematogenous Spread:</strong> Cells enter the bloodstream to reach distant organs.</li>
          <li><strong>Transcoelomic Spread:</strong> Direct seeding in body cavities (e.g., peritoneum).</li>
        </ul>

        <strong>Common Symptoms (Depending on Metastasis Site):</strong>
        <ul>
          <li><strong>Bone:</strong> Pain, fractures, high calcium levels.</li>
          <li><strong>Liver:</strong> Jaundice, abdominal swelling, elevated liver enzymes.</li>
          <li><strong>Lung:</strong> Shortness of breath, persistent cough, chest discomfort.</li>
          <li><strong>Brain:</strong> Headaches, seizures, neurological deficits.</li>
        </ul>

        <strong>Diagnosis &amp; Staging:</strong>
        <ul>
          <li><strong>Imaging:</strong> CT, MRI, PET scans to locate metastatic lesions.</li>
          <li><strong>Biopsy of Metastatic Site:</strong> Confirms that the tumor cells match the primary cancer.</li>
          <li><strong>Tumor Markers &amp; Blood Tests:</strong> May help track progression.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Systemic Therapies:</strong> Chemotherapy, targeted therapy, immunotherapy to address widespread disease.</li>
          <li><strong>Local Control:</strong> Surgery or radiation for symptomatic metastases (e.g., bone metastasis causing pain).</li>
          <li><strong>Supportive &amp; Palliative Care:</strong> Pain management, nutritional support, psychosocial care.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Prognosis depends on the primary cancer type, number and location of metastases, and overall patient health. Metastatic cancer is typically considered advanced, but new targeted and immunotherapies can significantly extend survival and quality of life.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/metastatic" target="_blank">NCI: Metastatic Cancer Overview</a></li>
          <li><a href="https://www.cancer.org/treatment/understanding-your-diagnosis/advanced-cancer.html" target="_blank">ACS: Advanced Cancer</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Metastatic Squamous Neck Cancer with Occult Primary (Head and Neck Cancer) -->
<div class="col-md-4 mb-4 article-card" data-category="head-neck-cancer">
  <div class="card">
    <img
      src="https://via.placeholder.com/350x200?text=Metastatic+Squamous+Neck+Cancer"
      class="card-img-top"
      alt="Metastatic Squamous Neck Cancer with Occult Primary"
    />
    <div class="card-body">
      <h5 class="card-title">Metastatic Squamous Neck Cancer with Occult Primary</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A condition where squamous cell carcinoma is found in cervical lymph nodes, but the primary tumor site is unknown.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Metastatic squamous neck cancer with occult primary means squamous cell carcinoma has spread to lymph nodes in the neck, yet imaging and endoscopic evaluations cannot locate the original tumor site. It’s a subset of head and neck cancers.

        <br /><br /><strong>Possible Sites &amp; Theories:</strong>
        <ul>
          <li><strong>Oropharynx (Tonsils/Base of Tongue):</strong> Common “hidden” location, especially if HPV-related.</li>
          <li><strong>Nasopharynx or Hypopharynx:</strong> Harder to visualize lesions.</li>
          <li><strong>Regressed Primary:</strong> The tumor may have spontaneously regressed or be too small to detect.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Neck Lump:</strong> Enlarged cervical lymph node, typically painless.</li>
          <li><strong>Sore Throat or Ear Pain:</strong> Referred pain via cranial nerves.</li>
          <li><strong>Dysphagia or Odynophagia:</strong> If lymph node compression or oropharyngeal subsite is involved.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Physical Exam &amp; Endoscopy:</strong> Nasopharyngoscopy, laryngoscopy to check for hidden lesions.</li>
          <li><strong>Imaging:</strong> CT/MRI/PET scans of the head and neck region.</li>
          <li><strong>Fine Needle Aspiration (FNA) or Excisional Biopsy:</strong> Confirms squamous cell histology.</li>
          <li><strong>HPV or EBV Testing:</strong> Oropharyngeal or nasopharyngeal involvement suspicion.</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Surgery (Neck Dissection):</strong> Removes affected lymph nodes.</li>
          <li><strong>Radiation Therapy:</strong> Directed at likely mucosal sites plus the neck region.</li>
          <li><strong>Chemotherapy:</strong> Combined with radiation for advanced nodal disease.</li>
          <li><strong>HPV-Related Cases:</strong> May have better response to chemo-radiation.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        Prognosis varies with the extent of nodal disease and potential HPV status. Even if the primary remains undiscovered, appropriate treatment of the neck and possible oropharyngeal region can lead to good outcomes. Frequent surveillance is needed to detect any emergent primary tumor.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/head-and-neck/patient/metastatic-squamous-neck-cancer-occult-primary-pdq" target="_blank">NCI: Metastatic Squamous Neck Cancer with Occult Primary</a></li>
          <li><a href="https://www.cancer.org/cancer/head-neck-cancer.html" target="_blank">ACS: Head &amp; Neck Cancers</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

<!-- Midline Tract Carcinoma With NUT Gene Changes -->
<div class="col-md-4 mb-4 article-card" data-category="nut-carcinoma">
  <div class="card">
    <img
      src="https://via.placeholder.com/350x200?text=NUT+Carcinoma"
      class="card-img-top"
      alt="Midline Tract Carcinoma With NUT Gene Changes"
    />
    <div class="card-body">
      <h5 class="card-title">Midline Tract Carcinoma With NUT Gene Changes</h5>
      <!-- Short Text (Visible by default) -->
      <p class="card-text short-text">
        A rare and aggressive cancer driven by NUT gene rearrangements, typically arising in midline structures.
      </p>
      <!-- Full Text (Initially hidden) -->
      <p class="card-text full-text" style="display: none;">
        <strong>Overview:</strong><br />
        Midline Tract Carcinoma with NUT gene changes (NUT carcinoma) is a rare, highly aggressive squamous cell cancer characterized by **rearrangements involving the NUT gene** (commonly BRD4-NUT fusion). It often appears in the nasopharynx, oropharynx, or other thoracic midline locations.

        <br /><br /><strong>Risk Factors &amp; Genetics:</strong>
        <ul>
          <li><strong>NUT Gene Rearrangements:</strong> BRD4-NUT or BRD3-NUT are the most common fusions.</li>
          <li><strong>Age:</strong> Can occur at any age, but often in adolescents or young adults.</li>
          <li><strong>Environmental/Lifestyle Factors:</strong> Not well defined due to rarity; genetic driver is the main cause.</li>
        </ul>

        <strong>Symptoms:</strong>
        <ul>
          <li><strong>Rapidly Growing Tumor:</strong> May present with neck mass, nasal obstruction, or chest symptoms.</li>
          <li><strong>Persistent Pain:</strong> Head, neck, or chest discomfort depending on tumor location.</li>
          <li><strong>Weight Loss &amp; Fatigue:</strong> Common in advanced disease.</li>
        </ul>

        <strong>Diagnosis:</strong>
        <ul>
          <li><strong>Biopsy &amp; Histopathology:</strong> Confirms squamous differentiation.</li>
          <li><strong>NUT Immunohistochemistry:</strong> A specific test to detect NUT protein overexpression.</li>
          <li><strong>Genetic Testing (FISH or PCR):</strong> Identifies the NUT gene fusion partner (BRD4, BRD3, etc.).</li>
        </ul>

        <strong>Treatment:</strong>
        <ul>
          <li><strong>Aggressive Multimodal Approach:</strong> Surgery, chemotherapy, and radiation.</li>
          <li><strong>Targeted Therapies:</strong> BET inhibitors (e.g., bromodomain inhibitors) are under investigation.</li>
          <li><strong>Clinical Trials:</strong> Due to rarity, enrollment in specialized trials is often recommended.</li>
        </ul>

        <strong>Prognosis &amp; Follow-up:</strong><br />
        NUT carcinoma is highly aggressive with poor prognosis if not treated promptly and aggressively. Early recognition and specialized treatment in tertiary centers can improve survival. Lifelong monitoring is critical to detect recurrence.

        <strong>References:</strong>
        <ol>
          <li><a href="https://www.cancer.gov/types/head-and-neck/hp/nut-midline-carcinoma-pdq" target="_blank">NCI: NUT Midline Carcinoma</a></li>
          <li><a href="https://www.cancer.org/cancer/nut-midline-carcinoma.html" target="_blank">ACS: NUT Carcinoma</a></li>
        </ol>
      </p>
      <button class="btn btn-primary read-more-btn">Read More</button>
    </div>
  </div>
</div>

  </div>
  
  
  
</div>




  
</div>


  <!-- Modal for Logout -->
  <div
    class="modal fade"
    id="staticBackdrop"
    data-bs-backdrop="static"
    data-bs-keyboard="false"
    tabindex="-1"
    aria-labelledby="staticBackdropLabel"
    aria-hidden="true"
  >
    <div class="modal-dialog">
      <div class="modal-content">
        <div class="modal-body">
          Are you sure you want to log out?
        </div>
        <div class="modal-footer">
          <button type="button" class="btn btn-secondary" data-bs-dismiss="modal">
            Cancel
          </button>
          <button type="button" class="btn btn-danger">Log Out</button>
        </div>
      </div>
    </div>
  </div>

  <script>
    // "Read More" Toggle (unchanged)
    document.querySelectorAll('.read-more-btn').forEach(button => {
      button.addEventListener('click', () => {
        const cardBody = button.closest('.card-body');
        const shortText = cardBody.querySelector('.short-text');
        const fullText = cardBody.querySelector('.full-text');
        
        if (window.getComputedStyle(fullText).display === 'none') {
          fullText.style.display = 'block';
          shortText.style.display = 'none';
          button.textContent = 'Show Less';
        } else {
          fullText.style.display = 'none';
          shortText.style.display = 'block';
          button.textContent = 'Read More';
        }
      });
    });
    document.getElementById("searchInput").addEventListener("input", function() {
	const query = this.value.toLowerCase().trim();
	const articles = document.querySelectorAll(".article-card");
	let matchedCount = 0;
	let firstHeading = "";
  
	articles.forEach(function(article) {
	  // Grab the h5 inside this article card
	  const h5Element = article.querySelector("h5");
	  if (!h5Element) {
		// If no <h5> found, hide the article
		article.style.display = "none";
		return;
	  }
  
	  const h5Text = h5Element.textContent.toLowerCase();
  
	  // Check if the query is in the h5 text
	  if (h5Text.includes(query)) {
		article.style.display = "block";
		// If it's the first match, store its heading text
		if (matchedCount === 0) {
		  firstHeading = h5Element.textContent;
		}
		matchedCount++;
	  } else {
		article.style.display = "none";
	  }
	});
  
	// Update the heading at the top or show "No results"
	const topHeadingContainer = document.getElementById("topHeading");
	const noResultsContainer = document.getElementById("noResults");
  
	if (matchedCount > 0) {
	  topHeadingContainer.textContent = firstHeading;
	  noResultsContainer.style.display = "none";
	} else {
	  topHeadingContainer.textContent = "Result Not Found";
	  noResultsContainer.style.display = "block";
	}
  });
  
  


  document.addEventListener("DOMContentLoaded", function() {
    const searchInput = document.getElementById("searchInput");
    const placeholderText = "Search for articles by keywords or categories...";
    let currentIndex = 0;
    
    function typePlaceholder() {
      if (currentIndex <= placeholderText.length) {
        searchInput.placeholder = placeholderText.substring(0, currentIndex);
        currentIndex++;
        setTimeout(typePlaceholder, 50); // Adjust speed (in ms) as desired
      }
    }
    typePlaceholder();
  });
</script>

  <!-- Footer -->
  <footer class="footer">
    <div class="footer-grid">
      <div class="footer-about">
        <div class="footer-logo">MediMind AI</div>
        <p>Revolutionizing healthcare through artificial intelligence and machine learning technologies.</p>
        <div class="footer-social">
          <a href="https://www.facebook.com/profile.php?id=61570853281295"><i class="fab fa-facebook-f"></i></a>
         
          <a href="https://www.linkedin.com/in/nikhil-bharti-063b9a225/"><i class="fab fa-linkedin-in"></i></a>
          <a href="https://www.instagram.com/ni.kh.il__18/"><i class="fab fa-instagram"></i></a>
        </div>
      </div>
      <div class="footer-links">
        <h3>Quick Links</h3>
        <ul>
          <li><a href="index.html">Home</a></li>
          <li><a href="about.html">About Us</a></li>
          <li><a href="E-healthcare.html">Services</a></li>
          <li><a href="emergency.html">Emergency</a></li>
          <li><a href="contact.html">Contact</a></li>
        </ul>
      </div>
     
      <div class="footer-links">
        <h3>Contact Us</h3>
        <ul>
          <li><i class="fas fa-map-marker-alt"></i> Nadaun Himachal Pradesh India</li>
          <li><i class="fas fa-phone"></i> +91 6230979061</li>
          <li><i class="fas fa-envelope"></i> nikhilbharti594@gmail.com</li>
        </ul>
      </div>
    </div>
    <div class="footer-bottom">
      <p>&copy; 2025 MediMind AI. All rights reserved. | <a href="privacy.html">Privacy Policy</a> | <a href="terms.html">Terms of Service</a></p>
    </div>
  </footer>

</body>
</html>
